Extinction of Cocaine Self-Administration Induces Metaplasticity in Nucleus Accumbens by Roberts-Wolfe, Douglas J.
Medical University of South Carolina 
MEDICA 
MUSC Theses and Dissertations 
2017 
Extinction of Cocaine Self-Administration Induces Metaplasticity 
in Nucleus Accumbens 
Douglas J. Roberts-Wolfe 
Medical University of South Carolina 
Follow this and additional works at: https://medica-musc.researchcommons.org/theses 
Recommended Citation 
Roberts-Wolfe, Douglas J., "Extinction of Cocaine Self-Administration Induces Metaplasticity in Nucleus 
Accumbens" (2017). MUSC Theses and Dissertations. 377. 
https://medica-musc.researchcommons.org/theses/377 
This Dissertation is brought to you for free and open access by MEDICA. It has been accepted for inclusion in 
MUSC Theses and Dissertations by an authorized administrator of MEDICA. For more information, please contact 
medica@musc.edu. 








Extinction of Cocaine Self-Administration Induces  




Douglas J Roberts-Wolfe 
 
 
A dissertation submitted to the faculty of the Medical University of South Carolina in partial fulfillment 
of the requirements for the degree of Doctor of Philosophy in the College of Graduate Studies. 
 





Approved by:  
 
Chairman, Advisory Committee 
Peter Kalivas, PhD  

















	   	  
	   ii	  
Table	  of	  Contents	  
Table	  of	  Contents	  ....................................................................................................................	  ii	  
Table	  of	  figures	  ......................................................................................................................	  iv	  
Acknowledgments	  ..................................................................................................................	  vi	  
Abstract	  ...............................................................................................................................	  viii	  
Chapter	  1	  Introduction	  ...........................................................................................................	  1	  
What	  is	  extinction?	  ..........................................................................................................................	  1	  
How	  do	  we	  study	  addiction?	  ............................................................................................................	  2	  
The	  mechanisms	  and	  measurement	  of	  glutamatergic	  neurotransmission	  .........................................	  6	  
What	  is	  nucleus	  accumbens	  (and	  its	  inputs	  and	  outputs)	  doing	  to	  promote	  or	  inhibit	  motivated	  
behavior?	  .......................................................................................................................................	  13	  
Nucleus	  accumbens	  core	  drives	  appetitive	  behavior	  ........................................................................	  13	  
Nucleus	  accumbens	  core	  suppresses	  behavior	  .................................................................................	  15	  
Nucleus	  accumbens	  shell	  suppresses	  appetitive	  behavior	  ................................................................	  18	  
Nucleus	  accumbens	  shell	  promotes	  behavior	  ...................................................................................	  27	  
Drugs	  of	  abuse	  induce	  synaptic	  plasticity	  in	  nucleus	  accumbens	  .....................................................	  30	  
Non-­‐contingent	  models	  .....................................................................................................................	  31	  
Self-­‐administration	  models	  ...............................................................................................................	  37	  
Transient	  synaptic	  potentiation	  during	  reinstatement	  of	  drug	  seeking	  ............................................	  39	  
Extinction	  training	  after	  drug	  self-­‐administration	  induces	  synaptic	  potentiation	  and/or	  
metaplasticity	  in	  nucleus	  accumbens	  .............................................................................................	  43	  
Chapter	  2	  Statement	  of	  the	  problem	  .....................................................................................	  44	  
Chapter	  3	  Methods	  ................................................................................................................	  45	  
Animals	  ..........................................................................................................................................	  45	  
Surgery	  ...........................................................................................................................................	  45	  
Behavior	  .........................................................................................................................................	  46	  
Self-­‐administration	  ............................................................................................................................	  46	  
Extinction/abstinence	  ........................................................................................................................	  46	  
Tests	  to	  assess	  transient	  synaptic	  potentiation	  (tSP)	  ........................................................................	  47	  
Tests	  to	  assess	  the	  necessity	  of	  adenosine	  A2a	  receptor	  in	  refraining	  behavior	  ..............................	  49	  
Electrophysiology	  ...........................................................................................................................	  49	  
Slice	  preparation	  ................................................................................................................................	  49	  
Recording	  ...........................................................................................................................................	  50	  
AMPA:NMDA	  ratio	  .............................................................................................................................	  51	  
AMPAR	  rectification	  index	  .................................................................................................................	  52	  
Spontaneous	  excitatory	  post-­‐synaptic	  currents	  ................................................................................	  53	  
Dendritic	  spine	  analysis	  ..................................................................................................................	  53	  
Zymography	  ...................................................................................................................................	  54	  
Statistics	  .........................................................................................................................................	  55	  
Electrophysiology	  ..............................................................................................................................	  55	  
Behavior	  .............................................................................................................................................	  55	  
Spines	  ................................................................................................................................................	  56	  
	   iii	  
General	  ..............................................................................................................................................	  56	  
Chapter	  4	  Transient	  synaptic	  potentiation	  (tSP)	  during	  refraining	  is	  distinct	  from	  
reinstatement	  tSP	  .................................................................................................................	  57	  
Introduction	  ...................................................................................................................................	  57	  
Results	  ...........................................................................................................................................	  60	  
Assessment	  of	  transient	  synaptic	  potentiation	  (tSP)	  during	  refraining	  and	  reinstatement	  ..............	  60	  
tSP	  (AMPA/NMDA	  increase)	  occurs	  in	  NA	  shell	  during	  refraining	  but	  not	  during	  reinstatement	  .....	  61	  
tSP	  occurs	  in	  NA	  core	  during	  reinstatement	  but	  not	  during	  refraining	  .............................................	  64	  
AMPA:NMDA	  ratio	  increases	  in	  NA	  core	  MSNs	  during	  15	  minutes	  of	  drug	  seeking	  ..........................	  65	  
NA	  core	  but	  not	  shell	  tSP	  is	  expressed	  as	  spine	  head	  expansion	  ......................................................	  66	  
Refraining	  does	  not	  increase	  gelatinase	  activity	  in	  NA	  shell	  .............................................................	  70	  
AMPARs	  incorporated	  into	  NA	  shell	  during	  refraining	  are	  not	  calcium	  permeable	  ..........................	  72	  
CP-­‐AMPARs	  are	  not	  inserted	  into	  NA	  shell	  MSNs	  during	  refraining	  as	  indicated	  by	  a	  lack	  of	  increase	  
in	  the	  rectification	  index	  (	  ..................................................................................................................	  73	  
Discussion	  ......................................................................................................................................	  73	  
Chapter	  5	  Extinction	  induces	  metaplasticity	  in	  accumbens	  core	  and	  shell	  ..............................	  77	  
Introduction	  ...................................................................................................................................	  77	  
Results	  ...........................................................................................................................................	  79	  
Assessment	  of	  transient	  synaptic	  potentiation	  (tSP)	  .........................................................................	  79	  
Extinction	  does	  not	  potentiate	  synapses	  in	  NA	  shell	  or	  NA	  core	  .......................................................	  81	  
Context-­‐induced	  drug	  seeking	  after	  abstinence	  does	  not	  induce	  AMPAR	  insertion	  in	  NA	  shell,	  NA	  
core,	  or	  dlCPu	  ....................................................................................................................................	  82	  
Cues	  do	  not	  rescue	  tSP	  during	  drug	  seeking	  after	  abstinence	  ..........................................................	  85	  
Discussion	  ......................................................................................................................................	  87	  
Chapter	  6	  Extinction	  enables	  D2-­‐MSN	  tSP,	  drug	  seeking	  induces	  D1-­‐MSN	  tSP	  .......................	  90	  
Introduction	  ...................................................................................................................................	  90	  
Results	  ...........................................................................................................................................	  92	  
Extinction	  attenuates	  cue-­‐induced	  drug	  seeking.	  .............................................................................	  92	  
Drug	  seeking	  causes	  transient	  synaptic	  potentiation	  in	  D1-­‐MSNs	  in	  NA	  coreregardless	  of	  extinction
	  ...........................................................................................................................................................	  95	  
D2-­‐MSN	  tSP	  occurs	  after	  extinction	  training	  .....................................................................................	  96	  
Drug	  seeking	  behavior	  is	  correlated	  with	  D1-­‐MSN	  AMPA:NMDA	  ratio	  only	  after	  extinction	  ...........	  98	  
Drug	  seeking	  induced	  by	  context	  alone	  selectively	  potentiates	  D1-­‐MSNs	  ........................................	  99	  
Refraining	  tSP	  in	  NA	  shell	  is	  expressed	  selectively	  on	  D2-­‐MSNs	  .....................................................	  102	  
Refraining	  and	  its	  associated	  tSP	  require	  adenosine	  A2a	  receptors	  ...............................................	  104	  
Discussion	  ....................................................................................................................................	  105	  
Chapter	  7	  General	  discussion	  and	  future	  directions	  .............................................................	  109	  
References	  ..........................................................................................................................	  119	  
	  
	   	  
	   iv	  
	  
Table	  of	  figures	  
Figure	  1-­‐1:	  Diagram	  integrating	  NA	  core	  circuitry,	  synaptic	  adaptations,	  and	  behavioral	  output.
	  ..............................................................................................................................................	  17	  
Figure	  1-­‐2.	  Diagram	  integrating	  NA	  shell	  circuitry,	  synaptic	  adaptations,	  and	  behavioral	  output.26	  
Figure	  3-­‐1.	  Behavioral	  paradigm	  for	  transient	  synaptic	  potentiation	  measurements.	  .................	  48	  
Figure	  4-­‐1.	  Behavioral	  design	  to	  assess	  transient	  synaptic	  potentiation	  after	  extinction.	  ............	  60	  
Figure	  4-­‐2.	  Self-­‐administration	  and	  extinction	  behavior.	  ..............................................................	  61	  
Figure	  4-­‐3.	  Refraining	  and	  cue-­‐induced	  drug	  seeking	  following	  extinction.	  .................................	  61	  
Figure	  4-­‐4.	  Transient	  synaptic	  potentiation	  (tSP)	  occurs	  in	  NA	  shell	  during	  refraining	  but	  not	  cue-­‐
induced	  drug	  seeking.	  ...........................................................................................................	  63	  
Figure	  4-­‐5.	  Transient	  synaptic	  potentiation	  (tSP)	  in	  NA	  shell	  is	  not	  associated	  with	  increased	  
sEPSC	  amplitude	  or	  frequency.	  .............................................................................................	  64	  
Figure	  4-­‐6.	  tSP	  occurs	  in	  NA	  core	  during	  cue-­‐induced	  reinstatement,	  but	  not	  refraining.	  ...........	  65	  
Figure	  4-­‐7.	  Transient	  synaptic	  potentiation	  (tSP)	  in	  NA	  core	  is	  not	  associated	  with	  increased	  
sEPSC	  amplitude	  or	  frequency.	  .............................................................................................	  66	  
Figure	  4-­‐8:	  Increased	  spine	  head	  diameter	  parallels	  increased	  AMPA:NMDA	  ratio	  during	  drug	  
seeking	  but	  not	  refraining.	  ....................................................................................................	  67	  
Figure	  4-­‐9.	  Spine	  density	  does	  not	  change	  during	  refraining	  or	  reinstatement	  in	  NA	  shell	  but	  	  
may	  change	  in	  NA	  core.	  ........................................................................................................	  69	  
Figure	  4-­‐10.	  Refraining	  tSP	  is	  not	  associated	  with	  matrix	  metalloproteinase	  (MMP)	  increases	  in	  
NA	  shell.	  ................................................................................................................................	  71	  
Figure	  4-­‐11.	  Refraining	  tSP	  is	  not	  driven	  by	  insertion	  of	  calcium	  permeable	  AMPARs.	  ................	  73	  
Figure	  5-­‐1.	  Experimental	  design	  for	  chapter	  2.	  ............................................................................	  79	  
Figure	  5-­‐2.	  Aggregated	  self-­‐administration	  data	  for	  all	  rats	  tested	  after	  abstinence.	  .................	  80	  
Figure	  5-­‐3.	  Drug	  seeking	  in	  rats	  after	  abstinence.	  .......................................................................	  81	  
Figure	  5-­‐4.	  Extinction	  does	  not	  cause	  constitutive	  synaptic	  potentiation.	  ..................................	  82	  
Figure	  5-­‐5.	  NA	  shell	  does	  not	  express	  tSP	  during	  drug	  seeking	  after	  abstinence.	  .......................	  83	  
Figure	  5-­‐6.	  NA	  core	  does	  not	  express	  tSP	  during	  drug	  seeking	  after	  abstinence.	  .......................	  84	  
Figure	  5-­‐7.	  Dorsolateral	  caudate	  putamen	  (dlCPu)	  does	  not	  express	  tSP	  during	  drug	  seeking	  
after	  abstinence.	  ..................................................................................................................	  85	  
Figure	  5-­‐8.	  NA	  core	  spines	  do	  not	  enlarge	  during	  drug	  seeking	  after	  abstinence.	  ......................	  86	  
Figure	  5-­‐9.	  NA	  core	  spine	  density	  may	  decrease	  during	  drug	  seeking	  after	  abstinence.	  ............	  86	  
Figure	  6-­‐1.	  Self-­‐administration	  and	  extinction	  data	  for	  mice.	  .....................................................	  93	  
Figure	  6-­‐2.	  Extinction	  attenuates	  cue-­‐induced	  drug	  seeking	  in	  mice.	  .........................................	  94	  
Figure	  6-­‐3.	  Extinction	  attenuates	  cue-­‐induced	  drug	  seeking	  in	  rats.	  ...........................................	  95	  
Figure	  6-­‐4.	  D1-­‐MSN	  tSP	  occurs	  during	  drug	  seeking	  and	  does	  not	  depend	  on	  prior	  extinction	  
training.	  ................................................................................................................................	  96	  
Figure	  6-­‐5.	  Extinction	  is	  necessary	  for	  D2-­‐MSN	  tSP	  during	  cue-­‐induced	  drug	  seeking.	  ...............	  97	  
Figure	  6-­‐6.	  tSP	  correlates	  with	  cue-­‐induced	  drug	  seeking	  after	  extinction.	  ................................	  98	  
	   v	  
Figure	  6-­‐7.	  tSP	  does	  not	  correlate	  with	  cue-­‐induced	  drug	  seeking	  after	  abstinence.	  .................	  99	  
Figure	  6-­‐8.	  Context	  alone	  induces	  drug	  seeking	  behavior	  in	  mice.	  ............................................	  100	  
Figure	  6-­‐9.	  Context	  induced	  drug	  seeking	  is	  also	  associated	  with	  tSP	  in	  D1-­‐MSNs	  but	  not	  D2-­‐
MSNs.	  .................................................................................................................................	  101	  
Figure	  6-­‐10.	  tSP	  does	  not	  correlate	  with	  context-­‐induced	  drug	  seeking	  after	  abstinence.	  .......	  102	  
Figure	  6-­‐11.	  NA	  shell	  MSNs	  undergo	  a	  transient	  synaptic	  re-­‐balancing	  during	  refraining	  that	  
favors	  D2-­‐MSN	  over	  D1-­‐MSN	  activation.	  ...........................................................................	  103	  
Figure	  6-­‐12.	  NA	  shell	  adenosine	  A2a	  receptors	  are	  necessary	  for	  refraining.	  ...........................	  105	  
Figure	  6-­‐13.	  Summary	  of	  transient	  synaptic	  potentiation	  (tSP)	  in	  D1-­‐MSNs	  and	  D2-­‐MSNs.	  .....	  106	  
Figure	  7-­‐1.	  Hypothesized	  mechanism	  inhibiting	  D2-­‐MSN	  tSP	  during	  drug	  seeking	  after	  
abstinence.	  .........................................................................................................................	  110	  
Figure	  7-­‐2.	  Hypothesized	  mechanism	  facilitating	  D2-­‐MSN	  tSP	  during	  drug	  seeking	  after	  
extinction.	  ..........................................................................................................................	  111	  
Figure	  7-­‐3.	  Mechanism	  of	  mGluR5	  induced	  depotentiation	  of	  D2-­‐MSNs.	  .................................	  112	  
	  
	   	  
	   vi	  
Acknowledgments	  
I	  thank	  my	  mentor,	  Dr.	  Peter	  Kalivas.	  I	  have	  been	  extremely	  fortunate	  to	  have	  the	  opportunity	  
to	  work	  with	  you,	  Peter.	  You	  have	  repeatedly	  inspired	  me	  with	  your	  combination	  of	  intuitive	  
leaps	  and	  linear	  stepwise	  thinking,	  your	  ability	  to	  simultaneously	  track	  the	  minute	  but	  critical	  
experimental	  details	  and	  the	  big	  picture	  of	  running	  a	  department	  and	  guiding	  the	  direction	  of	  
the	  field	  as	  a	  whole.	  The	  guidance	  I’ve	  received	  from	  you	  in	  the	  few	  brief	  years	  we’ve	  worked	  
together	  will	  influence	  the	  rest	  of	  my	  career,	  likely	  on	  every	  level.	  I	  have	  undoubtedly	  grown	  
under	  your	  direction,	  not	  only	  as	  a	  scientist	  but	  as	  a	  person.	  I	  cannot	  thank	  you	  enough	  for	  the	  
time	  we’ve	  spent	  together	  on	  these	  projects.	  
	  
I	  thank	  my	  committee;	  Dr.’s	  Colleen	  Hanlon,	  Tom	  Jhou,	  Patrick	  Mulholland,	  and	  John	  
Woodward.	  What	  an	  incredible	  team	  of	  scientists!	  Each	  one	  of	  your	  scientific	  careers	  is	  a	  power	  
of	  example,	  each	  of	  your	  scientific	  approaches	  is	  so	  different	  from	  the	  others,	  and	  each	  of	  you	  
is	  working	  tirelessly	  on	  the	  questions	  that	  may	  one	  day	  truly	  cure	  addiction.	  To	  be	  in	  the	  room	  
with	  you	  all	  during	  our	  meetings	  makes	  tangible	  why	  MUSC	  has	  such	  a	  strong	  reputation	  as	  a	  
world	  leader	  in	  this	  field.	  
	  
I	  thank	  my	  labmates	  in	  the	  Kalivas	  Lab.	  Our	  lab	  has	  a	  closeness	  more	  like	  a	  family	  than	  just	  a	  
workplace.	  This	  incredible	  group	  of	  people	  are	  there	  for	  each	  other	  in	  so	  many	  different	  ways.	  I	  
thank	  the	  various	  lab	  members	  who	  have	  mentored	  me	  in	  scientific	  methods	  –	  especially	  Yoni	  
Kupchik	  and	  Daniela	  Neuhofer,	  and	  also	  Mike	  Stefanik,	  and	  Cassie	  Gipson.	  I	  thank	  my	  
collaborators,	  whose	  contributions	  to	  this	  work	  made	  it	  possible,	  especially	  Ana	  Clara	  Bobadilla,	  
	   vii	  
and	  also	  Sade	  Spencer,	  Jasper	  Heinsbroek,	  and	  Alex	  Smith.	  I	  thank	  the	  wonderful	  students	  who	  
I’ve	  had	  a	  chance	  to	  work	  with:	  Emi	  Landry,	  Andrew	  Motts,	  Caleb	  Shields,	  and	  Kerry	  Wischusen.	  
I	  thank	  the	  talented	  lab	  managers	  who	  have	  kept	  the	  whole	  thing	  running:	  Charles	  Thomas	  and	  
Maddy	  Athreya.	  	  
	  
My	  greatest	  gratitude	  is	  to	  my	  family,	  who	  have	  unquestionably	  made	  the	  largest	  sacrifices	  and	  
contributions	  to	  my	  journey.	  My	  parents,	  Mary	  Wolfe	  and	  Tom	  Roberts.	  Your	  support	  and	  
generosity	  would	  require	  the	  remainder	  of	  this	  thesis	  to	  adequately	  describe.	  I	  will	  say	  only	  
how	  unusually	  lucky	  I	  am	  to	  be	  able	  to	  count	  you	  both	  among	  my	  closest	  friends.	  My	  daughter,	  
Lena	  Wolfe.	  I	  have	  never	  understood	  the	  meaning	  of	  “You	  are	  my	  sunshine”	  until	  I	  met	  you.	  
This	  work	  is	  for	  you,	  and	  I	  hope	  it	  will	  contribute	  in	  some	  small	  way	  to	  a	  better	  world	  when	  you	  
meet	  your	  own	  children	  (but	  no	  pressure).	  Most	  especially,	  my	  wonderful	  wife,	  Christine	  Wolfe.	  
Marrying	  you	  was	  the	  best	  decision	  I	  ever	  made.	  You	  are	  my	  co-­‐first	  author	  on	  this	  thesis,	  and	  
everything	  else	  to	  come.	   	  
	   viii	  
Abstract	  
Cocaine	  addiction	  remains	  a	  significant	  problem	  and	  is	  thought	  to	  be	  a	  disorder	  of	  
pathologically	  strong	  associations	  between	  environmental	  stimuli,	  motivated	  action,	  and	  drug	  
reward.	  Behavioral	  exposure	  therapies	  that	  repeatedly	  present	  the	  addicted	  patient	  with	  cues	  
but	  not	  drug	  could	  theoretically	  break	  this	  pathological	  association	  and	  enable	  addicts	  to	  
refrain	  from	  drug	  seeking.	  The	  neurobiological	  basis	  for	  the	  learned	  association	  between	  
environmental	  stimuli	  and	  drug	  seeking	  has	  been	  well	  characterized,	  especially	  regarding	  its	  
involvement	  of	  glutamatergic	  synaptic	  plasticity	  in	  the	  nucleus	  accumbens.	  The	  learning	  that	  
ultimately	  countermands	  the	  motivational	  value	  of	  the	  learned	  drug	  associations	  and	  leads	  to	  
patients	  refraining	  from	  drug	  seeking	  may	  likewise	  rely	  on	  glutamatergic	  synaptic	  plasticity	  in	  
nucleus	  accumbens.	  This	  therapeutic	  learning	  to	  inhibit	  drug	  seeking	  can	  be	  modeled	  in	  animals	  
by	  extinction	  training,	  in	  which	  an	  operant	  response	  (e.g.	  lever	  press)	  that	  previously	  delivered	  
drug	  fails	  to	  deliver	  a	  drug	  reinforcement,	  and	  animals	  gradually	  learn	  to	  refrain	  from	  emitting	  
the	  operant	  response.	  In	  the	  experiments	  contained	  in	  this	  thesis,	  I	  demonstrate	  that	  extinction	  
training	  induces	  a	  form	  of	  metaplasticity	  in	  D2	  dopamine	  receptor-­‐expressing	  medium	  spiny	  
neurons	  (D2-­‐MSNs).	  This	  enables	  D2-­‐MSNs	  to	  undergo	  transient	  synaptic	  potentiation	  (tSP)	  
when	  an	  animal	  is	  given	  the	  opportunity	  to	  seek	  drug,	  and	  the	  D2-­‐MSN	  potentiation	  suppresses	  
drug	  seeking.	  In	  contrast,	  D1-­‐MSN	  tSP	  underlies	  drug	  seeking	  and	  is	  not	  altered	  by	  extinction	  
training.	  Finally,	  tSP	  during	  refraining	  is	  distinct	  from	  tSP	  during	  reinstatement	  in	  its	  cellular	  
expression	  profile,	  anatomical	  locus,	  and	  signaling	  mechanisms.	  Overall,	  these	  findings	  suggest	  
that	  mechanisms	  supporting	  synaptic	  potentiation	  of	  D2-­‐MSNs	  may	  present	  therapeutic	  targets	  
for	  the	  treatment	  of	  cocaine	  addiction.	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Chapter	  1  Introduction	  
What	  is	  extinction?	  
Extinction	  is	  a	  form	  of	  learning	  that	  countermands,	  but	  does	  not	  erase,	  prior	  classical	  or	  
operant	  conditioning	  (Bouton,	  2002,	  2004).	  In	  this	  prior	  conditioning,	  a	  stimulus	  (the	  
“conditioned”	  stimulus	  in	  classical	  conditioning	  or	  the	  “discriminative”	  stimulus	  in	  operant	  
conditioning)	  becomes	  associated	  with	  an	  outcome	  or	  an	  unconditioned	  stimulus	  that	  has	  
intrinsic	  positive/rewarding	  or	  negative/punishing	  properties.	  Operant	  conditioning,	  the	  
primary	  subject	  of	  this	  dissertation,	  requires	  the	  conditionee	  to	  perform	  an	  action	  in	  the	  
presence	  of	  a	  discriminative	  stimulus.	  The	  outcome	  of	  this	  action	  either	  leads	  to	  the	  
conditionee	  repeating	  this	  action	  (in	  the	  case	  of	  reward)	  or	  avoiding	  it	  (in	  the	  case	  of	  
punishment).	  A	  change	  in	  action-­‐outcome	  association	  then	  modifies	  the	  likelihood	  of	  that	  
action	  being	  repeated.	  Extinction	  of	  reward	  seeking,	  in	  which	  the	  operant	  response	  no	  longer	  
results	  in	  reward,	  eventually	  leads	  to	  suppression	  of	  reward	  seeking.	  For	  the	  remainder	  of	  this	  
thesis,	  I	  will	  use	  the	  term	  “refraining”	  to	  refer	  to	  suppression	  of	  reward	  seeking	  induced	  by	  
extinction	  training.	  
	  
Importantly,	  extinction	  does	  not	  erase	  previous	  learning.	  The	  evidence	  for	  this	  is	  the	  fact	  that	  a	  
change	  in	  discriminative	  stimulus,	  context,	  or	  simply	  the	  passage	  of	  time	  is	  capable	  of	  reviving	  
the	  original	  behavior	  (technically,	  these	  three	  mechanisms	  of	  overriding	  extinction	  learning	  are	  
referred	  to	  as	  “reinstatement,”	  “renewal,”	  and	  “spontaneous	  recovery”	  –	  but	  I	  will	  use	  the	  term	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reinstatement	  henceforth).	  Reinstatement	  of	  the	  original	  association	  between	  the	  action	  and	  
outcome	  can	  re-­‐engage	  reward	  seeking,	  even	  after	  long	  periods	  of	  stable	  refraining.	  	  
	  
Behavioral	  therapies	  for	  treating	  addiction	  based	  on	  extinction	  training	  enjoyed	  some	  
popularity	  within	  the	  last	  decade	  before	  more	  recently	  falling	  out	  of	  favor.	  The	  reasons	  for	  the	  
failure	  of	  extinction-­‐based	  therapies	  are	  likely	  several.	  One	  reason	  is	  that	  these	  therapies,	  also	  
termed	  “cue	  exposure”	  therapies,	  are	  based	  on	  exposure	  therapies	  used	  to	  treat	  PTSD	  and	  
phobias.	  The	  difference	  between	  drug-­‐addicted	  patients	  and	  PTSD	  or	  phobia	  patients	  is	  that	  the	  
latter	  group	  is	  not	  repeatedly	  exposed	  to	  additional	  traumatic	  experiences	  (e.g.	  unconditioned	  
punishing	  stimuli	  or	  outcomes).	  If	  they	  were,	  the	  first	  step	  would	  be	  to	  protect	  them	  from	  
future	  trauma,	  rather	  than	  engage	  them	  in	  extensive	  exposure	  therapy.	  In	  contrast,	  the	  operant	  
response	  inherent	  in	  drug	  addiction	  is	  essentially	  always	  rewarded	  in	  real	  world	  situations,	  and	  
therefore	  cannot	  be	  extinguished.	  True	  extinction	  therapy	  would	  require	  a	  drug-­‐addicted	  
patient	  to	  take	  drugs	  without	  experiencing	  a	  reward.	  It	  is	  possible	  that	  the	  advent	  of	  successful	  
cocaine	  vaccines	  or	  cocaine	  hydrolases	  (Skolnick,	  2015)	  will	  one	  day	  accomplish	  this	  goal,	  and	  
truly	  enable	  extinction	  of	  not	  only	  cues	  but	  the	  operant	  response	  inherent	  in	  drug	  addiction.	  	  
	  
How	  do	  we	  study	  addiction?	  
Broadly,	  animal	  models	  of	  drug	  addiction	  involve	  either	  experimenter-­‐administered	  “non-­‐
contingent”	  drug	  exposure	  or	  drug	  “self-­‐administration”	  by	  the	  animal.	  Both	  involve	  
conditioning	  (classical	  in	  the	  case	  of	  experimenter	  administered	  drug,	  and	  operant	  in	  the	  case	  
of	  self-­‐administered	  drug).	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Drugs	  of	  abuse	  cause	  locomotor	  sensitization.	  A	  history	  of	  chronic	  drug	  exposure	  changes	  an	  
animal’s	  response	  to	  a	  “challenge”	  drug	  injection.	  The	  challenge	  injection	  elicits	  more	  
locomotor	  activity	  in	  drug-­‐exposed	  animals	  than	  drug-­‐naïve	  animals.	  Sensitization	  does	  not	  
require	  self-­‐administration,	  and	  is	  typically	  studied	  after	  non-­‐contingent	  drug	  administration,	  
but	  it	  can	  result	  from	  either	  administration	  route	  (Vezina,	  2004).	  Sensitization	  requires	  only	  one	  
prior	  exposure	  to	  the	  drug,	  provided	  that	  at	  least	  a	  week	  has	  elapsed	  since	  the	  previous	  
exposure	  (Valjent	  et	  al.,	  2010).	  The	  locomotor	  response	  to	  the	  drug-­‐associated	  context	  also	  
becomes	  sensitized	  and	  is	  then	  capable	  of	  driving	  enhanced	  locomotor	  activity	  independent	  of	  
the	  drug	  (Pierce	  et	  al.,	  1996;	  Whitaker	  et	  al.,	  2016),	  underscoring	  the	  importance	  of	  classical	  
conditioning	  in	  this	  model.	  	  	  	  	  
	  
The	  conditioned	  place	  preference	  model	  also	  involves	  non-­‐contingent	  drug	  administration.	  The	  
experimenter	  repeatedly	  administers	  drug	  in	  one	  chamber	  of	  a	  multi-­‐chamber	  test	  apparatus	  
and	  vehicle	  in	  a	  second	  chamber,	  then	  allows	  the	  animal	  to	  freely	  explore	  the	  two	  chambers	  on	  
a	  test	  day	  (when	  neither	  drug	  nor	  saline	  has	  been	  administered).	  A	  preference	  for	  the	  drug-­‐
paired	  or	  saline-­‐paired	  chamber	  indicates	  that	  the	  drug	  has	  rewarding	  or	  aversive	  qualities,	  
respectively.	  Thus	  the	  CPP	  model	  has	  an	  advantage	  over	  the	  sensitization	  model	  in	  assessing	  
reward.	  
	  
Self-­‐administration	  of	  drugs	  serves	  as	  the	  basis	  for	  all	  the	  remaining	  models	  described	  here.	  
Typically,	  drugs	  are	  self-­‐administered	  via	  a	  catheter	  inserted	  into	  the	  jugular	  vein,	  although	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other	  routes	  of	  self-­‐administration	  are	  sometimes	  used	  (Carroll	  et	  al.,	  1990).	  Operant	  actions,	  
such	  as	  lever	  presses	  or	  nose	  pokes,	  deliver	  a	  drug	  infusion,	  often	  paired	  with	  a	  discrete	  
compound	  cue	  (a	  combination	  of	  a	  light	  and	  a	  tone).	  	  
	  
Three	  important	  parameters	  of	  self-­‐administration	  distinguish	  various	  models.	  The	  first	  is	  the	  
length	  of	  the	  self-­‐administration	  sessions.	  “Short	  access”	  sessions	  last	  usually	  for	  around	  2	  
hours,	  while	  long	  access	  sessions	  last	  for	  6.	  Long	  access	  produces	  behavioral	  adaptations	  that	  
short	  access	  typically	  does	  not,	  for	  example,	  escalation	  of	  drug	  intake	  (Ahmed	  and	  Koob,	  1999).	  
	  
The	  second	  consideration	  is	  the	  schedule	  of	  reinforcement.	  Drug	  self-­‐administration	  studies	  
typically	  use	  one	  of	  two	  kinds	  of	  reinforcement	  schedules.	  The	  first	  is	  a	  fixed	  ratio	  schedule,	  in	  
which	  a	  fixed	  number	  of	  operant	  responses	  result	  in	  one	  drug	  infusion.	  The	  second	  is	  a	  
progressive	  ratio,	  in	  which	  each	  subsequent	  drug	  infusion	  requires	  an	  increasing	  number	  of	  
operant	  responses.	  The	  progressive	  ratio	  “breakpoint”,	  defined	  as	  the	  largest	  number	  of	  
operant	  responses	  completed,	  is	  a	  measure	  of	  the	  animal’s	  motivation	  to	  take	  drug.	  A	  more	  
nuanced	  and	  precise	  experimental	  design	  for	  measuring	  motivation	  is	  the	  “behavioral	  
economics”	  model	  (Bentzley	  et	  al.,	  2013;	  Bentzley	  et	  al.,	  2014),	  in	  which	  each	  lever	  press	  results	  
in	  an	  infusion	  but	  the	  dose	  of	  the	  infusions	  decrease	  progressively	  during	  sequential	  10	  minute	  
blocks.	  Behavioral	  economics	  mathematically	  disentangles	  motivation	  from	  non-­‐specific	  factors	  
such	  as	  tolerance.	  A	  variation	  on	  these	  assessments	  of	  motivation	  delivers	  a	  punishing	  stimulus	  
(e.g.	  a	  footshock	  with	  escalating	  intensity)	  simultaneously	  with	  a	  drug	  infusion.	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The	  third	  parameter	  of	  self-­‐administration	  is	  the	  inclusion	  of	  periods	  during	  which	  drug	  is	  
unavailable.	  “Time	  outs”	  can	  be	  included	  merely	  to	  protect	  the	  animal	  from	  inadvertently	  
overdosing,	  but	  some	  studies	  analyze	  time	  out	  responding	  to	  assess	  the	  animal’s	  level	  of	  
phenotypic	  “addiction”	  (Deroche-­‐Gamonet	  et	  al.,	  2004).	  
	  
Following	  self-­‐administration	  (and	  also	  non-­‐contingent	  administration),	  most	  studies	  include	  a	  
period	  of	  withdrawal	  from	  drug.	  During	  withdrawal,	  animals	  either	  engage	  in	  extinction	  training	  
or	  abstinent	  withdrawal	  in	  their	  home	  cage	  without	  return	  to	  the	  operant	  box	  (although	  other	  
designs	  are	  emerging	  which	  model	  voluntary	  abstinence	  (Caprioli	  et	  al.,	  2015)).	  	  
	  
Extinction	  training	  typically	  consists	  of	  unrewarded	  lever	  pressing,	  which	  occurs	  either	  in	  the	  
original	  self-­‐administration	  operant	  chamber	  but	  in	  the	  absence	  of	  contingent	  discrete	  cues	  or	  
in	  a	  new	  operant	  chamber	  in	  which	  contingent	  discrete	  cues	  are	  still	  delivered.	  Thus,	  along	  with	  
the	  operant	  response,	  either	  the	  cues	  or	  the	  context	  becomes	  extinguished.	  Subsequently,	  re-­‐
exposure	  to	  the	  non-­‐extinguished	  cue	  or	  context	  reinstates	  drug	  seeking.	  Drug-­‐seeking	  can	  also	  
be	  reinstated	  by	  a	  non-­‐contingent	  priming	  injection	  of	  the	  drug,	  or	  exposure	  to	  a	  stressor	  such	  
as	  yohimbine	  or	  a	  foot	  shock.	  Extinction	  training	  partly	  attenuates	  drug	  seeking	  (Buffalari	  et	  al.,	  
2013;	  Kim	  et	  al.,	  2015),	  relative	  to	  home	  cage	  abstinence.	  In	  contrast,	  a	  longer	  period	  of	  home	  
cage	  abstinence	  (<30	  days)	  combined	  with	  a	  history	  of	  long-­‐access	  cocaine	  exposure,	  causes	  
“incubation	  of	  craving”	  (Grimm	  et	  al.,	  2001),	  in	  which	  the	  magnitude	  of	  drug	  seeking	  behavior	  
increases	  relative	  to	  drug	  seeking	  evoked	  during	  early	  points	  of	  the	  withdrawal	  process.	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The	  mechanisms	  and	  measurement	  of	  glutamatergic	  neurotransmission	  
Glutamatergic	  neurotransmission	  in	  mammalian	  central	  synapses	  is	  most	  commonly	  studied	  by	  
examining	  excitatory	  post-­‐synaptic	  currents	  (EPSCs).	  A	  combination	  of	  clever	  techniques,	  
described	  below,	  enable	  researchers	  to	  mostly	  disentangle	  the	  contributions	  of	  signaling	  
mechanisms	  in	  different	  synaptic	  compartments	  contributing	  to	  the	  EPSC,	  such	  as	  
neurotransmitter	  packaging,	  release,	  and	  activation	  of	  receptors.	  However,	  the	  continued	  
development	  of	  complementary	  methodologies	  for	  studying	  glutamate	  (Xie	  et	  al.,	  2016)	  will	  
enhance	  our	  understanding	  of	  the	  specific	  loci	  of	  experience-­‐induced	  changes	  in	  glutamatergic	  
neurotransmission,	  such	  as	  exposure	  to	  drugs	  of	  abuse.	  
	  
All	  synaptic	  neurotransmission	  arguably	  begins	  with	  the	  packaging	  of	  neurotransmitter	  into	  
vesicles.	  These	  vesicles	  release	  neurotransmitter	  when	  they	  fuse	  with	  the	  cell	  membrane	  and	  
open	  a	  fusion	  pore	  (an	  single	  vesicle	  releasing	  neurotransmitter	  in	  this	  manner	  is	  called	  a	  
quantal	  event).	  The	  amount	  of	  neurotransmitter	  released	  during	  a	  quantal	  event	  depends	  both	  
on	  neurotransmitter	  packaging	  and	  the	  method	  of	  exocytosis.	  Both	  of	  these	  are,	  in	  turn,	  
affected	  by	  experimental	  conditions	  (Pothos	  et	  al.,	  1998).	  Unfortunately,	  direct	  measurement	  
of	  the	  amount	  of	  glutamate	  released	  during	  a	  quantal	  event	  remains	  difficult	  if	  not	  impossible,	  
and	  all	  of	  the	  studies	  cited	  here	  assume	  it	  remains	  constant.	  	  
	  
Bearing	  this	  assumption	  in	  mind,	  glutamate	  release	  depends	  on	  complex	  machinery	  that	  
contributes	  differentially	  to	  the	  various	  estimates	  of	  release	  probability	  derived	  from	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characteristics	  of	  the	  EPSC.	  There	  are	  arguably	  three	  such	  mechanisms	  of	  neurotransmitter	  
release	  (Kavalali,	  2015)	  that	  can	  be	  measured	  with	  one	  or	  more	  protocols.	  	  
	  
Synchronous	  evoked	  EPSCs	  (eEPSCs)	  result	  from	  optogenetic	  or	  electrical	  stimulation	  of	  several	  
glutamatergic	  terminals	  simultaneously,	  followed	  by	  the	  synchronous	  fusion	  of	  multiple	  vesicles	  
per	  terminal.	  The	  probability	  of	  evoked	  synchronous	  release	  can	  be	  measured	  by	  evoking	  two	  
EPSCs	  in	  quick	  succession	  (e.g.	  50	  msec	  apart)	  and	  dividing	  the	  amplitude	  of	  the	  second	  by	  the	  
amplitude	  of	  the	  first.	  The	  calcium	  influx	  leading	  to	  the	  first	  eEPSC	  results	  in	  an	  elevated	  level	  of	  
calcium	  within	  the	  terminal	  at	  the	  onset	  of	  the	  second	  eEPSC.	  The	  lower	  the	  release	  probability,	  
the	  more	  that	  elevated	  calcium	  baseline	  potentiates	  the	  release	  during	  the	  second	  eEPSC.	  As	  a	  
result,	  a	  higher	  paired	  pulse	  ratio	  implies	  a	  relatively	  low	  release	  probability	  (pre-­‐synaptic	  
depression)	  and	  vice	  versa.	  A	  second	  normalized	  measure	  of	  the	  probability	  of	  synchronous	  
evoked	  release	  is	  the	  coefficient	  of	  variation	  (CV).	  CV	  is	  calculated	  by	  dividing	  the	  square	  root	  of	  
the	  sample	  variance	  of	  eEPSC	  amplitude	  by	  the	  mean	  of	  eEPSC	  amplitude.	  Release	  failures	  will	  
increase	  the	  sample	  variance	  and	  therefore	  a	  low	  CV	  indicates	  high	  pre-­‐synaptic	  release	  
probability	  (pre-­‐synaptic	  potentiation)	  and	  vice	  versa.	  	  
	  
However,	  glutamate	  release	  can	  also	  occur	  in	  the	  absence	  of	  action	  potentials	  (e.g.	  determined	  
by	  adding	  a	  sodium	  channel	  blocker	  such	  as	  lidocaine	  or	  TTX).	  In	  this	  case,	  release	  is	  largely	  
quantal	  (Xu-­‐Friedman,	  2017),	  and	  gives	  rise	  to	  miniature	  EPSCs	  (mEPSCs).	  The	  frequency	  of	  
mEPSCs	  reflects	  the	  release	  probability.	  The	  third	  method	  of	  neurotransmitter	  release	  is	  
asynchronous	  evoked	  release,	  which	  is	  also	  more	  or	  less	  quantal.	  Two	  separate	  calcium	  sensors	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mediate	  the	  ability	  of	  action	  potentials	  (which	  can	  be	  evoked	  by	  optogenetic	  or	  electrical	  
stimulation)	  to	  increase	  release	  probability.	  Synchronous	  evoked	  release	  depends	  on	  a	  low	  
affinity	  calcium	  sensor	  that	  requires	  such	  high	  calcium	  concentrations	  that	  it	  is	  activated	  only	  
transiently,	  while	  asynchronous	  evoked	  release	  depends	  on	  a	  high	  affinity	  calcium	  sensor	  
whose	  activity	  is	  increased	  for	  a	  much	  longer	  period	  after	  terminal	  stimulation,	  and	  may	  
maintain	  some	  basal	  activity	  even	  when	  calcium	  homeostasis	  has	  been	  restored.	  Interfering	  
with	  the	  low	  affinity	  calcium	  sensor	  (using	  strontium)	  prevents	  synchronous	  evoked	  release	  but	  
not	  asynchronous	  evoked	  release	  (Bekkers	  and	  Clements,	  1999).	  The	  resulting	  asEPSCs	  can	  
therefore	  be	  thought	  of	  as	  an	  intermediate	  that	  includes	  the	  best	  of	  both	  worlds	  of	  
synchronous	  eEPSCs	  (in	  which	  the	  input	  is	  well-­‐characterized	  (e.g.	  by	  optogenetic	  stimulation),	  
but	  amplitude	  depends	  on	  many	  factors,	  including	  stimulation	  intensity)	  and	  mEPSCs	  (in	  which	  
the	  frequency	  and	  amplitude	  convey	  meaningful	  information,	  but	  the	  inputs	  are	  unspecified).	  	  
	  
After	  release,	  glutamate	  contacts	  post-­‐synaptic	  receptors	  through	  which	  EPSCs	  pass	  into	  the	  
post-­‐synaptic	  neuron.	  The	  number	  and/or	  permeability	  of	  these	  receptors	  determines	  the	  
amplitude	  of	  quantal	  events	  (e.g.	  mEPSCs	  or	  asEPSCs)	  but	  does	  not	  completely	  determine	  the	  
amplitude	  of	  eEPSCs	  (as	  mentioned	  above).	  The	  two	  primary	  ionotropic	  glutamate	  receptors	  
contributing	  to	  EPSCs	  are	  α-­‐amino-­‐3-­‐hydroxy-­‐5-­‐methyl-­‐4-­‐isoxazolepropionic	  acid	  receptors	  
(AMPARs)	  and	  N-­‐methyl-­‐d-­‐aspartate	  receptors	  (NMDARs).	  AMPARs	  are	  classically	  permeable	  to	  
sodium	  and	  potassium,	  are	  fully	  active	  at	  physiological	  (hyperpolarized)	  membrane	  potentials,	  
and	  depolarize	  the	  membrane	  potential	  when	  activated.	  NMDARs	  are	  additionally	  permeable	  
to	  calcium	  but	  are	  relatively	  impermeable	  at	  physiological	  membrane	  potentials	  due	  to	  the	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presence	  of	  a	  Mg++	  ion	  which	  blocks	  their	  pore	  (Mayer	  et	  al.,	  1984).	  These	  are	  classical	  
descriptions	  of	  AMPARs	  and	  NMDARs,	  which	  are	  subject	  to	  several	  exceptions.	  	  
	  
AMPARs	  can	  be	  calcium	  permeable	  (CP-­‐AMPARs).	  These	  CP-­‐AMPARs	  lack	  a	  GluA2	  subunit.	  The	  
role	  of	  CP-­‐AMPAR	  signaling	  in	  addiction	  is	  an	  active	  topic.	  CP-­‐AMPARs	  possess	  two	  key	  features	  
that	  distinguish	  them	  from	  calcium	  impermeable	  (CI)-­‐AMPARs	  (Liu	  and	  Cull-­‐Candy,	  2000).	  First,	  
CP-­‐AMPARs	  are	  inwardly	  rectifying,	  meaning	  that	  they	  pass	  inward	  current	  more	  effectively	  
than	  outward	  current,	  due	  the	  intracellular	  action	  of	  polyamines	  (which	  are	  
replaced/prevented	  from	  washing	  out	  during	  whole	  cell	  or	  single	  channel	  recordings	  by	  
inclusion	  of	  spermine	  in	  the	  internal	  solution).	  Second,	  they	  are	  selectively	  antagonized	  by	  
various	  compounds	  (e.g.	  philantotoxin,	  Naspm)	  that	  do	  not	  affect	  CI-­‐AMPARs.	  	  
	  
NMDARs’	  sensitivity	  to	  blockade	  by	  Mg++	  and	  permeability	  to	  Ca++	  also	  depends	  on	  their	  
subunit	  composition.	  After	  development,	  the	  majority	  of	  NMDARs	  are	  thought	  to	  be	  composed	  
of	  GluN1/GluN2A	  heterotetramers,	  with	  a	  minority	  of	  GluN1/GluN2B	  and	  
GluN1/GluN2A/GluN2B	  heterotetramers	  (Al-­‐Hallaq	  et	  al.,	  2007).	  However,	  exposure	  to	  drugs	  of	  
abuse	  causes	  incorporation	  of	  NMDARs	  that	  contain	  GluN2C/D	  subunits	  with	  decreased	  Mg++	  
binding	  (Joffe	  and	  Grueter,	  2016)	  and	  GluN3	  subunits	  that	  have	  decreased	  Ca++	  permeability	  
(Yuan	  et	  al.,	  2013).	  
	  
Considering	  the	  relationship	  between	  AMPAR	  and	  NMDAR	  currents	  also	  has	  advantages.	  As	  
mentioned	  above,	  the	  amplitude	  of	  quantal	  events	  is	  generally	  accepted	  as	  a	  measure	  of	  the	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number	  and/or	  permeability	  of	  ionotropic	  glutamate	  receptors,	  despite	  the	  fact	  that	  the	  
amount	  of	  glutamate	  released	  during	  a	  quantal	  event	  depends	  on	  glutamate	  packaging	  and	  the	  
method	  of	  glutamate	  exocytosis,	  which	  may	  be	  difficult	  to	  control	  for	  depending	  on	  the	  
experiment.	  One	  complementary	  method	  that	  circumvents	  this	  barrier	  relies	  on	  the	  analysis	  of	  
the	  ratio	  of	  AMPA:NMDA	  currents.	  To	  calculate	  this	  ratio,	  an	  experimenter	  records	  an	  average	  
dual-­‐component	  (AMPA	  +	  NMDA)	  eEPSC	  at	  depolarized	  holding	  potential	  (e.g.	  +40	  mV)	  in	  order	  
to	  relieve	  the	  Mg++	  blockade,	  then	  pharmacologically	  isolates	  one	  component	  (e.g.	  AMPA	  by	  
adding	  an	  NMDAR	  antagonist	  such	  as	  AP-­‐5),	  then	  subtracts	  the	  AMPAR	  current	  from	  the	  dual	  
current	  to	  calculate	  the	  NMDAR	  current.	  Theoretically,	  the	  AMPA:NMDA	  ratio	  (calculated	  by	  
dividing	  the	  peak	  amplitudes	  of	  the	  AMPAR	  current	  by	  the	  NMDAR	  current)	  is	  invariant	  to	  
artefacts	  introduced	  by	  the	  experimenter,	  and	  is	  assumed	  to	  primarily	  reflect	  changes	  in	  
AMPAR	  incorporation	  into	  synapses.	  	  
	  
Relying	  on	  the	  AMPA:NMDA	  ratio	  alone	  is	  problematic	  for	  a	  number	  of	  reasons.	  The	  first	  is	  that	  
post-­‐synaptic	  NMDARs	  can	  increase	  or	  decrease,	  for	  example	  after	  chronic	  exposure	  to	  drugs	  of	  
abuse	  (Huang	  et	  al.,	  2009)	  or	  electrical	  stimulation	  protocols	  	  (Kombian	  and	  Malenka,	  1994).	  In	  
theory,	  whether	  AMPARs	  or	  NMDARs	  are	  responsible	  for	  a	  change	  in	  AMPA:NMDA	  ratio	  can	  be	  
determined	  by	  examining	  mEPSCs	  or	  asEPSCs.	  Under	  physiological	  conditions,	  these	  quantal	  
amplitudes	  are	  determined	  by	  AMPARs,	  but	  quantal	  NMDAR	  EPSCs	  can	  also	  be	  measured	  with	  
the	  right	  experimental	  conditions	  (Thomas	  et	  al.,	  2001).	  Alternatively,	  glutamate	  uncaging	  onto	  
individual	  spines	  evokes	  uEPSCs	  that	  can	  be	  manipulated	  to	  reflect	  AMPAR	  and	  NMDAR	  
components	  (Bock	  et	  al.,	  2013).	  Both	  approaches	  have	  demonstrated	  that	  AMPAR	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incorporation	  often	  is	  the	  underlying	  mechanism	  behind	  AMPA:NMDA	  ratio	  increases	  resulting	  
from	  exposure	  to	  drugs	  of	  abuse.	  Another	  caveat	  to	  interpreting	  the	  AMPA:NMDA	  ratio	  
(recorded	  in	  the	  way	  described	  above)	  assumes	  that	  the	  blockade	  of	  NMDARs	  will	  not	  affect	  
release	  probability,	  which	  is	  probably	  wrong	  at	  least	  some	  of	  the	  time	  (Park	  et	  al.,	  2014).	  
	  
Considering	  the	  AMPAR	  and	  NMDAR	  currents	  together	  also	  allows	  for	  measurement	  of	  silent	  
synapses.	  Synaptic	  release	  is	  assumed	  to	  follow	  a	  binomial	  probability	  distribution.	  Binomial	  
distributions	  are	  modeled	  using	  two	  parameters	  that,	  in	  the	  case	  of	  synaptic	  release,	  
theoretically	  have	  physical	  meanings	  –	  p	  (release	  probability)	  and	  n	  (number	  of	  synapses).	  In	  
some	  experimental	  preparations	  the	  number	  of	  synapses	  can	  be	  assumed	  to	  remain	  constant,	  
and	  therefore	  changes	  in	  markers	  such	  as	  coefficient	  of	  variation	  (CV)	  and	  mEPSC	  frequency	  are	  
thought	  to	  represent	  changes	  only	  in	  release	  probability.	  However,	  LTP	  induction	  in	  a	  slice	  is	  
capable	  of	  decreasing	  AMPAR	  CV	  without	  affecting	  NMDAR	  CV.	  Since	  a	  change	  in	  release	  
probability	  would	  affect	  both,	  this	  suggests	  that	  the	  number	  of	  synapses	  contributing	  to	  the	  
AMPAR	  eEPSC	  can	  increase,	  without	  affecting	  the	  number	  of	  synapses	  contributing	  to	  the	  
NMDAR	  eEPSC.	  This,	  in	  turn,	  suggests	  that	  prior	  to	  the	  LTP	  induction,	  some	  synapses	  can	  
express	  NMDARs	  but	  not	  AMPARs,	  and	  are	  therefore	  functionally	  silent	  (Kullmann,	  1994).	  Thus	  
the	  AMPAR	  CV	  divided	  by	  the	  NMDAR	  CV	  is	  proportional	  to	  the	  number	  of	  silent	  synapses.	  
Silent	  synapses	  can	  also	  be	  measured	  using	  the	  minimal	  stimulation	  assay,	  in	  which	  stimulation	  
intensity	  is	  decreased	  to	  the	  point	  where	  failure	  to	  evoke	  AMPAR	  eEPSCs	  occurs	  during	  
approximately	  half	  of	  all	  trials.	  The	  AMPAR	  eEPSC	  failure	  rate	  (e.g.	  recorded	  at	  -­‐80	  mV)	  is	  then	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normalized	  to	  the	  dual	  current	  eEPSC	  failure	  rate	  (e.g.	  recorded	  at	  +40	  mV)	  and	  the	  ratio	  is	  
proportional	  to	  the	  number	  of	  silent	  synapses.	  	  
	  
As	  mentioned	  above,	  the	  binomial	  distribution	  model	  of	  synaptic	  release	  is	  determined	  by	  
release	  probability	  and	  the	  number	  of	  synaptic	  contacts.	  If	  the	  number	  of	  synaptic	  contacts	  is	  
assumed	  to	  be	  constant	  then	  measures	  of	  synaptic	  release	  (such	  as	  1/CV	  or	  mEPSC	  frequency)	  
primarily	  reflect	  release	  probability.	  This	  is	  probably	  a	  fair	  assumption	  in	  the	  case	  of	  some	  
experimental	  protocols,	  such	  as	  assessing	  whether	  a	  drug	  acts	  pre-­‐	  or	  post-­‐synaptically	  to	  alter	  
glutamate	  transmission.	  However,	  chronic	  in	  vivo	  exposure	  to	  drugs	  of	  abuse	  arguably	  has	  the	  
potential	  to	  alter	  either	  of	  these	  features.	  As	  a	  result,	  a	  change	  in	  synaptic	  transmission	  (e.g.	  
increased	  mEPSC	  frequency)	  in	  the	  absence	  of	  a	  change	  in	  release	  probability	  (e.g.	  decreased	  
PPR),	  implies	  an	  increase	  in	  the	  number	  of	  synaptic	  contacts.	  	  
	  
It	  is	  likely	  clear	  by	  now	  that	  EPSCs	  can	  imply	  a	  lot	  about	  glutamatergic	  transmission,	  but	  
definitive	  answers	  require	  complementary	  methodologies.	  For	  example,	  an	  increase	  in	  synaptic	  
contacts	  should	  go	  along	  with	  an	  increased	  density	  of	  dendritic	  spines.	  More	  silent	  synapses	  
should	  mean	  more	  thin	  spines	  in	  particular.	  Synaptic	  AMPAR	  incorporation,	  indicated	  by	  an	  
increase	  in	  AMPA:NMDA	  ratio	  and	  increase	  in	  mEPSC	  amplitude,	  should	  parallel	  an	  
enlargement	  of	  dendritic	  spines	  (which	  represent	  the	  post-­‐synaptic	  locus	  of	  the	  glutamatergic	  
synapse),	  and	  an	  increased	  response	  to	  glutamate	  uncaging	  at	  those	  spines.	  Increased	  release	  
probability	  should	  be	  revealed	  by	  shifts	  in	  the	  input	  output	  curve	  for	  fluorescent	  false	  
neurotransmitters	  (Pereira	  et	  al.,	  2016),	  or	  genetically	  encoded	  fluorescent	  reporters	  (Xie	  et	  al.,	  
	   13	  
2016).	  Ultimately	  studies	  incorporating	  these	  complementary	  methods	  may	  require	  a	  re-­‐
interpretation	  of	  the	  literature	  I	  have	  presented	  in	  this	  introduction.	  
What	  is	  nucleus	  accumbens	  (and	  its	  inputs	  and	  outputs)	  doing	  to	  promote	  or	  inhibit	  
motivated	  behavior?	  
Nucleus	  accumbens	  (NA)	  has	  at	  least	  two	  distinct	  compartments:	  NA	  core	  and	  shell	  (although	  at	  
least	  the	  shell	  likely	  has	  additional	  functional	  subcompartments).	  Whether	  neurons	  in	  these	  
two	  compartments	  promote	  or	  suppress	  reward	  seeking	  depends	  on	  several	  additional	  
considerations,	  including	  the	  nature	  of	  the	  reward	  (drug	  vs.	  natural	  reward),	  the	  component	  of	  
the	  seeking	  studied	  (initiation	  vs.	  maintenance),	  and	  the	  model	  or	  experimental	  paradigm	  (e.g.	  
the	  particular	  reinstating	  stimuli,	  incubation	  of	  craving,	  etc.).	  If	  we	  only	  consider	  the	  particular	  
self-­‐administration/extinction/reinstatement	  model	  of	  cocaine	  seeking	  used	  in	  my	  experiments,	  
it	  is	  safe	  to	  say	  that	  NA	  core	  mediates	  reinstatement	  of	  drug	  seeking	  and	  NA	  shell	  mediates	  
refraining.	  However,	  I	  have	  attempted	  to	  provide	  a	  broader	  description	  of	  the	  literature	  in	  this	  
introduction.	  	  
	  
Nucleus	  accumbens	  core	  drives	  appetitive	  behavior	  
NA	  core	  drives	  drug	  seeking	  across	  a	  variety	  of	  experimental	  paradigms	  and	  multiple	  classes	  of	  
drugs	  (Kalivas	  and	  McFarland,	  2003;	  Backstrom	  and	  Hyytia,	  2007;	  LaLumiere	  and	  Kalivas,	  2008;	  
Rocha	  and	  Kalivas,	  2010).	  NA	  core	  neurons	  broadly	  encode	  both	  sensory	  and	  motor	  
components	  of	  drug	  seeking.	  However,	  the	  most	  important	  contribution	  of	  these	  neurons	  is	  
likely	  that	  they	  drive	  the	  initiation	  of	  drug	  seeking	  rather	  than	  the	  maintenance.	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This	  was	  suggested	  by	  a	  study	  (Guillem	  et	  al.,	  2014)	  that	  disentangled	  the	  role	  of	  NA	  core	  and	  
shell	  in	  incubation	  of	  drug	  seeking.	  Rats	  self-­‐administered	  cocaine	  in	  long	  access	  (6	  hour)	  
sessions	  for	  16	  days,	  remained	  abstinent	  for	  30	  days	  and	  again	  self-­‐administered	  cocaine	  for	  8	  
days.	  Each	  self-­‐administration	  session	  began	  with	  a	  period	  of	  drug	  unavailability.	  During	  this	  
period,	  rats	  pressed	  the	  active	  lever	  but	  did	  not	  receive	  cocaine.	  The	  period	  of	  drug	  
unavailability	  ended	  after	  5	  unrewarded	  lever	  presses.	  The	  speed	  with	  which	  rats	  completed	  
these	  5	  presses	  served	  as	  a	  marker	  of	  craving.	  The	  speed	  with	  which	  rats	  completed	  the	  drug	  
unavailability	  period	  increased	  after	  30	  days	  of	  abstinence,	  demonstrating	  incubation	  of	  
craving.	  Progressive	  ratio	  breakpoint	  also	  increased,	  further	  confirming	  an	  increase	  in	  
motivated	  drug	  seeking	  after	  abstinence.	  In	  parallel,	  increased	  neurons	  in	  NA	  core	  encoded	  the	  
lever	  presses	  (both	  rewarded	  and	  unrewarded)	  and	  the	  cues.	  Neurons	  encoded	  for	  these	  
components	  by	  either	  increasing	  or	  decreasing	  their	  rate	  of	  firing.	  The	  increase	  in	  NA	  core	  
neurons	  encoding	  the	  unrewarded	  initial	  lever	  presses	  during	  the	  drug	  unavailability	  period	  
correlated	  strongly	  with	  the	  increased	  cocaine	  intake.	  However,	  the	  increased	  number	  of	  NA	  
core	  neurons	  encoding	  the	  cues	  and	  the	  rewarded	  lever	  presses	  during	  self-­‐administration	  did	  
not	  correlate	  with	  increased	  cocaine	  intake.	  This	  suggests	  that	  neurons	  in	  NA	  core	  are	  
responsive	  to	  many	  components	  of	  drug	  self-­‐administration,	  but	  their	  encoding	  of	  initiation	  
rather	  than	  maintenance	  predicts	  motivated	  behavior.	  	  
	  
The	  prelimbic	  prefrontal	  cortex	  (PL-­‐PFC)	  and	  basolateral	  amygdala	  (BLA)	  projections	  to	  NA	  core	  
also	  drive	  drug	  seeking	  (Stefanik	  and	  Kalivas,	  2013).	  One	  recent	  study	  to	  examine	  the	  PL-­‐PFC	  
projection	  to	  NA	  core	  used	  optogenetics	  to	  selectively	  stimulate	  terminal	  fields	  (Ma	  et	  al.,	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2014).	  The	  authors	  delivered	  an	  in	  vivo	  optogenetic	  LTD	  protocol	  that	  reversed	  the	  drug	  
induced	  adaptations	  induced	  by	  drug	  exposure	  in	  this	  projection,	  which	  in	  turn	  prevented	  
reinstatement.	  
	  
Nucleus	  accumbens	  core	  suppresses	  behavior	  
D2-­‐MSNs	  in	  NA	  core	  can	  suppress	  drug	  seeking.	  This	  is	  true	  for	  both	  the	  initiation	  and	  
maintenance	  phases	  of	  drug	  seeking.	  Mice	  expressing	  Cre	  under	  the	  control	  of	  the	  Drd2	  
promoter	  received	  infusions	  of	  Cre	  dependent	  hM4Di	  (inhibitory	  Gi-­‐DREADD).	  CNO	  was	  thus	  
capable	  of	  abolishing	  GABA	  release	  from	  D2-­‐MSN	  terminals	  in	  ventral	  pallidum.	  Systemic	  CNO	  
potentiated	  cue	  induced	  reinstatement,	  suggesting	  that	  D2-­‐MSNs	  are	  probably	  suppressing	  
reinstatement	  behavior	  even	  as	  it	  is	  ongoing	  (Heinsbroek	  et	  al.,	  2016).	  	  
	  
D2-­‐MSNs	  in	  NA	  core	  also	  suppress	  the	  maintenance	  of	  reward	  seeking	  (Bock	  et	  al.,	  2013).	  This	  
study	  calculated	  a	  “compulsivity”	  score	  based	  on	  animals’	  behavior	  during	  cocaine	  self-­‐
administration.	  The	  two	  behavioral	  features	  considered	  were	  perseverance	  (active	  lever	  
pressing	  during	  the	  periods	  of	  drug	  non-­‐availability)	  and	  motivation	  (progressive	  ratio	  
breakpoint).	  These	  features	  were	  z-­‐score	  transformed,	  and	  the	  z-­‐scores	  summed	  to	  create	  a	  
compulsivity	  score	  in	  which	  higher	  numbers	  indicated	  greater	  compulsivity.	  Potentiation	  of	  
synaptic	  inputs	  to	  D2-­‐MSNs	  showed	  a	  strong	  inverse	  correlation	  with	  compulsivity	  score,	  
whereas	  D1-­‐MSN	  synaptic	  inputs	  were	  unrelated	  to	  compulsivity.	  In	  mice	  whose	  D2-­‐MSNs	  
expressed	  Gi-­‐DREADD	  (via	  the	  adora2a	  promoter),	  systemic	  CNO	  increased	  progressive	  ratio,	  
demonstrating	  that	  D2-­‐MSNs	  suppress	  motivation	  to	  take	  drug.	  This	  was	  further	  demonstrated	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in	  the	  converse	  experiment,	  in	  which	  optogenetic	  excitation	  of	  D2-­‐MSNs	  decreased	  progressive	  
ratio	  breakpoint.	  Thus	  D2-­‐MSNs	  in	  NA	  core	  are	  both	  necessary	  and	  sufficient	  to	  suppress	  drug	  
seeking.	  Importantly,	  this	  study	  also	  demonstrated	  that	  NA	  core	  D2-­‐MSNs	  don’t	  affect	  food	  
self-­‐administration	  and	  that	  that	  dorsal	  striatal	  D2-­‐MSNs	  don’t	  influence	  cocaine	  self-­‐
administration.	  	  
	  
Both	  of	  these	  studies	  suggested	  but	  did	  not	  prove	  that	  D2-­‐MSNs	  suppress	  drug	  seeking	  via	  their	  
projections	  to	  ventral	  pallidum.	  However,	  lateral	  inhibition	  of	  D1-­‐MSNs	  by	  D2-­‐MSNs	  may	  also	  
have	  contributed	  to	  suppression	  of	  drug	  seeking	  (Dobbs	  et	  al.,	  2016).	  The	  authors	  of	  this	  study	  
generated	  a	  mouse	  line	  in	  which	  D2R	  dopamine	  receptors	  were	  knocked	  out	  of	  D2-­‐MSNs,	  by	  
crossing	  Adora2a-­‐Cre	  mice	  with	  Drd2	  loxP/loxP	  mice.	  Optogenetic	  activation	  of	  D2-­‐MSNs	  
laterally	  inhibited	  putative	  D1-­‐MSNs	  in	  a	  brain	  slice	  (decreased	  action	  potential	  firing	  evoked	  by	  
injected	  current,	  an	  effect	  which	  depended	  on	  GABAa	  receptors).	  This	  lateral	  inhibition	  (but	  not	  
downstream	  VP	  inhibition)	  could	  be	  prevented	  by	  specifically	  activating	  D2R	  receptors	  on	  D2-­‐
MSNs.	  The	  ability	  of	  cocaine	  to	  acutely	  increase	  locomotor	  activity	  required	  intact	  D2R	  signaling	  
in	  D2-­‐MSNs,	  and	  was	  thus	  likely	  primarily	  mediated	  by	  signaling	  in	  NA	  core	  rather	  than	  by	  
projections	  to	  VP.	  Although	  this	  study	  employed	  a	  different	  behavioral	  model,	  it	  suggests	  
possible	  mechanisms	  of	  action	  underlying	  the	  often	  overlooked	  ability	  of	  NA	  core	  D2-­‐MSNs	  to	  
suppress	  drug	  seeking.	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Figure	  1-­‐1:	  Diagram	  integrating	  NA	  core	  circuitry,	  synaptic	  adaptations,	  and	  behavioral	  output.	  
The	  initiation	  of	  drug	  seeking,	  when	  drug	  reward	  is	  unavailable,	  depends	  on	  specific	  synaptic	  
adaptations	  expressed	  on	  different	  MSN	  classes	  in	  NA	  core.	  Prelimbic	  prefrontal	  cortex	  (PL)	  
input	  to	  D1-­‐MSNs	  in	  NA	  core	  signals	  via	  calcium	  impermeable	  (CI)	  AMPARs	  to	  promote	  drug	  
seeking.	  AMPAR	  expression	  levels	  on	  D2-­‐MSNs	  are	  negatively	  correlated	  with	  drug	  seeking,	  but	  
these	  AMPARs’	  inputs	  and	  subunit	  composition	  are	  unknown.	  CP-­‐AMPARs	  mediate	  incubation	  of	  
drug	  seeking	  after	  long-­‐access	  self-­‐administration	  and	  extended	  withdrawal,	  but	  the	  pre-­‐
synaptic	  input	  and	  post-­‐synaptic	  MSN	  class	  in	  which	  these	  CP-­‐AMPARs	  are	  located	  remain	  
unknown.	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Nucleus	  accumbens	  shell	  suppresses	  appetitive	  behavior	  
NA	  shell	  suppresses	  reinstatement	  of	  cocaine	  seeking	  when	  activated	  by	  inputs	  from	  infralimbic	  
PFC	  (IL-­‐PFC)	  (Peters	  et	  al.,	  2008).	  IL-­‐PFC	  activity	  is	  necessary	  for	  refraining;	  inactivating	  IL-­‐PFC	  
spontaneously	  reinstates	  cocaine	  seeking	  in	  the	  absence	  of	  cues.	  IL-­‐PFC	  is	  also	  capable	  of	  
suppressing	  cocaine	  primed	  reinstatement,	  if	  directly	  activated	  (e.g.	  via	  microinjection	  of	  
AMPA).	  NA	  shell	  is	  similarly	  necessary	  for	  refraining	  (although	  bilateral	  inactivation	  of	  NA	  shell	  
also	  generally	  increases	  locomotor	  activity).	  The	  projection	  from	  IL-­‐PFC	  to	  NA	  shell	  is	  also	  likely	  
necessary	  for	  refraining,	  as	  reinstatement	  caused	  by	  unilateral	  NA	  shell	  inactivation	  was	  
potentiated	  by	  unilateral	  IL-­‐PFC	  inactivation.	  However,	  ipsilateral	  and	  contralateral	  inactivation	  
of	  IL-­‐PFC	  and	  NA	  shell	  reinstated	  drug	  seeking	  equally	  effectively,	  an	  unusual	  result	  in	  a	  
pharmacological	  disconnection	  study.	  The	  IL-­‐PFC	  to	  NA	  shell	  projection	  suppresses	  classical	  
reinstatement	  circuitry,	  including	  BLA	  and	  PL-­‐PFC	  (Stefanik	  and	  Kalivas,	  2013;	  Stefanik	  et	  al.,	  
2013),	  as	  IL-­‐PFC	  inactivation	  only	  induced	  drug	  seeking	  when	  these	  brain	  regions	  were	  capable	  
of	  activity.	  Extinction	  training	  may	  be	  necessary	  for	  the	  IL-­‐PFC	  to	  NA	  shell	  circuit	  to	  suppress	  
drug	  seeking,	  as	  inactivation	  of	  these	  structures	  did	  not	  affect	  drug	  seeking	  on	  the	  first	  day	  of	  
extinction.	  	  
	  
The	  ability	  of	  IL-­‐PFC	  to	  suppress	  drug	  seeking	  via	  inputs	  to	  NA	  shell	  is	  countermanded	  by	  
dopamine	  signaling	  (LaLumiere	  et	  al.,	  2012).	  In	  this	  study,	  IL-­‐PFC	  was	  activated	  by	  PEPA	  (a	  
positive	  allosteric	  modulator	  of	  AMPA	  receptors,	  which	  enhances	  rather	  than	  mimics	  glutamate	  
input	  (Sekiguchi	  et	  al.,	  2002)).	  IL-­‐PFC	  activation	  decreased	  cue-­‐induced	  reinstatement	  after	  
extinction.	  However,	  microinjections	  of	  dopamine	  into	  BLA,	  prelimbic	  PFC,	  or	  NA	  shell	  rescued	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reinstatement	  behavior	  from	  IL-­‐PFC	  activation.	  Dopamine	  microinjections	  into	  NA	  shell	  also	  
caused	  spontaneous	  reinstatement,	  consistent	  with	  previous	  findings	  (Schmidt	  et	  al.,	  2006).	  
Interestingly,	  VTA	  activation	  by	  microinjection	  of	  DAMGO	  neither	  spontaneously	  reinstated	  
drug	  seeking	  nor	  potentiated	  cue-­‐induced	  reinstatement,	  but	  did	  reversed	  the	  effect	  of	  IL-­‐PFC	  
activation.	  Thus,	  IL-­‐PFC	  activation	  might	  augment,	  rather	  than	  suppress,	  cue-­‐induced	  
reinstatement	  if	  VTA	  is	  simultaneously	  active	  (although	  this	  effect	  did	  not	  quite	  reach	  statistical	  
significance).	  	  
	  
These	  studies	  examined	  the	  IL-­‐PFC	  projection	  to	  NA	  shell	  after	  extinction,	  and	  suggested	  that	  
extinction	  training	  enabled	  this	  pathway	  to	  suppress	  drug	  seeking.	  However,	  it	  appears	  that	  a	  
period	  of	  extended	  withdrawal,	  with	  or	  without	  extinction	  training,	  is	  sufficient	  to	  imbue	  the	  IL-­‐
PFC	  to	  NA	  shell	  pathway	  with	  the	  ability	  to	  suppress	  drug	  seeking.	  The	  study	  mentioned	  above	  
(Ma	  et	  al.,	  2014)	  also	  used	  an	  in	  vivo	  optogenetic	  LTD	  protocol	  to	  interfere	  with	  the	  IL-­‐PFC	  
projection	  to	  NA	  shell.	  Strikingly,	  interfering	  with	  this	  projection	  potentiated	  incubation	  of	  
craving,	  demonstrating	  that	  this	  pathway	  suppresses	  drug	  seeking	  after	  a	  period	  of	  withdrawal	  
regardless	  of	  prior	  extinction	  training.	  This	  study	  further	  suggests	  that	  the	  IL-­‐PFC	  to	  NA	  shell	  
projection	  is	  actively	  suppressing	  drug	  seeking	  in	  this	  model,	  but	  is	  opposed	  by	  other	  more	  
influential	  projections	  that	  are	  simultaneously	  driving	  drug	  seeking.	  	  
	  
IL-­‐PFC	  to	  NA	  shell	  synapses	  responsible	  for	  suppressing	  initiation	  of	  cocaine	  seeking	  appear	  to	  
be	  located	  on	  D1-­‐MSNs	  (Pascoli	  et	  al.,	  2014).	  The	  IL-­‐PFC	  to	  NA	  shell	  D1-­‐MSN	  synapse	  is	  
potentiated	  after	  30	  days	  of	  abstinent	  withdrawal	  following	  cocaine	  self-­‐administration.	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Specifically	  reversing	  this	  potentiation	  via	  an	  LTD	  protocol	  increases	  lever	  pressing	  during	  a	  cue-­‐
induced	  reinstatement	  test.	  Interestingly,	  mice	  specifically	  increase	  inactive	  lever	  pressing,	  and	  
this	  could	  be	  attributed	  to	  generally	  increased	  locomotor	  activity	  (although	  this	  was	  not	  
tested).	  However,	  the	  LTD	  protocol	  employed	  in	  this	  study	  and	  the	  one	  describe	  above	  targeted	  
the	  same	  neural	  circuit	  and	  both	  protocols	  specifically	  removed	  calcium	  permeable	  AMPARs	  
(CP-­‐AMPARs)	  from	  IL-­‐PFC	  to	  NA	  shell	  synapses.	  CP-­‐AMPARs	  are	  inserted	  into	  IL-­‐PFC	  to	  NA	  shell	  
synapses	  on	  D1-­‐MSNs	  but	  not	  D2-­‐MSNs	  (Terrier	  et	  al.,	  2016).	  It	  is	  likely,	  therefore,	  that	  the	  LTD	  
protocol	  employed	  in	  the	  previous	  study	  (Ma	  et	  al.,	  2014)	  also	  enhanced	  drug	  seeking	  by	  
depotentiating	  IL-­‐PFC	  synapses	  selectively	  on	  D1-­‐MSNs.	  
	  
These	  studies	  suggest	  that	  unrewarded	  drug	  seeking	  is	  suppressed	  by	  the	  IL-­‐PFC	  to	  NA	  shell	  
pathway,	  but	  this	  also	  appears	  to	  be	  the	  case	  for	  unrewarded	  sucrose	  seeking	  (Ghazizadeh	  et	  
al.,	  2012).	  This	  study	  employed	  a	  discriminative	  stimulus	  model	  of	  sucrose	  seeking	  and	  
examined	  responses	  during	  the	  CS-­‐	  (the	  cue	  that	  predicted	  non-­‐availability	  of	  sucrose).	  Rats	  
learn	  to	  refrain	  from	  sucrose	  seeking	  during	  the	  CS-­‐	  after	  repeated	  unrewarded	  seeking.	  
Activity	  in	  IL-­‐PFC	  is	  necessary	  for	  refraining	  from	  sucrose	  seeking	  during	  the	  CS-­‐.	  Interestingly,	  
increased	  CS-­‐	  responding	  due	  to	  IL-­‐PFC	  inactivation	  requires	  dopamine	  signaling,	  and	  can	  be	  
blocked	  by	  systemically	  inactivating	  D1	  and	  D2	  receptors.	  IL-­‐PFC	  inactivation	  increases	  the	  
number	  of	  NA	  shell	  neurons	  encoding	  the	  CS-­‐	  and	  the	  unrewarded	  lever	  press,	  through	  a	  
mixture	  of	  phasic	  increases	  or	  decreases	  in	  firing.	  Some	  of	  the	  neurons	  newly	  recruited	  by	  IL-­‐
PFC	  inactivation	  to	  encode	  the	  CS-­‐	  are	  the	  same	  that	  encode	  the	  CS+.	  The	  CS+	  continues	  to	  
evoke	  sucrose	  seeking,	  and	  recruitment	  of	  the	  CS+	  encoding	  neurons	  to	  the	  CS-­‐	  may	  partly	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explain	  the	  loss	  of	  refraining	  during	  CS-­‐	  presentation	  after	  IL-­‐PFC	  inactivation.	  IL-­‐PFC	  
inactivation	  also	  decreased	  tonic	  activity	  in	  NA	  shell	  neurons,	  but	  this	  was	  selective	  for	  neurons	  
encoding	  stimuli	  by	  phasic	  reductions	  in	  firing.	  Overall,	  this	  suggests	  that	  IL-­‐PFC	  suppresses	  
unrewarded	  sucrose	  seeking	  by	  suppressing	  dopamine	  signaling.	  Dopamine,	  in	  turn,	  drives	  
unrewarded	  sucrose	  seeking	  by	  phasically	  exciting	  one	  group	  of	  neurons	  (likely	  D1-­‐MSNs)	  and	  
phasically	  and	  tonically	  inhibiting	  a	  separate	  population	  (likely	  D2-­‐MSNs).	  	  	  
	  
Before	  leaving	  the	  subject	  of	  the	  infralimbic	  projection	  to	  NA	  shell,	  it	  is	  worth	  considering	  two	  
points.	  The	  finding	  above,	  that	  ipsilateral	  and	  contralateral	  inactivation	  of	  IL-­‐PFC	  and	  NA	  shell	  
reinstated	  drug	  seeking	  equally	  (Peters	  et	  al.,	  2008),	  somewhat	  weakens	  the	  argument	  that	  IL-­‐
PFC	  and	  NA	  shell	  work	  in	  a	  single	  serial	  circuit	  to	  suppress	  drug	  seeking.	  One	  possible	  
explanation	  is	  that	  NA	  shell	  may	  not	  be	  the	  only	  projection	  target	  of	  IL-­‐PFC	  that	  is	  important	  for	  
suppression	  of	  drug	  seeking	  after	  extinction.	  For	  example,	  IL-­‐PFC	  projections	  to	  both	  NA	  shell	  
and	  also	  to	  dorsomedial	  hypothalamus	  suppress	  alcohol	  seeking	  after	  extinction	  (McNally,	  
2014),	  and	  it	  is	  possible	  that	  the	  same	  would	  hold	  true	  for	  other	  drugs	  of	  abuse.	  The	  second	  
point	  is	  that	  the	  infralimbic	  cortex	  is	  also	  capable	  of	  promoting	  drug	  seeking	  in	  the	  incubation	  
model,	  which	  does	  not	  involve	  extinction	  training	  (Koya	  et	  al.,	  2009).	  However,	  this	  may	  be	  
mediated	  by	  a	  separate	  projection	  target,	  as	  the	  projection	  to	  NA	  shell	  appears	  to	  suppress	  
drug	  seeking	  in	  both	  models	  as	  described	  above.	  	  
	  
So	  far,	  the	  discussion	  has	  been	  confined	  to	  NA	  shell	  suppressing	  the	  initiation	  of	  sucrose	  or	  
cocaine	  seeking,	  but	  there	  is	  also	  evidence	  that	  NA	  shell	  suppresses	  rewarded	  behavior	  during	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the	  maintenance	  phase,	  for	  example	  cocaine	  self-­‐administration.	  Long-­‐access	  cocaine	  self-­‐
administration	  leads	  both	  to	  incubation	  of	  craving	  and	  also	  escalation	  of	  intake.	  While	  
incubation	  of	  craving	  is	  likely	  encoded	  by	  NA	  core	  as	  described	  above,	  NA	  shell	  may	  encode	  for	  
escalation	  of	  cocaine	  intake	  (Guillem	  et	  al.,	  2014).	  Specifically,	  NA	  shell	  neurons	  decreased	  their	  
rates	  of	  tonic	  firing	  during	  initial	  cocaine	  escalation	  and	  subsequent	  re-­‐escalation	  following	  a	  30	  
day	  abstinence	  period	  (during	  which	  escalation	  reversed).	  Tonic	  firing	  rates	  of	  NA	  shell	  neurons	  
correlated	  negatively	  with	  initial	  escalation,	  positively	  with	  de-­‐escalation	  during	  abstinence,	  
and	  negatively	  with	  re-­‐escalation.	  This	  suggests	  that	  NA	  shell	  activity	  is	  generally	  anti-­‐correlated	  
with	  the	  amount	  of	  cocaine	  intake.	  Interestingly,	  phasic	  release	  of	  dopamine	  is	  also	  anti-­‐
correlated	  with	  cocaine	  escalation	  (Willuhn	  et	  al.,	  2014).	  This	  suggests	  that	  a	  paucity	  of	  
dopamine	  may	  simultaneously	  be	  responsible	  for	  the	  increase	  in	  drug	  taking	  and	  the	  decrease	  
in	  NA	  shell	  firing,	  which	  in	  turn	  suggests	  that	  the	  cells	  displaying	  decreased	  firing	  may	  be	  D1-­‐
MNS.	  This	  stands	  in	  contrast	  to	  the	  situation	  described	  above	  involving	  the	  initiation	  of	  reward	  
seeking,	  in	  which	  dopamine	  signaling	  is	  driving	  behavior.	  	  
	  
In	  addition,	  glutamatergic	  inputs	  to	  NA	  shell	  suppress	  feeding	  (Prado	  et	  al.,	  2016).	  This	  study	  
employed	  transgenic	  mice	  that	  expressed	  ChR2	  under	  the	  control	  of	  the	  Thy1	  promoter.	  This	  
promoter	  leads	  to	  expression	  patterns	  that	  vary	  widely	  between	  founder	  lines	  in	  a	  seemingly	  
random	  fashion	  (Feng	  et	  al.,	  2000),	  although	  the	  present	  study	  used	  a	  line	  that	  expresses	  ChR2	  
in	  glutamatergic	  neurons	  primarily	  in	  cortex,	  hippocampus,	  cerebellum,	  and	  thalamus	  (Arenkiel	  
et	  al.,	  2007).	  As	  such,	  this	  study	  cannot	  differentiate	  between	  the	  role	  that	  specific	  inputs	  to	  the	  
NA	  shell	  may	  play.	  This	  study	  employed	  a	  variety	  of	  behavioral	  assays	  that	  essentially	  all	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demonstrated	  that	  glutamate	  inputs	  to	  NA	  shell	  dramatically	  decrease	  feeding.	  Interestingly,	  
these	  same	  animals	  self-­‐stimulated	  for	  optical	  activation	  of	  terminals	  in	  NA	  shell.	  This	  suggests	  
that	  activation	  of	  these	  inputs	  is	  both	  rewarding	  and	  suppresses	  seeking	  of	  natural	  rewards.	  	  In	  
addition,	  it	  confirms	  the	  finding	  that	  glutamate	  release	  into	  NA	  shell	  is	  rewarding,	  regardless	  of	  
the	  source	  of	  that	  glutamate	  (Britt	  et	  al.,	  2012).	  Since	  optical	  activation	  of	  D1-­‐MSNs	  is	  
rewarding	  and	  optical	  activation	  of	  D2-­‐MSNs	  aversive	  (Kravitz	  et	  al.,	  2012),	  this	  study	  also	  
suggests	  that	  D1-­‐MSN	  activation	  suppresses	  ongoing	  rewarded	  seeking	  behavior.	  	  
	  
The	  first	  study	  to	  conclusively	  demonstrate	  that	  D1-­‐MSNs	  are	  indeed	  the	  cells	  in	  NA	  shell	  
responsible	  for	  inhibiting	  feeding	  used	  a	  rodent	  model	  of	  self-­‐administration	  of	  high	  fat	  food	  
(lipofundin)	  (O'Connor	  et	  al.,	  2015).	  This	  study	  examined	  the	  projection	  of	  NA	  shell	  to	  lateral	  
hypothalamus,	  which	  has	  a	  well-­‐established	  role	  in	  suppressing	  food	  intake	  (Prado	  et	  al.,	  2016).	  
Cre-­‐dependent	  ChR2	  expression	  in	  defined	  cell	  types	  allowed	  for	  detailed	  circuitry	  dissection.	  
The	  majority	  of	  MSNs	  projecting	  to	  LH	  are	  D1-­‐MSNs,	  based	  on	  a	  combination	  of	  retrograde	  
tracing	  (with	  CTB)	  and	  synaptic	  responses	  evoked	  in	  LH	  neurons	  by	  optogenetic	  stimulation	  of	  
terminals	  from	  D1-­‐	  or	  D2-­‐MSNs.	  “Phototagged”	  D1-­‐	  and	  D2-­‐MSNs	  (Kravitz	  et	  al.,	  2013)	  are	  anti-­‐
correlated	  and	  uncorrelated	  with	  feeding,	  respectively.	  Optogenetic	  inhibition	  of	  D1-­‐MSNs	  
drives	  feeding	  behavior	  (even	  under	  distraction	  that	  normally	  prevents	  feeding),	  and	  
stimulation	  of	  D1-­‐MSN	  terminals	  in	  the	  LH	  suppresses	  feeding.	  D2-­‐MSN	  activation	  and	  
inhibition	  had	  no	  effect	  on	  feeding.	  D1-­‐MSNs	  are	  suppressing	  feeding	  by	  inhibiting	  GABAergic	  
cells	  in	  LH	  rather	  than	  orexin	  or	  MCH	  expressing	  cells.	  This	  suggests	  that,	  if	  these	  GABAergic	  
cells	  are	  at	  all	  involved	  in	  a	  serial	  circuit	  with	  orexin	  or	  MCH	  neurons,	  there	  must	  be	  an	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interposed	  GABAergic	  or	  other	  inhibitory	  cell.	  This	  follows	  from	  the	  fact	  that	  both	  the	  
GABAergic	  cells	  identified	  in	  this	  study	  and	  the	  orexin	  (Sakurai	  et	  al.,	  1998)	  and	  MCH	  (Qu	  et	  al.,	  
1996)	  cells	  promote	  feeding.	  This	  study	  clearly	  demonstrates	  that	  D1-­‐MSNs,	  not	  D2-­‐MSNs,	  
suppress	  feeding.	  It	  also	  suggests	  that	  D1-­‐MSNs	  in	  NA	  shell	  projecting	  to	  LH	  are	  also	  responsible	  
for	  the	  inhibition	  of	  alcohol	  seeking	  after	  extinction	  (Millan	  et	  al.,	  2010),	  as	  they	  make	  up	  the	  
vast	  majority	  of	  this	  projection.	  However,	  food	  seeking	  serves	  both	  a	  homeostatic	  and	  hedonic	  
role,	  and	  it	  is	  important	  to	  note	  that	  the	  projection	  from	  NA	  shell	  to	  VP	  may	  be	  more	  important	  
for	  the	  hedonic	  motivation	  to	  eat	  (Cromwell	  and	  Berridge,	  1993).	  The	  projection	  to	  the	  VP	  may	  
thus	  be	  more	  relevant	  for	  suppression	  of	  appetitive	  behaviors	  that	  do	  not	  have	  a	  homeostatic	  
component	  (such	  as	  cocaine	  self-­‐administration).	  
	  
There	  is	  also	  evidence	  that	  NA	  shell	  may	  inhibit	  aversive	  as	  well	  as	  appetitive	  behaviors,	  and	  
that	  the	  locus	  of	  each	  type	  of	  inhibition	  may	  depend	  on	  a	  rostral	  caudal	  gradient,	  with	  rostral	  
NA	  shell	  inhibiting	  appetitive	  behaviors	  and	  caudal	  NA	  shell	  inhibiting	  aversive/defensive	  
behaviors	  (Reynolds	  and	  Berridge,	  2003).	  Both	  forms	  of	  behavioral	  suppression	  require	  intact	  
AMPARs.	  In	  contrast,	  NA	  core	  plays	  a	  modest	  and	  inconsistent	  role	  in	  suppressing	  behavior.	  
Interestingly,	  NMDARs	  appear	  to	  promote	  appetitive	  behaviors.	  Importantly,	  blockade	  of	  
AMPARs	  in	  NA	  shell	  is	  aversive,	  consistent	  with	  the	  finding	  that	  glutamate	  in	  NA	  shell	  is	  both	  
rewarding	  and	  inhibits	  reward	  seeking.	  	  
	  
In	  summary,	  NA	  shell	  appears	  to	  be	  capable	  of	  suppressing	  both	  phases	  of	  reward	  seeking	  -­‐	  
initiation	  (e.g.	  reinstatement)	  and	  maintenance	  (e.g.	  self-­‐administration	  or	  feeding).	  A	  synthesis	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of	  the	  available	  information	  suggests	  that	  NA	  shell	  D1-­‐MSN	  activation	  by	  direct	  optogenetic	  
stimulation	  or	  action	  of	  glutamate	  is	  rewarding	  and	  suppresses	  feeding	  via	  projections	  to	  lateral	  
hypothalamus.	  D1-­‐MSN	  activation	  may	  also	  suppress	  drug	  seeking,	  and	  loss	  of	  dopamine	  inputs	  
may	  lead	  to	  simultaneous	  decrease	  in	  D1-­‐MSN	  tonic	  activity	  and	  escalation	  of	  intake,	  but	  this	  
has	  been	  less	  well	  characterized.	  	  
	  
In	  contrast,	  NA	  shell’s	  ability	  to	  suppress	  initiation	  of	  reward	  seeking	  appears	  to	  depend	  
specifically	  on	  activation	  by	  glutamate	  released	  from	  IL-­‐PFC,	  in	  the	  absence	  of	  concurrent	  
dopamine	  signaling.	  As	  mentioned	  before,	  IL-­‐PFC	  synapses	  onto	  D1-­‐MSNs	  incorporate	  CP-­‐
AMPARs	  after	  drug	  exposure,	  and	  CP-­‐AMPARs	  receiving	  IL-­‐PFC	  input	  suppress	  drug	  seeking.	  D1-­‐
MSNs	  in	  NA	  shell	  likely	  drive	  drug	  seeking	  (although	  this	  has	  never	  been	  conclusively	  
demonstrated	  to	  my	  knowledge).	  This	  suggests	  that	  CP-­‐AMPARs	  in	  IL-­‐PFC	  synapses	  may,	  
somewhat	  surprisingly,	  inhibit	  activity	  in	  D1-­‐MSNs.	  	  
	  
There	  are	  probably	  many	  possible	  explanations	  that	  reconcile	  this	  counterintuitive	  role	  for	  
these	  receptors	  with	  the	  effects	  of	  dopamine	  signaling.	  Dopamine	  either	  cancels	  the	  IL-­‐PFC	  
input	  to	  NA	  shell	  or	  transforms	  it	  from	  a	  suppressor	  of	  drug	  seeking	  to	  a	  promoter.	  One	  
mechanism	  that	  may	  explain	  both	  features	  of	  IL-­‐PFC	  transmission	  involves	  SK	  channels.	  
Synaptic	  calcium	  influx	  via	  ionotropic	  glutamate	  receptors	  can	  decrease	  cellular	  excitability	  
(Creed	  et	  al.,	  2016)	  and	  synaptic	  plasticity	  (Ngo-­‐Anh	  et	  al.,	  2005)	  via	  activation	  of	  SK	  channels.	  
Thus,	  SK	  channels	  may	  suppress	  D1-­‐MSN	  activity	  upon	  activation	  by	  calcium	  influx	  via	  CP-­‐
AMPARs.	  In	  turn,	  dopamine	  suppresses	  the	  function	  of	  SK	  channels	  (Han	  et	  al.,	  2007),	  and	  this	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may	  bias	  the	  outcome	  of	  calcium	  passing	  through	  CP-­‐AMPARs	  toward	  other	  outcomes	  that	  do	  
not	  result	  in	  suppression	  of	  activity.	  	  
	  
	  
Figure	  1-­‐2.	  Diagram	  integrating	  NA	  shell	  circuitry,	  synaptic	  adaptations,	  and	  behavioral	  output.	  
The	  initiation	  of	  drug	  seeking	  (i.e.	  when	  drug	  reward	  is	  unavailable)	  depends	  on	  specific	  synaptic	  
adaptations	  expressed	  in	  synapses	  defined	  by	  pre-­‐synaptic	  input	  and	  post-­‐synaptic	  MSN	  class	  in	  
NA	  shell.	  Infralimbic	  prefrontal	  cortex	  (IL)	  input	  to	  D1-­‐MSNs	  in	  NA	  shell	  signals	  via	  calcium	  
permeable	  (CP)	  AMPARs	  to	  inhibit	  drug	  seeking	  (although	  dopamine	  countermands	  IL-­‐PFC	  
action).	  Hippocampal	  (HPC)	  input	  to	  D1-­‐MSNs	  in	  NA	  shell	  signals	  via	  calcium	  impermeable	  (CI)	  
AMPARs	  to	  promote	  drug	  seeking.	  D1-­‐MSNs	  display	  both	  the	  IL-­‐PFC	  to	  CP-­‐AMPAR	  and	  the	  vHPC	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to	  CI-­‐AMPAR	  synaptic	  adaptations	  after	  short	  access	  self-­‐administration,	  as	  well	  as	  non-­‐
contingent	  exposure	  to	  cocaine	  and	  morphine.	  Long	  access	  self-­‐administration	  followed	  by	  
extended	  abstinent	  withdrawal	  causes	  CP-­‐AMPAR	  insertion	  into	  D2-­‐MSNs.	  These	  CP-­‐AMPARs	  
receive	  BLA	  input	  and	  this	  adaptation	  mediates	  incubation	  of	  craving	  but	  not	  reinstatement	  per	  
se.	  The	  specific	  inputs	  to	  CI-­‐AMPARs	  on	  D2-­‐MSNs	  and	  the	  role	  of	  these	  receptors	  in	  drug	  seeking	  
remain	  unknown.	  
Nucleus	  accumbens	  shell	  promotes	  behavior	  
Contrasting	  the	  abundant	  literature	  supporting	  IL-­‐PFC	  regulation	  of	  NAshell	  to	  inhibit	  behavior,	  
other	  glutamatergic	  inputs	  to	  NA	  shell	  appear	  to	  promote	  the	  initiation	  of	  drug	  seeking	  
behavior.	  Different	  glutamatergic	  inputs	  are	  activated	  in	  different	  reinstatement	  paradigms.	  
Contextual	  information,	  processed	  by	  the	  hippocampus,	  enters	  the	  NA	  shell	  via	  projections	  
from	  the	  ventral	  subiculum	  (Bossert	  et	  al.,	  2016),	  and	  ventral	  hippocampus	  (vHPC)	  is	  the	  
strongest	  input	  to	  NA	  shell	  (Britt	  et	  al.,	  2012).	  As	  a	  result,	  it	  is	  perhaps	  unsurprising	  that	  
context-­‐induced	  reinstatement	  is	  driven	  by	  NA	  shell	  rather	  than	  NA	  core.	  	  
	  
For	  example,	  engram	  cells	  (defined	  by	  c-­‐fos	  expression)	  in	  NA	  shell	  but	  not	  NA	  core	  mediate	  
context-­‐induced	  reinstatement	  (Cruz	  et	  al.,	  2014).	  This	  study	  compared	  c-­‐fos	  expression	  in	  the	  
self-­‐administration	  and	  extinction	  contexts	  as	  well	  as	  a	  third	  novel	  context.	  Both	  NA	  core	  and	  
shell	  neurons	  displayed	  c-­‐fos	  activation	  in	  all	  three	  contexts,	  with	  the	  novel	  context	  inducing	  
expression	  in	  the	  greatest	  number	  of	  cells	  and	  the	  extinction	  context	  almost	  no	  cells.	  This	  study	  
used	  the	  Daun02	  inactivation	  procedure	  in	  which	  beta-­‐galactosidase	  (expressed	  under	  the	  
control	  of	  the	  c-­‐fos	  promotor)	  converts	  Daun02	  into	  daunorubicin	  to	  specifically	  inactivate	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engram	  cells	  (Cruz	  et	  al.,	  2013).	  Inactivation	  of	  the	  NA	  shell	  engram	  cells	  encoding	  the	  cocaine	  
self-­‐administration	  context	  attenuated	  context-­‐induced	  reinstatement.	  However,	  neither	  
inactivation	  of	  NA	  core	  engram	  cells	  encoding	  the	  cocaine	  self-­‐administration	  context,	  nor	  NA	  
shell	  engram	  cells	  encoding	  the	  novel	  context	  was	  capable	  of	  attenuating	  context-­‐induced	  
reinstatement.	  This	  provides	  evidence	  that	  NA	  shell	  neurons	  are	  driving	  the	  initiation	  of	  drug	  
seeking	  in	  this	  model,	  although	  NA	  shell	  is	  not	  uniquely	  coding	  for	  drug	  seeking	  nor	  is	  drug	  
seeking	  uniquely	  encoded	  by	  NA	  shell.	  Importantly,	  this	  study	  suggests	  that	  suppression	  of	  drug	  
seeking	  (in	  the	  extinction	  context)	  does	  not	  naturally	  lend	  itself	  to	  study	  with	  engram	  
technologies,	  as	  indicated	  by	  the	  extremely	  sparse	  c-­‐fos	  inductions.	  	  
	  
vHPC	  projections	  to	  NA	  shell,	  specifically	  onto	  D1-­‐MSNs,	  also	  drive	  drug	  seeking	  behavior	  
(Pascoli	  et	  al.,	  2014).	  These	  synapses	  potentiate	  after	  a	  period	  of	  abstinent	  withdrawal.	  Unlike	  
IL-­‐PFC	  to	  D1-­‐MSN	  synapses,	  which	  incorporate	  CP-­‐AMPARs,	  vHPC	  to	  D1-­‐MSNs	  incorporate	  
calcium	  impermeable	  AMPARs	  (CI-­‐AMPARs).	  LTD	  protocols	  which	  depotentiate	  the	  vHPC	  to	  D1-­‐
MSN	  pathway	  decrease	  drug	  seeking	  behavior,	  suggesting	  that	  the	  vHPC	  pathway	  opposes	  the	  
action	  of	  the	  IL-­‐PFC	  pathway	  (as	  depotentiating	  the	  IL-­‐PFC	  input	  enhances	  drug	  seeking	  (Ma	  et	  
al.,	  2014).	  The	  fact	  that	  different	  types	  of	  AMPARs	  are	  removed	  by	  depotentiating	  these	  two	  
synapses	  further	  suggests	  a	  mechanism	  by	  which	  these	  converging	  inputs	  differentially	  
manipulate	  the	  output	  of	  the	  D1-­‐MSNs.	  	  
	  
The	  group	  responsible	  for	  elucidating	  the	  role	  of	  NA	  shell	  in	  context-­‐induced	  reinstatement	  has	  
provided	  evidence	  that	  IL-­‐PFC	  activity	  is	  also	  helping	  to	  drive	  context-­‐induced	  reinstatement	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(Bossert	  et	  al.,	  2012),	  specifically	  for	  heroin	  seeking.	  This	  would	  seem	  to	  contradict	  the	  
assertion	  above	  that	  IL-­‐PFC	  to	  NA	  shell	  projections	  suppress	  drug	  seeking.	  However,	  this	  study	  
demonstrated	  that	  simultaneous	  activity	  in	  IL-­‐PFC	  and	  dopamine	  signaling	  in	  NA	  shell	  are	  
required	  for	  context-­‐induced	  reinstatement	  of	  heroin	  seeking,	  as	  contralateral	  or	  ipsilateral	  IL-­‐
PFC	  inactivation	  and	  D1/D5	  antagonism	  prevents	  context-­‐induced	  reinstatement.	  This	  is	  
consistent	  with	  the	  role	  of	  IL-­‐PFC	  described	  above,	  which	  either	  drives	  cue-­‐induced	  cocaine	  
seeking	  after	  extinction	  or	  suppresses	  it	  depending	  on	  whether	  or	  not	  VTA	  is	  concurrently	  
activated	  by	  DAMGO	  microinjection	  (LaLumiere	  et	  al.,	  2012).	  This	  study	  therefore	  suggests	  that	  
dopamine	  is	  present	  in	  NA	  shell	  during	  context-­‐induced	  reinstatement	  of	  heroin	  seeking,	  and	  as	  
a	  result	  IL-­‐PFC	  inputs	  are	  driving	  drug	  seeking	  behavior.	  	  
	  
The	  presence	  of	  dopamine	  in	  NA	  shell	  during	  context-­‐induced	  reinstatement	  may	  result	  from	  
dopamine	  terminal	  activation	  by	  vHPC.	  vHPC	  inputs	  to	  NA	  shell	  are	  active	  during	  context-­‐
induced	  reinstatement	  of	  heroin	  seeking	  (Bossert	  et	  al.,	  2016)	  and	  vHPC	  activity	  causes	  
dopamine	  release	  in	  NA	  shell	  (Peleg-­‐Raibstein	  and	  Feldon,	  2006).	  Dopamine,	  in	  turn,	  may	  
specifically	  impair	  the	  functional	  outcome	  of	  IL-­‐PFC	  synapses	  but	  not	  vHPC	  synapses	  onto	  D1-­‐
MSNs.	  	  
	  
Regardless	  of	  the	  mechanism,	  it	  appears	  that	  IL-­‐PFC	  suppresses	  initiation	  of	  drug	  seeking	  
depending	  on	  whether	  dopamine	  signaling	  is	  occurring	  in	  NA	  shell,	  while	  vHPC	  input	  to	  NA	  shell	  
drives	  drug	  seeking.	  The	  third	  commonly	  considered	  glutamatergic	  input	  to	  NA	  shell	  that	  
deserves	  consideration	  is	  BLA.	  BLA	  inputs	  to	  accumbens	  are	  especially	  important	  for	  cue-­‐
	   30	  
induced	  initiation	  of	  reward	  seeking	  (Stuber	  et	  al.,	  2011),	  which	  distinguishes	  this	  pathway	  from	  
vHPC.	  BLA	  to	  NA	  shell	  synapses	  do	  not	  incorporate	  new	  AMPARs	  under	  most	  drug	  exposure	  
paradigms	  (MacAskill	  et	  al.,	  2014;	  Terrier	  et	  al.,	  2016).	  However,	  BLA	  to	  NA	  shell	  CP-­‐AMPARs	  do	  
emerge	  in	  parallel	  with	  incubation	  of	  craving,	  and	  removal	  of	  CP-­‐AMPARs	  from	  this	  synapse	  via	  
an	  LTD	  protocol	  reverses	  incubation	  (Lee	  et	  al.,	  2013).	  Interestingly,	  these	  CP-­‐AMPARs	  are	  
selectively	  inserted	  into	  D2-­‐MSNs.	  If	  D2-­‐MSNs	  in	  NA	  shell	  normally	  suppress	  drug	  seeking,	  then	  
CP-­‐AMPAR	  insertion	  appears	  to	  be	  inhibiting	  the	  normal	  function	  of	  these	  cells	  as	  well	  as	  the	  
D1-­‐MSNs	  described	  above.	  	  
	  
In	  summary,	  as	  outlined	  in	  Figure	  1-­‐2,	  inputs	  to	  NA	  shell	  appear	  to	  be	  driving	  different	  facets	  of	  
drug	  seeking,	  with	  IL-­‐PFC	  to	  NA	  shell	  input	  normally	  suppressing	  drug	  seeking,	  vHPC	  to	  NA	  shell	  
initiating	  drug	  seeking,	  and	  BLA	  to	  NA	  shell	  pathologically	  amplifying	  drug	  seeking	  in	  the	  
incubation	  model.	  Concurrent	  dopamine	  signaling	  appears	  to	  suppress	  or	  even	  reverse	  the	  
ability	  of	  IL-­‐PFC	  input	  to	  NA	  shell	  to	  suppress	  drug	  seeking,	  although	  the	  mechanism	  for	  this	  
remains	  unclear.	  	  
Drugs	  of	  abuse	  induce	  synaptic	  plasticity	  in	  nucleus	  accumbens	  
Drugs	  of	  abuse	  cause	  dopamine	  to	  be	  released	  into	  nucleus	  accumbens	  (Di	  Chiara	  and	  
Imperato,	  1988),	  which	  in	  turn	  promotes	  glutamatergic	  synaptic	  plasticity	  (Anderson	  et	  al.,	  
2008).	  As	  a	  result,	  non-­‐contingent	  models	  of	  drug	  exposure	  such	  as	  sensitization	  and	  
conditioned	  place	  preference	  provide	  a	  high	  throughput	  model	  for	  simultaneously	  studying	  
enduring	  synaptic	  and	  behavioral	  adaptations	  resulting	  from	  chronic	  drug	  exposure,	  which	  is	  
the	  topic	  of	  the	  first	  section.	  The	  behavioral	  consequences	  of	  non-­‐contingent	  drug	  exposure	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may	  or	  may	  not	  represent	  simplified	  versions	  of	  enduring	  motivation	  to	  seek	  drugs	  that	  is	  
arguably	  the	  crux	  of	  addiction,	  and	  which	  can	  only	  be	  modeled	  through	  self-­‐administration	  
paradigms,	  which	  represent	  the	  second	  section.	  Finally,	  chronic	  exposure	  to	  drugs	  of	  abuse,	  
whether	  non-­‐contingent	  or	  based	  in	  self-­‐administration,	  can	  lead	  to	  apparently	  opposite	  
neuroadaptations	  as	  a	  result	  of	  specific	  pharmacological	  differences	  (Russo	  et	  al.,	  2010)	  and	  yet	  
all	  result	  in	  drug	  seeking,	  which	  can	  be	  measured	  in	  animals	  after	  self-­‐administration	  as	  active	  
lever	  pressing.	  Transient	  synaptic	  potentiation	  in	  nucleus	  accumbens	  specifically	  during	  active	  
drug	  seeking	  represents	  the	  third	  and	  final	  subsection.	  	  	  
	  
Non-­‐contingent	  models	  
Although	  arguably	  a	  simplified	  model,	  cocaine	  sensitization	  creates	  a	  complex	  and	  interesting	  
time	  course	  of	  synaptic	  potentiation	  as	  assessed	  by	  AMPA:NMDA	  ratio	  in	  mice	  sacrificed	  at	  
different	  time	  points	  (Kourrich	  et	  al.,	  2007).	  Mice	  sacrificed	  after	  sensitization,	  but	  before	  a	  
cocaine	  challenge,	  show	  increased	  synaptic	  AMPAR	  incorporation	  in	  NA	  shell,	  specifically	  
calcium	  impermeable	  AMPARs	  (CI-­‐AMPARs).	  Simultaneously,	  these	  mice	  likely	  have	  more	  
synapses	  (as	  indicated	  by	  increased	  mEPSC	  frequency,	  in	  the	  absence	  of	  increased	  release	  
probability	  (Kullmann,	  1994)).	  Chronic	  drug	  exposure	  is	  necessary	  for	  this	  AMPAR	  
incorporation;	  a	  single	  cocaine	  injection	  does	  not	  produce	  it	  regardless	  of	  the	  dose	  or	  
withdrawal	  period.	  The	  withdrawal	  period	  is	  also	  necessary	  for	  AMPAR	  incorporation	  and	  this	  
study	  reported	  a	  decrease	  in	  AMPA:NMDA	  ratio	  24	  hours	  after	  chronic	  cocaine	  exposure.	  Later	  
work	  demonstrated	  this	  was	  due	  to	  generation	  of	  new	  silent	  synapses	  (Huang	  et	  al.,	  
2009),which	  are	  the	  sites	  of	  AMPAR	  incorporation	  demonstrated	  in	  the	  current	  study.	  Re-­‐
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exposure	  to	  cocaine	  removes	  these	  newly	  inserted	  AMPARs,	  without	  removing	  previously	  
inserted	  AMPARs	  (e.g.	  in	  cocaine	  naïve	  animals).	  
	  
The	  AMPAR	  removal	  resulting	  from	  a	  cocaine	  challenge	  occurs	  in	  NA	  shell	  but	  not	  NA	  core	  
(Thomas	  et	  al.,	  2001).	  It	  also	  appears	  to	  be	  input	  specific,	  as	  no	  global	  changes	  in	  mEPSC	  
amplitude	  (either	  AMPAR	  or	  NMDAR)	  or	  frequency	  were	  reported.	  Decreased	  asEPSC	  
amplitude	  (Goda	  and	  Stevens,	  1994),	  however,	  confirmed	  AMPAR	  removal	  as	  the	  mechanism	  
for	  the	  AMPA:NMDA	  ratio	  decrease.	  This	  suggests	  that	  AMPARs	  were	  selectively	  removed	  from	  
synapses	  contacted	  by	  IL-­‐PFC	  (due	  to	  the	  placement	  of	  the	  stimulating	  electrode).	  Thus,	  while	  
cocaine	  exposure	  likely	  creates	  and	  then	  unsilences	  synapses	  receiving	  contact	  from	  a	  variety	  of	  
glutamatergic	  inputs,	  the	  ability	  of	  cocaine	  re-­‐exposure	  to	  re-­‐silence	  synapses	  appears	  to	  be	  
more	  restricted	  in	  its	  expression	  based	  on	  the	  source	  of	  glutamate	  input.	  	  
	  
Synapses	  on	  NA	  shell	  neurons	  receiving	  different	  inputs	  differ	  at	  baseline,	  prior	  to	  cocaine	  
exposure,	  and	  these	  baseline	  differences	  likely	  explain	  in	  part	  the	  specific	  adaptations	  they	  
exhibit	  after	  cocaine	  exposure	  (Britt	  et	  al.,	  2012).	  AMPAR	  density	  and	  subunit	  composition	  is	  
similar	  in	  synapses	  from	  each	  input.	  However,	  BLA	  terminals	  exhibit	  decreased	  glutamate	  
release	  probability	  relative	  to	  IL-­‐PFC	  and	  vHPC	  inputs.	  vHPC	  provides	  the	  strongest	  input	  to	  NA	  
shell	  and	  NMDARs	  contacted	  by	  vHPC	  pass	  more	  current	  at	  hyperpolarized	  potentials	  (possibly	  
due	  to	  different	  subunit	  composition).	  Cocaine	  sensitization	  causes	  AMPAR	  insertion	  (of	  CI-­‐
AMPARs)	  in	  vHPC	  but	  neither	  BLA	  nor	  IL-­‐PFC	  inputs,	  possibly	  due	  to	  basal	  differences	  in	  
NMDARs	  in	  vHPC	  synapses.	  Glutamate	  release	  from	  vHPC	  terminals	  into	  NAshell	  is	  both	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necessary	  and	  sufficient	  for	  the	  acute	  locomotor	  response	  to	  cocaine	  but	  not	  locomotor	  
sensitization	  or	  basal	  locomotor	  activity.	  Stimulation	  of	  these	  vHPC	  inputs	  to	  NA	  shell	  is	  
intrinsically	  rewarding	  as	  assessed	  by	  a	  real-­‐time	  place	  preference	  test	  and	  self-­‐administration	  
of	  optogenetic	  activation	  of	  these	  fibers.	  However,	  interestingly,	  the	  same	  is	  true	  of	  stimulation	  
of	  any	  of	  the	  glutamatergic	  inputs	  or	  direct	  stimulation	  of	  NA	  shell	  neurons.	  
	  
However,	  AMPAR	  insertion	  and/or	  spine	  creation	  after	  from	  cocaine	  sensitization	  depends	  not	  
only	  on	  the	  specific	  glutamatergic	  input	  but	  the	  cell	  type	  contacted	  by	  that	  input	  (MacAskill	  et	  
al.,	  2014).	  In	  this	  study,	  vHPC	  or	  BLA	  terminals	  were	  optogenetically	  stimulated	  to	  evoke	  EPSCs	  
or	  calcium	  transients	  in	  dendritic	  spines	  in	  D1-­‐	  and	  D2-­‐MSNs.	  D1-­‐	  and	  D2-­‐MSNs	  in	  this	  study	  
were	  “paired”	  by	  virtue	  of	  their	  proximity	  in	  the	  slice,	  and	  a	  D1/D2	  ratio	  was	  generated	  for	  each	  
pair	  on	  all	  spine	  and	  EPSC	  metrics.	  When	  specific	  inputs	  were	  not	  considered,	  these	  animals	  
showed	  an	  overall	  increase	  in	  D1/D2	  mEPSC	  frequency	  and	  spine	  density	  after	  cocaine	  
experience,	  suggesting	  that	  D1-­‐MSNs	  gained	  synaptic	  connections	  and	  therefore	  
responsiveness	  to	  glutamate,	  relative	  to	  D2-­‐MSNs.	  However,	  they	  showed	  no	  change	  in	  D1/D2	  
mEPSC	  amplitude	  or	  spine	  volume.	  Optogenetically	  evoked	  EPSCs	  showed	  increased	  D1/D2	  
amplitude	  for	  BLA	  inputs	  and	  decreased	  D1/D2	  amplitude	  for	  vHPC	  inputs.	  However,	  BLA	  
adaptations	  were	  driven	  by	  growth	  of	  new	  spines	  (and	  subsequent	  AMPAR	  insertion)	  on	  D1-­‐
MSNs,	  and	  vHPC	  adaptations	  by	  insertion	  of	  AMPARs	  into	  pre-­‐existing	  spines	  on	  D2-­‐MSNs.	  This	  
was	  determined	  by	  two	  methods:	  optogenetically	  evoked	  asEPSCs	  (in	  which	  BLA	  inputs	  showed	  
increased	  D1/D2	  frequency	  and	  vHPC	  showed	  decreased	  D1/D2	  amplitude)	  and	  analysis	  of	  
spines	  that	  were	  tagged	  to	  a	  specific	  input	  by	  the	  presence	  of	  optogenetically	  evoked	  calcium	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transients	  (in	  which	  BLA	  inputs	  showed	  increased	  D1/D2	  density	  and	  vHPC	  inputs	  showed	  
decreased	  D1/D2	  volume).	  Both	  of	  these	  adaptations	  require	  intact	  glutamate	  signaling	  during	  
cocaine	  exposure.	  Both	  can	  be	  blocked	  by	  concurrent	  MK-­‐801	  blockade	  of	  NMDARs,	  and	  the	  
BLA	  adaptation	  can	  be	  selectively	  blocked	  by	  concurrent	  BLA	  inhibition	  (using	  Gi-­‐DREADD),	  and	  
either	  of	  these	  manipulations	  reverses	  sensitization.	  Overall	  this	  study	  suggests	  that	  BLA	  
adaptations	  drive	  sensitization	  by	  increasing	  excitation	  of	  D1-­‐MSNs	  relative	  to	  D2-­‐MSNs,	  and	  
this	  manifests	  as	  an	  overall	  increase	  in	  the	  number	  of	  synapses	  on	  D1-­‐MSNs	  relative	  to	  D2-­‐
MSNs,	  detectable	  even	  without	  considering	  specific	  inputs.	  	  
	  
Morphine	  sensitization	  results	  in	  similar	  outcomes	  as	  cocaine	  sensitization	  via	  opposite	  
mechanisms	  (Graziane	  et	  al.,	  2016).	  Silent	  synapses	  appear	  on	  MSNs	  in	  NA	  shell	  one	  day	  after	  
withdrawal	  from	  either	  cocaine	  or	  morphine.	  The	  cocaine-­‐induced	  silent	  synapses	  express	  
GluN2B-­‐containing	  NMDARs,	  consistent	  with	  de	  novo	  synaptogenesis,	  as	  previously	  described	  
(Huang	  et	  al.,	  2009).	  In	  contrast,	  morphine	  generated	  silent	  synapses	  appear	  to	  result	  from	  the	  
internalization	  of	  CI-­‐AMPARs.	  Tat-­‐GluA23Y,	  a	  synthetic	  peptide	  that	  prevents	  endocytosis	  of	  CI-­‐
AMPARs,	  prevented	  the	  generation	  of	  silent	  synapses	  in	  morphine	  but	  not	  cocaine	  exposed	  
animals.	  Cocaine	  increased	  the	  number	  of	  spines	  with	  both	  “long/thin”	  and	  “filopodia”	  
morphology,	  whereas	  morphine	  converted	  long/thin	  spines	  to	  filopodia	  via	  AMPAR	  
endocytosis.	  Extended	  withdrawal	  from	  morphine	  then	  (probably)	  pruned	  the	  newly	  formed	  
filopodia,	  while	  extended	  withdrawal	  from	  cocaine	  (probably)	  caused	  AMPAR	  insertion	  into	  the	  
newly	  created	  filopodia	  and	  further	  growth	  of	  additional	  filopodia.	  Overall	  this	  suggests	  a	  
gradual	  potentiation	  of	  MSNs	  following	  cocaine	  exposure	  and	  a	  depotentiation	  following	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morphine	  exposure,	  which	  is	  generally	  supported	  by	  previous	  literature	  (Russo	  et	  al.,	  2010).	  
However,	  this	  study	  demonstrates	  that	  morphine	  specifically	  de-­‐potentiates	  D2-­‐MSNs	  and	  
cocaine	  specifically	  potentiates	  D1-­‐MSNs.	  Both	  drugs	  therefore	  potentiate	  the	  D1/D2	  ratio	  of	  
responsiveness	  to	  glutamate.	  Finally,	  the	  retention	  of	  morphine	  CPP	  but	  neither	  cocaine	  CPP	  
nor	  morphine	  sensitization	  requires	  AMPAR	  endocytosis.	  This	  suggests	  a	  functional	  role	  for	  this	  
enduring	  synaptic	  alteration.	  
	  
While	  GluA2	  containing	  CI-­‐AMPARs	  are	  selectively	  removed	  from	  D2-­‐MSNs,	  GluA2	  lacking	  CP-­‐
AMPARs	  appear	  to	  be	  inserted	  into	  D1-­‐MSNs	  in	  NA	  shell	  following	  morphine	  sensitization	  and	  
morphine	  CPP	  (Hearing	  et	  al.,	  2016),	  as	  assessed	  via	  optogenetic	  activation	  of	  IL-­‐PFC	  terminals	  
in	  NA	  shell.	  In	  addition,	  morphine	  sensitization	  increased	  and	  decreased	  the	  probability	  of	  
glutamate	  release	  from	  IL-­‐PFC	  terminals	  onto	  D1-­‐	  and	  D2-­‐MSNs,	  respectively.	  Ceftriaxone,	  
which	  restores	  glutamate	  uptake	  by	  astrocytes,	  (Roberts-­‐Wolfe	  and	  Kalivas,	  2015)	  reversed	  all	  
these	  synaptic	  adaptations,	  and	  prevented	  reinstatement	  of	  CPP	  after	  extinction.	  In	  vivo	  
optogenetic	  LTD	  delivered	  via	  IL-­‐PFC	  inputs	  to	  NA	  shell	  accomplished	  the	  same	  effect.	  
Morphine	  thus	  mimics	  cocaine	  both	  in	  the	  appearance	  of	  CP-­‐AMPARs	  on	  IL-­‐PFC	  to	  D1-­‐MSN	  
terminals	  (Terrier	  et	  al.,	  2016)	  and	  the	  normalization	  of	  this	  synapse	  by	  targeted	  delivery	  of	  
optogenetic	  LTD	  (Pascoli	  et	  al.,	  2014).	  This	  study	  suggests	  two	  additional	  mechanisms	  by	  which	  
chronic	  morphine	  exposure	  increases	  glutamate	  transmission	  onto	  D1-­‐MSNs	  relative	  to	  D2-­‐
MSNs,	  and	  suggests	  that	  these	  mechanisms	  also	  contribute	  to	  positive	  contextual	  associations	  
with	  morphine.	  Additionally,	  this	  study	  confirmed	  that	  only	  depotentiation	  of	  D2-­‐MSN	  inputs,	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and	  not	  potentiation	  of	  D1-­‐MSN	  inputs,	  occurs	  in	  NA	  core	  following	  opiate	  exposure	  (Shen	  et	  
al.,	  2011).	  	  
	  
Optogenetic	  stimulation	  protocols	  like	  the	  one	  in	  the	  previous	  study	  provide	  the	  best	  evidence	  
that	  synaptic	  adaptations	  specifically	  cause	  behavior.	  Translating	  this	  knowledge	  into	  new	  
therapies	  for	  addiction,	  however,	  will	  likely	  occur	  through	  electrical	  deep	  brain	  stimulation	  
rather	  than	  optogenetic	  stimulation	  (Luigjes	  et	  al.,	  2012).	  However,	  the	  precision	  of	  
optogenetics	  can	  guide	  the	  development	  of	  deep	  brain	  stimulation	  protocols	  for	  treating	  
addiction	  models	  (Creed	  et	  al.,	  2015).	  This	  study	  compared	  “classical”	  high	  frequency	  HF-­‐DBS	  
(130	  Hz)	  to	  a	  low	  frequency	  LF-­‐DBS	  protocol	  based	  on	  optogenetic	  stimulation	  parameters	  
known	  to	  reverse	  both	  synaptic	  potentiation	  of	  D1-­‐MSNs	  and	  cocaine	  locomotor	  sensitization	  
when	  delivered	  to	  NA	  shell	  (Pascoli	  et	  al.,	  2011).	  Specifically,	  D1-­‐MSNs	  show	  insertion	  of	  CP-­‐
AMPAR	  into	  synapses	  contacted	  by	  IL-­‐PFC	  and	  CI-­‐AMPARs	  into	  synapses	  contacted	  by	  vHPC	  
after	  cocaine	  sensitization	  (Terrier	  et	  al.,	  2016).	  Although	  HF-­‐DBS	  prevented	  the	  expression	  of	  
cocaine	  locomotor	  sensitization,	  the	  effect	  was	  extremely	  transient	  (gone	  by	  4	  hours	  after	  
turning	  off	  DBS).	  This	  was	  likely	  due	  to	  the	  failure	  of	  HF-­‐DBS	  to	  reverse	  AMPAR	  insertion	  in	  D1-­‐
MSNs.	  In	  contrast,	  optogenetic	  low	  frequency	  (LF)	  stimulation	  (12	  Hz)	  targeted	  to	  the	  IL-­‐PFC	  
input	  to	  NA	  shell	  both	  reversed	  locomotor	  sensitization	  (up	  to	  a	  week	  after	  turning	  off	  
stimulation)	  and	  removed	  AMPARs	  inserted	  into	  D1-­‐MSNs.	  Electrical	  LF-­‐DBS	  delivered	  to	  NA	  
shell	  was	  incapable,	  on	  its	  own,	  of	  replicating	  optogenetic	  stimulation	  in	  this	  regard.	  However,	  
concurrent	  pharmacological	  blockade	  of	  dopamine	  D1/D5	  receptors	  enabled	  LF-­‐DBS	  to	  produce	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the	  same	  effects	  as	  optogenetic	  LF	  stimulation.	  This	  provides	  a	  strong	  rationale	  for	  clinical	  trials	  
combining	  LF-­‐DBS	  with	  D1/D5	  antagonists	  for	  treating	  addiction.	  	  
	  
Self-­‐administration	  models	  
Taken	  together,	  the	  literature	  seems	  to	  support	  the	  likelihood	  that	  the	  same	  synaptic	  
adaptations	  that	  cause	  cocaine	  locomotor	  sensitization	  also	  promote	  drug	  seeking	  (Pascoli	  et	  
al.,	  2014).	  D1-­‐MSNs	  incorporate	  CP-­‐AMPARs	  in	  synapses	  contacted	  by	  IL-­‐PFC,	  which	  appear	  to	  
be	  selectively	  inserted	  into	  silent	  synapses	  generated	  during	  self-­‐administration	  and/or	  early	  
withdrawal	  (Ma	  et	  al.,	  2014).	  CI-­‐AMPARs	  incorporate	  in	  D1-­‐MSN	  synapses	  contacted	  by	  vHPC.	  
As	  described	  above,	  these	  synaptic	  adaptations	  exert	  opposite	  effects	  on	  drug	  seeking,	  with	  CP-­‐
AMPARs	  contacted	  by	  IL-­‐PFC	  likely	  inhibiting	  and	  CI-­‐AMPARs	  contacted	  by	  vHPC	  promoting	  
drug	  seeking.	  Optogenetically	  stimulating	  one	  of	  these	  two	  terminal	  fields	  using	  one	  of	  two	  LTD	  
protocols	  causes	  four	  possible	  outcomes.	  vHPC	  stimulation	  with	  a	  1	  Hz	  (NMDAR	  dependent)	  
LTD	  protocol	  removes	  homosynaptic	  CI-­‐AMPARs,	  while	  vHPC	  stimulation	  with	  a	  13	  Hz	  (mGluR	  
dependent)	  LTD	  protocol	  removes	  heterosynaptic	  CP-­‐AMPARs.	  In	  contrast,	  IL-­‐PFC	  stimulation	  
either	  simultaneously	  removes	  both	  classes	  of	  AMPAR	  (13	  Hz)	  or	  neither	  (1	  Hz).	  This	  
experiment	  led	  to	  the	  conclusions	  about	  the	  opposing	  roles	  of	  D1-­‐MSN	  synaptic	  adaptations	  
described	  above.	  Somewhat	  surprisingly,	  simultaneously	  removing	  both	  classes	  of	  AMPAR	  
completely	  abolished	  reinstatement	  of	  drug	  seeking.	  This	  supports	  the	  need	  for	  a	  clinical	  trial	  of	  
DBS	  targeting	  NA	  shell	  for	  treating	  addiction	  as	  described	  above,	  which	  replicates	  these	  effects	  
in	  a	  non-­‐contingent	  model.	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D1-­‐MSNs	  show	  these	  same	  adaptations	  in	  a	  variety	  of	  models,	  including	  non-­‐contingent	  
exposure,	  short	  access	  self-­‐administration	  and	  incubation	  models	  (in	  which	  extended	  
withdrawal	  potentiates	  cue-­‐induced	  craving	  after	  long-­‐access	  cocaine	  self-­‐administration).	  
However,	  only	  the	  incubation	  model	  induces	  CP-­‐AMPAR	  insertion	  on	  D2-­‐MSNs	  (Terrier	  et	  al.,	  
2016).	  These	  CP-­‐AMPARs	  are	  uniquely	  contacted	  by	  BLA	  (as	  opposed	  to	  D1-­‐MSN	  CP-­‐AMPARs	  
which	  are	  contacted	  uniquely	  by	  IL-­‐PFC).	  CP-­‐AMPARs	  contacted	  by	  BLA	  are	  inserted	  selectively	  
into	  silent	  synapses	  generated	  in	  NA	  shell	  during	  self-­‐administration	  and/or	  early	  withdrawal,	  
and	  removing	  these	  specific	  CP-­‐AMPARs	  prevents	  incubation	  of	  craving	  (but	  not	  reinstatement	  
of	  drug	  seeking)	  (Lee	  et	  al.,	  2013).	  Synthesizing	  these	  studies,	  BLA	  promotes	  incubation	  of	  
craving	  but	  not	  reinstatement	  via	  activation	  of	  CP-­‐AMPARs	  selectively	  located	  on	  D2-­‐MSNs.	  	  
	  
CP-­‐AMPARs	  located	  in	  NA	  core	  also	  play	  a	  role	  in	  incubation	  of	  craving.	  Expression	  of	  GluA1	  but	  
not	  GluA2	  subunits	  increase	  during	  incubation	  of	  craving,	  creating	  CP-­‐AMPARs	  that	  are	  likely	  
GluA1	  homomers	  (Conrad	  et	  al.,	  2008),	  although	  it	  is	  not	  known	  which	  input	  contacts	  these	  
receptors	  or	  whether	  they	  are	  expressed	  on	  D1-­‐MSNs,	  D2-­‐MSNs,	  or	  both.	  Activity	  of	  these	  CP-­‐
AMPARs	  in	  NA	  core	  selectively	  drives	  incubation	  of	  craving,	  but	  not	  reinstatement	  of	  cocaine	  
seeking	  per	  se.	  	  
	  
In	  contrast,	  reinstatement	  appears	  to	  depend	  on	  CI-­‐AMPARs	  in	  NA	  core	  (Ma	  et	  al.,	  2014).	  These	  
CI-­‐AMPARs	  are	  inserted	  after	  incubation	  of	  craving	  into	  silent	  synapses	  that	  appear	  either	  
during	  drug	  seeking	  or	  early	  withdrawal.	  However,	  an	  LTD	  protocol	  that	  removes	  these	  
receptors	  not	  only	  prevents	  incubation	  of	  craving	  but	  blocks	  reinstatement,	  suggesting	  they	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exert	  a	  more	  profound	  influence	  on	  drug	  seeking.	  In	  addition,	  these	  receptors	  are	  inserted	  
primarily	  into	  D1-­‐MSNs	  (Bock	  et	  al.,	  2013)	  and	  do	  not	  require	  incubation	  of	  craving	  or	  even	  self-­‐
administration	  experience	  (McCutcheon	  et	  al.,	  2011).	  
	  
Thus,	  overall	  it	  appears	  that	  drug-­‐self	  administration	  largely	  causes	  many	  of	  the	  same	  synaptic	  
adaptations	  as	  non-­‐contingent	  administration.	  Silent	  synapses	  sprout	  and	  then	  incorporate	  
AMPARs.	  CI-­‐AMPARs	  insert	  into	  silent	  synapses	  on	  D1-­‐MSNs,	  and	  thereby	  drive	  the	  initiation	  of	  
drug	  seeking.	  vHPC	  contacts	  CI-­‐AMPARs	  incorporated	  into	  NA	  shell	  D1-­‐MSNs	  and	  PL-­‐PFC	  those	  
incorporated	  into	  NA	  core	  D1-­‐MSNs.	  NA	  shell	  D1-­‐MSNs	  additionally	  incorporate	  CP-­‐AMPARs	  
contacted	  by	  IL-­‐PFC	  that	  suppress	  drug	  seeking.	  Incubation	  of	  craving	  causes	  additional	  
incorporation	  of	  CP-­‐AMPARs.	  In	  NA	  shell	  these	  additional	  CP-­‐AMPARs	  are	  incorporated	  into	  D2-­‐
MSN	  synapses	  receiving	  input	  from	  BLA,	  whereas	  the	  specific	  synapses	  in	  NA	  core	  incorporating	  
CP-­‐AMPARs	  remain	  unclear.	  Although	  they	  are	  responsible	  for	  incubated	  craving,	  they	  appear	  
to	  play	  a	  modulatory	  role,	  and	  their	  overall	  contribution	  to	  drug	  seeking	  is	  less	  profound	  than	  
CI-­‐AMPARs	  in	  both	  NA	  core	  (Conrad	  et	  al.,	  2008;	  Ma	  et	  al.,	  2014)	  and	  NA	  shell	  (Lee	  et	  al.,	  2013;	  
Pascoli	  et	  al.,	  2014).	  	  
	  
Transient	  synaptic	  potentiation	  during	  reinstatement	  of	  drug	  seeking	  
This	  brings	  us	  to	  the	  phenomenon	  of	  transient	  synaptic	  potentiation	  (tSP)	  (Gipson	  et	  al.,	  2014;	  
Smith	  et	  al.,	  2015).	  In	  tSP,	  synapses	  rapidly	  potentiate	  during	  drug	  seeking	  and	  then	  
depotentiate	  at	  the	  cessation	  of	  drug	  seeking.	  AMPAR	  insertion,	  spine	  head	  enlargement,	  and	  
other	  synaptic	  potentiation	  endpoints	  occur	  during	  the	  first	  15	  minutes	  of	  a	  reinstatement	  test	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but	  reverse	  by	  the	  end	  of	  the	  two	  hour	  test.	  Regardless	  of	  whether	  animals	  previously	  self-­‐
administered	  cocaine,	  heroin,	  or	  nicotine,	  regardless	  of	  whether	  drug	  seeking	  was	  initiated	  by	  
cues,	  context,	  or	  a	  priming	  injection	  of	  drug,	  tSP	  accompanies	  drug	  seeking.	  An	  acute	  
presentation	  of	  conditioned	  cues	  can	  potentiate	  synapses	  as	  effectively	  as	  chronic	  cocaine	  
exposure,	  which	  is	  an	  extremely	  striking	  effect.	  tSP	  requires	  metaplasticity	  –	  a	  potentiation	  of	  
signaling	  cascades	  that	  in	  turn	  potentiate	  synapses	  -­‐	  conferred	  by	  a	  history	  of	  drug	  self-­‐
administration.	  The	  metaplasticity	  underlying	  tSP	  is	  unusual	  in	  that	  most	  studies	  report	  a	  loss,	  
rather	  than	  a	  gain,	  of	  metaplasticity	  after	  chronic	  exposure	  to	  drugs	  of	  abuse	  (Scofield	  et	  al.,	  
2016),	  with	  the	  possible	  exception	  of	  ethanol	  (Mulholland	  et	  al.,	  2016).	  The	  studies	  of	  tSP	  
conducted	  to	  date	  are	  reviewed	  below.	  
	  
A	  priming	  injection	  of	  heroin	  both	  induces	  heroin	  seeking	  and	  tSP	  (Shen	  et	  al.,	  2011).	  A	  heroin	  
injection	  potentiates	  field	  EPSPs	  in	  the	  PL-­‐PFC	  to	  NA	  core	  projection	  (but	  only	  for	  rats	  with	  a	  
heroin	  self-­‐administration	  history).	  Withdrawal	  after	  heroin	  self-­‐administration	  decreased	  head	  
diameter	  but	  not	  density	  of	  dendritic	  spines	  in	  NA	  core,	  but	  a	  heroin	  injection	  both	  increased	  
head	  diameter	  and	  density	  of	  dendritic	  spines	  (again	  only	  in	  heroin	  treated	  animals).	  
Withdrawal	  after	  heroin	  inserted	  NMDARs	  with	  GluN2B	  subunits,	  and	  these	  GluN2B-­‐containing	  
NMDARs	  induced	  tSP	  following	  a	  heroin	  injection,	  suggesting	  that	  GluN2Bs	  mediate	  the	  gain	  of	  
metaplasticity	  after	  heroin	  exposure.	  GluN2B-­‐containing	  NMDARs	  in	  NA	  core	  also	  drove	  drug	  
seeking	  following	  re-­‐exposure	  to	  heroin-­‐paired	  cues.	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Nicotine	  withdrawal	  causes	  insertion	  of	  both	  GluN2B-­‐	  and	  GluN2A-­‐containing	  NMDARs,	  both	  of	  
which	  mediate	  the	  ability	  of	  cues	  to	  reinstate	  nicotine	  seeking	  and	  induce	  tSP	  (Gipson	  et	  al.,	  
2013b).	  Glutamate	  overflow	  during	  reinstatement	  activates	  these	  NMDARs.	  Different	  from	  
heroin,	  withdrawal	  after	  nicotine	  enlarges	  spine	  heads,	  which	  enlarge	  further	  during	  
reinstatement,	  and	  AMPAR	  incorporation	  is	  likewise	  induced	  by	  withdrawal	  and	  further	  by	  
reinstatement.	  New	  spines	  are	  not	  generated	  after	  either	  nicotine	  withdrawal	  or	  during	  
reinstatement,	  suggesting	  that	  AMPARs	  are	  incorporated	  into	  existing	  spines.	  	  
	  
Cue-­‐induced	  cocaine	  seeking	  also	  induces	  tSP	  (Gipson	  et	  al.,	  2013a).	  Withdrawal	  from	  cocaine	  
enlarges	  spines	  via	  AMPAR	  incorporation,	  and	  reinstatement	  enhances	  this	  potentiation.	  The	  
magnitude	  of	  drug	  seeking	  correlates	  strongly	  with	  both	  synaptic	  potentiation	  markers.	  Sucrose	  
seeking	  neither	  enlarges	  spines	  nor	  incorporates	  AMPARs,	  suggesting	  tSP	  is	  specifically	  induced	  
by	  drug	  seeking.	  PL-­‐PFC	  drives	  both	  reinstatement	  and	  tSP	  during	  cocaine	  seeking	  via	  glutamate	  
release	  into	  NA	  core	  (Stefanik	  et	  al.,	  2016).	  Surprisingly	  (Cruz	  et	  al.,	  2014),	  context-­‐induced	  
cocaine	  seeking	  also	  induces	  tSP	  in	  NA	  core	  (Stankeviciute	  et	  al.,	  2013).	  	  
	  
The	  metabotropic	  glutamate	  receptor	  mGluR5	  mediates	  cocaine-­‐induced	  metaplasticity	  and	  
the	  ability	  of	  cues	  to	  drive	  drug	  seeking.	  PL-­‐PFC	  (and	  other	  inputs)	  release	  glutamate	  into	  NA	  
core,	  and	  astroglia	  normally	  uptake	  this	  glutamate	  via	  GLT-­‐1.	  Exposure	  to	  drugs	  of	  abuse	  
decreases	  GLT-­‐1	  expression	  and/or	  function	  (Roberts-­‐Wolfe	  and	  Kalivas,	  2015),	  enabling	  
glutamate	  to	  spill	  over	  into	  the	  extra-­‐synaptic	  space,	  where	  it	  drives	  drug-­‐seeking	  via	  mGluR5s	  
(Reissner	  et	  al.,	  2015).	  Some	  of	  these	  mGluR5s	  are	  located	  on	  a	  special	  class	  of	  interneurons	  in	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NA	  core	  that	  express	  neuronal	  nitric	  oxide	  synthase	  (nNOS).	  MGluR5	  activates	  nNOS,	  which	  
creates	  nitric	  oxide,	  which	  in	  turn	  nitrosylates	  cysteine	  residues	  on	  matrix	  metalloproteinases	  	  
(MMPs)	  (Smith	  et	  al.,	  2016).	  S-­‐nitrosylation	  activates	  MMPs	  2	  and	  9.	  MMP-­‐2	  drives	  spine	  
generation	  in	  NA	  core	  MSNs	  following	  cocaine	  withdrawal,	  while	  MMP-­‐9	  drives	  AMPAR	  
incorporation	  during	  reinstatement.	  Both	  mediate	  the	  ability	  of	  cues	  to	  drive	  cocaine	  seeking,	  
and	  likely	  also	  heroin	  and	  nicotine	  seeking	  (Smith	  et	  al.,	  2014).	  Thus,	  in	  addition	  to	  GluN2B-­‐
containing	  NMDARs,	  the	  metaplasticity	  underlying	  tSP	  may	  rely	  on	  a	  complicated	  signaling	  
cascade	  enabled	  by	  chronic	  self-­‐administration	  of	  drugs	  of	  abuse.	  
	  
Interestingly,	  re-­‐exposure	  to	  cocaine	  suppresses	  tSP	  driven	  by	  drug	  seeking	  (Spencer	  et	  al.,	  
2016).	  Allowing	  animals	  to	  self-­‐administer	  cocaine	  after	  a	  brief	  period	  of	  unsuccessful	  cocaine	  
seeking	  decreases	  active	  lever	  pressing	  (presumably	  due	  to	  rats	  self-­‐titrating	  their	  brain	  cocaine	  
levels	  (Zittel-­‐Lazarini	  et	  al.,	  2007)).	  Along	  with	  decreasing	  drug	  seeking,	  cocaine	  re-­‐exposure	  
reverses	  the	  cue-­‐induced	  incorporation	  of	  AMPARs,	  dendritic	  spine	  enlargement,	  and	  MMP	  
activation.	  Subsequently,	  ending	  access	  to	  cocaine	  robustly	  revives	  drug	  seeking,	  and	  increases	  
the	  aforementioned	  markers	  of	  tSP.	  A	  similar	  increase	  in	  drug	  seeking	  and	  tSP	  markers	  can	  be	  
seen	  after	  sufficient	  clearance	  of	  brain	  cocaine	  after	  a	  priming	  injection	  of	  cocaine	  or	  heroin	  
(Shen	  et	  al.,	  2011;	  Smith	  et	  al.,	  2014).	  Surprisingly,	  activity	  in	  PL-­‐PFC	  and	  VTA	  mediate	  drug	  
seeking	  and	  tSP	  driven	  by	  falling	  brain	  cocaine	  levels	  in	  opposite	  ways.	  VTA	  promotes	  both	  tSP	  
and	  drug	  seeking,	  while	  PL-­‐PFC	  promotes	  drug	  seeking	  but	  inhibits	  tSP	  (opposite	  to	  what	  is	  seen	  
during	  cue-­‐induced	  cocaine	  seeking)	  (Shen	  et	  al.,	  2014).	  Interestingly,	  VTA	  activity	  drives	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AMPAR	  incorporation	  (but	  not	  spine	  enlargement	  or	  drug	  seeking)	  after	  a	  cocaine	  injection	  
even	  in	  cocaine-­‐naïve	  animals.	  	  	  
	  
Extinction	  training	  after	  drug	  self-­‐administration	  induces	  synaptic	  potentiation	  and/or	  
metaplasticity	  in	  nucleus	  accumbens	  	  
Surprisingly	  little	  is	  known	  about	  the	  modulation	  of	  accumbens	  synapses	  by	  extinction,	  despite	  
the	  fact	  that	  it	  was	  first	  characterized	  15	  years	  ago	  in	  a	  high	  profile	  paper	  (Sutton	  et	  al.,	  2003).	  
Extinction	  after	  cocaine	  but	  not	  sucrose	  self-­‐administration	  upregulates	  AMPAR	  subunits.	  
Extinction	  of	  the	  context	  upregulates	  GluA2,	  while	  extinction	  of	  the	  operant	  response	  
upregulates	  GluA1.	  Over-­‐expression	  of	  either	  AMPAR	  subunit	  hastens	  extinction	  learning	  and	  
prevents	  subsequent	  drug	  seeking	  driven	  by	  footshock	  (but	  not	  cues).	  Interestingly,	  however,	  
extinction-­‐induced	  GluA1	  upregulation	  correlates	  negatively	  with	  subsequent	  cue-­‐induced	  drug	  
seeking.	  AMPAR	  upregulation	  after	  extinction	  is	  transient,	  and	  normalizes	  gradually	  after	  
discontinuation	  of	  daily	  extinction	  sessions.	  	  	  
	  
Unfortunately,	  AMPARs	  that	  are	  upregulated	  by	  extinction	  are	  not	  incorporated	  into	  synapses	  
in	  NA	  shell	  (Knackstedt	  et	  al.,	  2010).	  However,	  extinction	  upregulates	  Homer1b/c	  in	  NA	  core	  
synapses.	  Homer1b/c	  internalizes	  mGluR5,	  which	  prevents	  electrical	  induction	  of	  LTD	  and	  also	  
attenuates	  drug	  seeking.	  Thus	  it	  appears	  that	  extinction	  may	  modulate	  metaplasticity	  but	  
neither	  potentiate	  nor	  depotentiate	  synapses	  in	  accumbens.	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Chapter	  2  Statement	  of	  the	  problem	  
A	  considerable	  body	  of	  work	  has	  demonstrated	  that	  nucleus	  accumbens	  promotes	  or	  
suppresses	  appetitive	  behavior	  depending	  on	  the	  subcompartment,	  cell	  type,	  and	  behavioral	  
model	  considered.	  Moreover,	  chronic	  exposure	  to	  drugs	  of	  abuse	  both	  alters	  glutamatergic	  
synapses	  and	  modifies	  their	  ability	  to	  undergo	  further	  alteration	  in	  response	  to	  an	  
environmental	  stimulus.	  However,	  the	  specific	  role	  that	  extinction	  plays	  in	  altering	  
glutamatergic	  synapses	  in	  nucleus	  accumbens	  and	  thereby	  altering	  drug	  seeking	  behavior	  
remains	  understudied.	  The	  purpose	  of	  the	  experiments	  described	  in	  the	  following	  chapters	  is	  to	  
further	  elucidate	  this	  area	  of	  study.	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Chapter	  3  Methods	  
Animals	  
All	  experiments	  were	  carried	  out	  in	  accordance	  with	  the	  Guide	  for	  the	  Care	  and	  Use	  of	  
Laboratory	  Animals.	  Mice	  employed	  in	  these	  experiments	  were	  BAC	  transgenic	  heterozygotes	  
(male	  and	  female,	  20-­‐30	  grams,	  Vanderbilt	  University)	  expressing	  	  either	  tdTomato	  under	  the	  
control	  of	  the	  Drd1a	  promoter	  (Shuen	  et	  al.,	  2008),	  eGFP	  under	  the	  control	  of	  the	  DRD2	  
promoter	  (Gong	  et	  al.,	  2003),	  or	  both.	  Rats	  were	  male	  Sprague-­‐Dawley	  rats	  (Charles	  River,	  
weighing	  200-­‐225	  grams	  upon	  arrival).	  Animals	  were	  housed	  in	  a	  reverse	  light	  cycle	  vivarium	  
with	  humidity	  and	  temperature	  controls	  and	  were	  fed	  ad	  libitum	  prior	  to	  the	  beginning	  of	  




Animals	  were	  anesthetized	  (mice	  with	  isofluorane,	  induction	  3-­‐5%	  v/v,	  maintenance	  1-­‐2%	  v/v;	  
rats	  with	  ketamine	  HCl	  and	  xylazine)	  and	  implanted	  with	  indwelling	  jugular	  venous	  catheters.	  
Intracranial	  guide	  cannula	  were	  implanted	  in	  rats	  to	  end	  two	  mm	  above	  the	  medial	  NA	  shell	  
(WRT	  Bregma:	  A/P	  +1.7,	  M/L	  +3.0,	  D/V	  -­‐5.6,	  17	  degree	  angle).	  




After	  recovering	  from	  surgery,	  animals	  began	  training	  in	  cocaine	  self-­‐administration.	  Self-­‐
administration	  occurred	  in	  operant	  chambers	  equipped	  with	  two	  levers,	  a	  house	  light,	  tone	  
generator,	  and	  cue	  light.	  The	  lever	  closest	  to	  the	  chamber	  opening	  was	  designated	  as	  the	  active	  
lever,	  and	  each	  press	  on	  the	  active	  lever	  triggered	  an	  infusion	  of	  cocaine	  (for	  mice	  0.025	  mg/12	  
µL/infusion,	  for	  rats	  0.2	  mg/50	  µL/infusion)	  along	  with	  a	  compound	  cue	  that	  included	  a	  tone	  	  
and	  light	  that	  were	  presented	  during	  the	  infusion.	  Following	  each	  infusion,	  a	  20	  second	  time	  
out	  was	  signaled	  by	  the	  loss	  of	  illumination	  of	  the	  house	  light,	  and	  active	  lever	  presses	  during	  
the	  timeout	  were	  recorded	  but	  resulted	  in	  no	  programmed	  consequence.	  Presses	  on	  the	  




Following	  self-­‐administration,	  animals	  were	  not	  connected	  to	  the	  infusion	  line	  for	  the	  
remainder	  of	  the	  experiments.	  Animals	  either	  underwent	  2-­‐3	  weeks	  of	  extinction	  training	  or	  
remained	  abstinent	  in	  their	  home	  cages.	  Extinction	  consisted	  of	  training	  in	  the	  operant	  
chamber,	  with	  neither	  the	  previously	  active	  or	  inactive	  levers	  capable	  of	  delivering	  any	  
programmed	  consequence	  (no	  cocaine	  infusions,	  no	  cues,	  no	  house	  light	  illumination	  changes).	  
Home	  cage	  abstinent	  animals	  were	  handled	  and	  weighed	  daily	  and	  were	  kept	  in	  their	  cages	  in	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the	  room	  housing	  the	  operant	  chambers	  while	  their	  conspecifics	  engaged	  in	  extinction	  training,	  




Tests	  to	  assess	  transient	  synaptic	  potentiation	  (tSP)	  
At	  the	  end	  of	  extinction	  or	  abstinence,	  animals	  destined	  for	  baseline	  measurements	  of	  
neurobiological	  endpoints	  (e.g.	  electrophysiology)	  were	  sacrificed	  without	  return	  to	  the	  
operant	  chamber.	  Animals	  destined	  for	  tSP	  measurements	  of	  neurobiological	  endpoints	  were	  
returned	  to	  the	  operant	  chamber	  for	  a	  behavioral	  test	  before	  being	  sacrificed.	  During	  this	  test,	  
animals	  either	  did	  or	  did	  not	  receive	  cues	  previously	  paired	  with	  cocaine	  in	  response	  to	  each	  
press	  of	  the	  active	  lever	  (Figure	  3-­‐1).	  Thus,	  reinstatement	  behavior	  was	  either	  driven	  by	  the	  
drug-­‐paired	  cues	  +	  context	  or	  the	  context	  alone.	  Presses	  on	  both	  levers	  were	  recorded	  but	  
inactive	  lever	  presses	  never	  resulted	  in	  any	  programmed	  consequence.	  Animals	  were	  sacrificed	  
at	  the	  end	  of	  the	  reinstatement	  test	  for	  preparation	  of	  brain	  slices	  for	  electrophysiology.	  
	  
	   48	  
	  
Figure	  3-­‐1.	  Behavioral	  paradigm	  for	  transient	  synaptic	  potentiation	  measurements.	  Following	  
cocaine	  self-­‐administration,	  animals	  underwent	  2-­‐3	  weeks	  of	  extinction	  or	  home	  cage	  
abstinence.	  Next	  animals	  engaged	  in	  a	  behavioral	  test,	  during	  which	  active	  lever	  presses	  either	  
delivered	  cues	  or	  no	  programmed	  consequences	  (NC).	  The	  behavioral	  test	  concluded	  after	  15	  
minutes,	  (or	  30	  minutes	  in	  the	  case	  of	  drug	  seeking	  (DS)	  tests	  in	  mice).	  Re-­‐exposure	  to	  drug-­‐
paired	  cues	  alone	  (after	  extinction),	  drug	  paired	  context	  alone	  (after	  abstinence),	  or	  drug-­‐paired	  
cues	  and	  context	  together	  (after	  abstinence)	  induced	  drug	  seeking	  (DS).	  The	  behavior	  outcomes	  
of	  these	  four	  tests	  are	  color	  coded	  consistently	  throughout	  the	  rest	  of	  the	  dissertation.	  Animals	  
were	  sacrificed	  at	  the	  end	  of	  the	  behavioral	  test	  for	  measures	  of	  transient	  synaptic	  potentiation	  








Tests	  to	  assess	  the	  necessity	  of	  adenosine	  A2a	  receptor	  in	  refraining	  behavior	  
Post-­‐synaptic	  potentiation	  of	  D2-­‐MSNs	  requires	  adenosine	  A2aR	  signaling	  (Flajolet	  et	  al.,	  2008;	  
Shen	  et	  al.,	  2008b),	  and	  I	  hypothesized	  would	  be	  required	  for	  refraining	  behavior.	  After	  self-­‐
administration	  and	  extinction,	  rats	  received	  three	  behavioral	  trials	  to	  test	  the	  necessity	  of	  
adenosine	  A2a	  receptors	  in	  refraining	  behavior.	  The	  highly	  selective	  A2aR	  antagonist	  MSX-­‐3	  
(Yuzlenko	  and	  Kiec-­‐Kononowicz,	  2006)	  was	  microinjected	  into	  NA	  shell	  10	  minutes	  prior	  to	  the	  
beginning	  of	  the	  2	  hour	  test.	  During	  the	  test,	  active	  levers	  resulted	  in	  no	  programmed	  
consequences	  but	  were	  counted	  (along	  with	  inactive	  lever	  presses).	  The	  microinjection	  was	  500	  
nL/side	  of	  saline	  with	  0	  µg	  (vehicle),	  10	  µg,	  or	  20	  µg	  dissolved	  MSX-­‐3.	  Microinjections	  were	  
delivered	  in	  a	  latin	  squares	  design;	  animals	  were	  randomized	  to	  receive	  doses	  in	  one	  of	  three	  
orders	  (0	  à	  10	  à	  20,	  10	  à	  20	  à	  0,	  20	  à	  0	  à	  10).	  Animals	  received	  4-­‐5	  days	  of	  additional	  
extinction	  between	  test	  days,	  and	  an	  average	  of	  active/inactive	  lever	  presses	  during	  “baseline	  





Rats	  were	  anesthetized	  with	  ketamine	  and	  decaptitated.	  The	  brain	  was	  removed	  and	  
transferred	  to	  ice	  cold	  aCSF	  containing	  (in	  mM)	  NaCl	  (126),	  KCl	  (2.5),	  MgCl2	  (1.2),	  NaH2PO4	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(1.4),	  CaCl2	  (2.4),	  glucose	  (11),	  NaHCO3	  (25),	  ascorbate	  (0.4),	  pyruvate	  (2).	  Slices	  were	  prepared	  
on	  a	  Leica	  VT1200S	  vibratome	  (Leica,	  Wetzlar,	  Germany).	  Slices	  were	  220	  micron	  thick,	  coronal,	  
containing	  NA	  core	  (approximately	  AP	  coordinates	  between	  2.3-­‐1.2	  mm	  anterior	  to	  bregma	  
according	  to	  (Paxinos	  and	  Watson,	  2007).	  Slices	  were	  cut	  in	  ice	  cold	  aCSF	  additionally	  
containing	  kynurenic	  acid	  (5	  mM)	  and	  D-­‐AP5	  (50	  uM)	  bubbled	  continuously	  with	  carbogen	  gas	  
(95%	  O2,	  5%	  CO2).	  Once	  cut,	  slices	  were	  transferred	  to	  incubation	  solution	  (identical	  to	  cutting	  
solution	  except	  at	  room	  temperature).	  
	  
Recording	  
All	  recordings	  were	  done	  in	  aCSF	  additionally	  containing	  picrotoxin	  (0.1	  mM),	  bubbled	  
continuously	  with	  carbogen	  gas	  for	  a	  final	  osmolarity	  of	  305	  mOsm	  and	  pH	  of	  7.35.	  The	  solution	  
was	  additionally	  heated	  to	  physiological	  temperature	  using	  a	  Warner	  Instruments	  Dual	  Channel	  
Heater	  Controller,	  TC-­‐344B	  (Hamden,	  CT,	  USA).	  Slices	  were	  visualized	  using	  an	  Olympus	  Fixed	  
Stage	  Upright	  Microscope,	  BX51WI	  (Tokyo,	  Japan)	  mounted	  on	  a	  Kinetic	  Systems	  Vibration	  
Isolation	  Table,	  9100	  Series	  (Boston,	  MA,	  USA).	  Recording	  pipettes	  were	  prepared	  on	  a	  
Narishige	  Puller,	  PC-­‐10	  (East	  Meadow,	  NY,	  USA)	  from	  World	  Precision	  Instruments	  thinwall	  
glass	  capillaries	  (Sarasota,	  FL,	  USA)	  to	  create	  a	  series	  resistance	  of	  1.9-­‐2.4	  MOhms,	  and	  were	  
manipulated	  using	  a	  Siskiyou	  Motion	  Control	  MC-­‐1000e	  (Grants	  Pass,	  OR,	  USA).	  Pipettes	  were	  
filled	  with	  ice	  cold	  internal	  solution	  containing	  (in	  mM)	  CsMs	  (128),	  EGTA	  (1),	  HEPE-­‐K	  (10),	  
MgCl2	  (1),	  NaCl	  (10),	  Mg-­‐ATP	  (2),	  Na-­‐GTP	  (0.3),	  QX-­‐314-­‐Cl	  (3),	  final	  pH	  7.35,	  295	  mOsm.	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All	  recordings	  were	  amplified	  using	  an	  Axon/Molecular	  Devices	  Multiclamp	  Amplifier	  700B	  
(Sunnyvale,	  CA),	  digitized	  at	  20	  KHz	  using	  a	  HEKA/Harvard	  Bioscience	  InstruTECH	  Digitizer,	  ITC-­‐
18	  (Holliston,	  MA,	  USA)	  and	  recorded	  filtered	  at	  2	  KHz	  using	  Axograph	  Software	  version	  1.5.4	  
(Berkeley,	  CA,	  USA).	  A	  continuous	  record	  was	  also	  saved	  using	  an	  ADInstruments	  PowerLab	  
2/26	  (Sydney,	  AUS).	  
	  
NA	  core	  neurons	  were	  chosen	  to	  be	  dorsomedial	  to	  the	  anterior	  commissure,	  and	  NA	  shell	  
neurons	  medial	  and	  ventral	  to	  the	  ventral-­‐most	  extension	  in	  the	  slice	  of	  the	  lateral	  ventricle.	  
Series	  resistance	  was	  monitored	  continuously	  during	  final	  approach	  to	  the	  cell	  using	  a	  
hyperpolarizing	  step	  of	  2	  mV	  over	  40	  msec.	  Following	  formation	  of	  a	  gigaohm	  seal,	  negative	  
pressure	  was	  used	  to	  transition	  from	  cell-­‐attached	  to	  whole	  cell	  recording	  mode,	  as	  evidenced	  
by	  the	  appearance	  of	  an	  RC	  curve.	  Baseline	  cell	  characteristics	  were	  ascertained	  by	  fitting	  a	  
double	  exponential	  to	  this	  curve,	  and	  putative	  interneurons	  were	  excluded	  based	  on	  a	  
combination	  of	  low	  capacitance	  and	  high	  membrane	  resistance.	  Putative	  MSNs	  had	  membrane	  
capacitance	  ranging	  between	  80-­‐120	  pF,	  membrane	  resistance	  ranging	  between	  100-­‐300	  
mOhms,	  and	  resting	  membrane	  potential	  ranging	  between	  negative	  70-­‐85	  mV	  (without	  
correcting	  for	  liquid	  junction	  potential).	  
	  
AMPA:NMDA	  ratio	  
A	  bipolar	  stimulating	  electrode	  (FHC,	  Bowdoin,	  ME,	  USA)	  was	  placed	  dorsomedial	  to	  the	  neuron	  
being	  recorded.	  Excitatory	  Post-­‐Synaptic	  Currents	  were	  electrically	  evoked,	  and	  the	  stimulation	  
intensity	  calibrated	  to	  evoke	  EPSCs	  between	  200	  and	  450	  pA.	  Evoked	  EPSCs	  were	  recorded	  at	  a	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holding	  potential	  of	  -­‐80	  mV	  during	  a	  5	  minute	  baseline	  to	  insure	  stability	  of	  the	  response.	  The	  
cell’s	  holding	  potential	  was	  then	  adjusted	  to	  +40	  mV	  to	  relieve	  the	  magnesium	  block	  on	  NMDA	  
receptors.	  Evoked	  EPSCs,	  consisting	  of	  a	  mixture	  of	  AMPA	  and	  NMDA	  currents,	  were	  recorded.	  
Then,	  D-­‐AP5,	  an	  NMDA	  receptor	  antagonist,	  was	  applied	  and	  evoked	  EPSCs	  consisting	  of	  pure	  
AMPA	  receptor	  mediated	  currents	  were	  recorded.	  The	  average	  AMPA	  receptor	  current	  trace	  
was	  subtracted	  from	  the	  average	  mixed	  current	  trace	  in	  order	  to	  calculate	  a	  pure	  NMDA	  
current	  trace.	  AMPA:NMDA	  ratios	  were	  calculated	  by	  dividing	  the	  (baseline	  corrected)	  peak	  
amplitude	  of	  the	  AMPA	  current	  by	  the	  peak	  amplitude	  of	  the	  NMDA	  current.	  Changes	  in	  access	  
resistance	  of	  >20%	  between	  the	  two	  recording	  conditions	  resulted	  in	  removal	  of	  the	  cell	  from	  
further	  analyses.	  
	  
AMPAR	  rectification	  index	  
These	  recordings	  included	  spermine	  (100	  uM)	  in	  the	  internal	  solution,	  but	  were	  otherwise	  
identical	  to	  the	  CsMs-­‐based	  solution	  described	  above.	  EPSCs	  were	  first	  calibrated	  as	  described	  
above.	  Then	  AMPAR	  currents	  (in	  the	  presence	  of	  d-­‐AP5,	  as	  described	  above)	  were	  evoked	  while	  
holding	  the	  cell	  at	  a	  series	  of	  membrane	  voltages	  (+40	  mV,	  +20mV,	  +10mV,	  0mV,	  -­‐40mV,	  -­‐80	  
mV).	  The	  resulting	  EPSCs	  were	  averaged	  across	  10	  sweeps.	  The	  peak	  amplitude	  was	  plotted	  
against	  the	  holding	  potential	  at	  which	  it	  was	  recorded.	  Two	  separate	  regression	  lines	  were	  
calculated	  for	  inward	  and	  outward	  currents.	  These	  lines	  converged	  at	  the	  reversal	  potential,	  
which	  was	  typically	  slightly	  positively	  shifted	  (~5	  mV),	  likely	  due	  to	  uncorrected	  liquid	  junction	  
potential.	  As	  a	  result,	  three	  points	  were	  typically	  available	  for	  calculating	  both	  slopes.	  The	  
AMPAR	  rectification	  index	  (RI)	  was	  calculated	  as	  the	  slope	  of	  the	  IV	  relationship	  for	  inward	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currents	  divided	  by	  the	  slope	  of	  the	  IV	  curve	  for	  outward	  currents.	  This	  results	  in	  an	  RI	  >	  1	  for	  
inwardly	  rectifying	  (i.e.	  calcium-­‐permeable)	  AMPA	  receptors,	  and	  an	  RI	  </=	  1	  for	  non-­‐rectifying	  
or	  outwardly	  rectifying	  CI-­‐AMPARs	  (Kamboj	  et	  al.,	  1995;	  Liu	  and	  Cull-­‐Candy,	  2002).	  	  
	  
Spontaneous	  excitatory	  post-­‐synaptic	  currents	  
Spontaneous	  EPSCs	  were	  recorded	  at	  -­‐80	  mV.	  The	  epochs	  examined	  for	  sEPSCs	  were	  at	  least	  10	  
seconds	  after	  the	  electrical	  stimulus	  evoking	  eEPSCs,	  as	  the	  release	  probability	  for	  
asynchronous	  EPSCs	  decays	  over	  several	  seconds	  after	  evoked	  synchronous	  release	  (Kavalali,	  
2015).	  A	  template	  function	  was	  initially	  defined	  from	  a	  single	  sEPSC	  and	  was	  used	  to	  detect	  all	  
the	  available	  sEPSCs.	  Then,	  the	  average	  sEPSC	  was	  defined	  as	  a	  new	  template	  function	  and	  a	  
second	  round	  of	  detection	  occurred.	  sEPSCs	  detected	  during	  this	  second	  round	  were	  excluded	  if	  
their	  amplitude	  or	  baseline	  offset	  values	  were	  statistical	  outliers	  (based	  on	  visual	  inspection	  of	  
the	  histogram).	  The	  minimum	  amplitude	  cutoff	  was	  defined	  as	  4	  x	  the	  standard	  deviation	  of	  the	  
noise,	  and	  at	  least	  10	  pA	  (although	  repeating	  the	  analyses	  without	  a	  minimum	  amplitude	  cutoff	  
did	  not	  change	  the	  results).	  	  
	  
Dendritic	  spine	  analysis	  
Rats	  were	  injected	  with	  ketamine/xylazine	  and	  transcardially	  perfused	  with	  PB,	  followed	  by	  
1.5%	  PfA.	  The	  brain	  was	  removed	  and	  blocked	  at	  the	  level	  of	  the	  cerebral	  
peduncles/mammillary	  bodies,	  and	  further	  perfused	  with	  1.5%	  PfA	  for	  an	  additional	  hour	  
before	  being	  sliced	  in	  PBS.	  Coronal	  slices	  containing	  nucleus	  accumbens	  (200	  um)	  were	  made	  
on	  a	  HM	  650V	  vibrating	  blade	  microtome	  (ThermoFisher	  Scientific,	  Waltham,	  MA,	  USA).	  Slices	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were	  diolistically	  labeled	  using	  a	  Helios	  System	  gene	  gun	  (Biorad,	  Hercules,	  CA,	  USA)	  to	  deliver	  
tungsten	  particles	  coated	  with	  the	  lipophilic	  carbocyanine	  dye	  DiI	  (1,1'-­‐Dioctadecyl-­‐3,3,3',3'-­‐
Tetramethylindocarbocyanine	  Perchlorate;	  ThermoFisher	  cat	  #D282).	  This	  protocol	  has	  also	  
been	  extensively	  described	  by	  our	  lab	  	  (Shen	  et	  al.,	  2008a).	  DiI	  labeled	  slices	  were	  imaged	  on	  a	  
confocal	  microscope	  (Leica,	  Wetzler,	  Germany)	  using	  an	  oil	  immersion	  63x	  objective	  with	  a	  
numerical	  aperture	  of	  1.4	  (lens	  material	  number	  506188),	  using	  a	  HeNe	  543	  laser	  with	  a	  voxel	  
size	  of	  47x47x100	  nm.	  Medium	  spiny	  neurons	  (visually	  identified	  by	  extensive	  and	  heavily	  spiny	  
arborization)	  were	  chosen	  to	  be	  dorsomedial	  to	  the	  anterior	  commissure	  (NA	  core)	  or	  
ventromedial	  to	  the	  ventral	  tip	  of	  the	  lateral	  ventricle	  (NA	  shell).	  A	  50	  um	  dendritic	  segment	  
beginning	  at	  least	  75	  um	  from	  the	  soma	  and	  distal	  to	  the	  first	  branch	  point	  was	  imaged.	  Gain	  
was	  calibrated	  separately	  for	  each	  segment	  due	  to	  the	  high	  variability	  of	  DiI	  staining,	  and	  was	  
chosen	  to	  maximize	  signal	  without	  causing	  intensity	  saturation	  within	  spine	  heads.	  Successive	  Z	  
planes	  (0.07	  um)	  were	  constructed	  by	  averaging	  four	  line	  scans.	  The	  final	  reconstructed	  
segment	  was	  deconvolved	  using	  Autoquant	  software	  (Media	  Cybernetics,	  Rockville,	  MD,	  USA)	  
and	  spine	  quantification	  (terminal	  point	  diameter	  and	  density)	  was	  performed	  using	  Imaris	  
software	  (Bitplane,	  Zurich,	  Switzerland).	  	  
	  
Zymography	  
Dye-­‐quenched	  gelatin	  (ThermoFisher	  cat	  #	  D12054)	  was	  microinjected	  into	  NA	  shell	  at	  a	  volume	  
of	  1.5	  uL,	  15	  minutes	  prior	  to	  sacrifice	  (with	  or	  without	  re-­‐exposure	  to	  the	  extinguished	  
context).	  Rats	  were	  anesthetized	  with	  pentobarbital	  and	  transcardially	  perfused	  with	  PB	  and	  
10%	  formalin.	  Coronal	  slices	  containing	  nucleus	  accumbens	  (50	  um)	  were	  made	  on	  a	  HM	  650V	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vibrating	  blade	  microtome	  (ThermoFisher	  Scientific,	  Waltham,	  MA,	  USA).	  DiI	  labeled	  slices	  were	  
imaged	  on	  a	  confocal	  microscope	  (Leica,	  Wetzler,	  Germany)	  using	  an	  10x	  objective	  using	  an	  
argon	  488	  laser.	  Only	  slices	  containing	  the	  injection	  tract	  were	  imaged.	  Integrated	  density	  of	  
FITC	  fluorescence	  was	  quantified	  using	  ImageJ	  (Research	  Services	  Branch,	  National	  Institutes	  of	  
Health,	  Bethesda,	  MD),	  with	  the	  exclusion	  of	  the	  injection	  tract,	  the	  anterior	  commissure,	  and	  




Data	  (e.g.	  AMPA:NMDA	  ratio,	  AMPAR	  rectification	  index,	  sEPSC	  amplitude/frequency)	  were	  
analyzed	  using	  cell	  values	  as	  sample	  population.	  One-­‐way	  analyses	  of	  variance	  (ANOVAs)	  were	  
conducted	  when	  two	  or	  more	  groups	  were	  being	  compared	  to	  a	  common	  baseline	  (e.g.	  
extinction	  baseline	  compared	  to	  refraining	  and	  cue-­‐induced	  reinstatement).	  Two	  way	  ANOVAs	  
(Factor	  1:	  (baseline	  vs.	  drug	  seeking)	  X	  Factor	  2:	  (extinction	  vs.	  abstinent)	  were	  used	  to	  examine	  




Some	  experiments	  involved	  comparisons	  of	  two	  behavioral	  paradigms	  (e.g.	  cue-­‐induced	  drug	  
seeking	  after	  abstinence	  vs.	  extinction;	  refraining	  vs.	  cue-­‐induced	  reinstatement).	  These	  data	  
were	  analyzed	  by	  two-­‐way	  ANOVA	  (Factor	  1:	  behavioral	  paradigm	  X	  Factor	  2:	  operand	  (active	  
vs.	  inactive)).	  Effects	  of	  microinjecting	  MSX-­‐3	  into	  NA	  shell	  were	  examined	  using	  a	  repeated-­‐
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measures	  two-­‐way	  ANOVA	  (Factor	  1:	  Dose	  (vehicle	  vs.	  10	  µg	  vs.	  20	  µg)	  X	  Factor	  2:	  operand	  
(active	  vs.	  inactive)).	  	  
	  
Spines	  
Data	  were	  analyzed	  using	  a	  nested	  (hierarchical)	  ANOVA,	  in	  which	  cell	  values	  were	  grouped	  by	  
subject	  and	  subjects	  were	  grouped	  by	  condition	  (McDonald,	  2009;	  Aarts	  et	  al.,	  2014).	  This	  
analysis	  strategy	  disentangles	  the	  amount	  of	  variance	  accounted	  for	  by	  between-­‐group	  
differences	  from	  between-­‐subject/within-­‐group	  differences	  and	  has	  been	  used	  for	  spine	  
analyses	  in	  our	  previous	  publications	  (Spencer	  et	  al.,	  2016).	  
	  
General	  
All	  data	  were	  analyzed	  using	  Prism,	  version	  6.0	  (GraphPad	  Software,	  La	  Jolla,	  CA,	  USA),	  except	  
the	  hierarchical	  ANOVA	  which	  was	  done	  using	  a	  freely	  available	  excel	  spreadsheet	  (McDonald,	  
2009).	  Outliers	  were	  removed	  using	  the	  ROUT	  module	  of	  Prism	  (Motulsky	  and	  Brown,	  2006).	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Chapter	  4  Transient	  synaptic	  potentiation	  (tSP)	  during	  refraining	  is	  
distinct	  from	  reinstatement	  tSP	  
Introduction	  
Despite	  the	  significant	  progress	  made	  in	  treating	  cocaine	  addiction	  (Dutra	  et	  al.,	  2008),	  there	  is	  
a	  continuing	  need	  for	  better	  treatments	  and	  a	  deeper	  understanding	  of	  the	  basic	  brain	  
mechanisms	  supporting	  drug	  seeking	  and	  refraining	  from	  drug	  seeking.	  Exposure	  therapy	  has	  
enjoyed	  considerable	  success	  in	  treating	  other	  psychiatric	  disorders	  (Force,	  2000).	  An	  
understanding	  of	  the	  synaptic	  mechanisms	  supporting	  exposure	  therapy	  led	  to	  the	  creation	  of	  
targeted	  pharmacological	  enhancement	  of	  these	  behavior	  therapies	  (Ressler	  et	  al.,	  2004).	  
Although	  analogous	  approaches	  have	  thus	  far	  failed	  in	  treating	  drug	  addiction,	  this	  may	  be	  due	  
to	  a	  lack	  of	  understanding	  of	  the	  specific	  synaptic	  mechanisms	  that	  support	  extinction	  of	  drug	  
addiction	  as	  opposed	  to	  other	  psychiatric	  disorders	  (McNally,	  2014).	  	  Also,	  while	  extinction	  
training	  alone	  has	  not	  been	  successful,	  understanding	  mechanisms	  of	  inhibitory	  learning	  may	  
provide	  a	  therapeutically	  relevant	  target	  as	  part	  of	  a	  combination	  treatment	  where	  multiple	  
endophenotypes	  of	  substance	  use	  disorder	  (SUD)	  are	  simultaneously	  targeted	  
pharmacologically	  and/or	  through	  psychosocial	  intervention.	  
	  
The	  ultimate	  goal	  of	  extinction	  therapies	  is	  the	  suppression	  of	  drug	  seeking	  (henceforth	  
“refraining”).	  The	  neural	  substrates	  of	  refraining	  after	  extinction	  therapies	  have	  been	  partly	  
elucidated	  in	  research	  with	  animal	  models.	  Specifically,	  the	  infralimbic	  prefrontal	  cortex	  (IL-­‐PFC)	  
projection	  to	  nucleus	  accumbens	  (NA)	  shell	  suppresses	  drug	  seeking,	  both	  during	  refraining	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(Peters	  et	  al.,	  2008)	  and	  reinstatement	  of	  drug	  seeking	  (Ma	  et	  al.,	  2014).	  	  Also,	  augmenting	  
activity	  in	  the	  IL-­‐PFC	  to	  NA	  shell	  pathway	  can	  additionally	  suppress	  reinstatement	  (LaLumiere	  et	  
al.,	  2012;	  Augur	  et	  al.,	  2016).	  	  	  
	  
The	  prelimbic	  (PL)-­‐PFC	  projection	  to	  NA	  core	  is	  similarly	  important	  for	  reinstatement	  of	  drug	  
seeking	  (Stefanik	  et	  al.,	  2013).	  During	  reinstatement,	  the	  PL-­‐PFC	  projection	  induces	  a	  form	  of	  
synaptic	  potentiation	  in	  NA	  core	  neurons	  that	  we	  have	  termed	  transient	  synaptic	  potentiation	  
(tSP)	  (Gipson	  et	  al.,	  2013a;	  Stefanik	  et	  al.,	  2016).	  tSP	  is	  expressed	  as	  both	  a	  rapid	  increase	  in	  
AMPA:NMDA	  ratio	  and	  dendritic	  spine	  head	  diameter	  that	  reverts	  to	  baseline	  levels	  by	  the	  end	  
of	  a	  two	  hour	  reinstatement	  test.	  The	  magnitude	  of	  drug	  seeking	  during	  cue-­‐induced	  
reinstatement	  is	  highly	  correlated	  with	  the	  magnitude	  of	  tSP,	  and	  manipulations	  that	  block	  tSP	  
also	  block	  drug	  seeking	  (Shen	  et	  al.,	  2011;	  Gipson	  et	  al.,	  2013b).	  	  	  
	  
The	  finding	  that	  the	  PL-­‐PFC	  projection	  to	  NA	  core	  may	  drive	  drug	  seeking	  in	  part	  by	  inducing	  tSP	  
led	  us	  to	  hypothesize	  that	  the	  IL-­‐PFC	  projection	  to	  NA	  shell	  may	  drive	  refraining	  by	  a	  similar	  
mechanism.	  I	  hypothesize	  that	  15	  minutes	  of	  refraining	  will	  increase	  AMPA:NMDA	  ratios	  and	  
dendritic	  spine	  head	  diameter	  in	  NA	  shell	  neurons,	  and	  that	  these	  markers	  will	  revert	  to	  
baseline	  levels	  by	  the	  end	  of	  the	  two	  hour	  refraining	  test.	  Further,	  I	  hypothesize	  that	  refraining	  
tSP	  will	  not	  be	  expressed	  in	  NA	  core,	  and	  that	  reinstatement	  tSP	  will	  be	  expressed	  in	  NA	  core	  
but	  not	  in	  NA	  shell.	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Matrix	  metalloproteinase	  (MMP)	  activity	  closely	  correlates	  with	  increases	  in	  spine	  head	  
diameter	  and	  AMPA:NMDA	  ratio	  that	  characterize	  tSP	  (Spencer	  et	  al.,	  2016).	  MMPs	  are	  
activated	  by	  nitrosylation,	  downstream	  of	  mGluR5	  stimulation	  of	  neuronal	  nitric	  oxide	  
synthase,	  and	  this	  cascade	  appears	  to	  be	  both	  necessary	  and	  sufficient	  for	  tSP	  (Smith	  et	  al.,	  
2014;	  Smith	  et	  al.,	  2016).	  MMP	  activity	  is	  also	  necessary	  for	  induction	  of	  synaptic	  plasticity	  in	  
other	  preparations	  as	  well	  (Nagy	  et	  al.,	  2006;	  Bozdagi	  et	  al.,	  2007;	  Wang	  et	  al.,	  2008).	  	  I	  
hypothesize	  that	  MMP	  activity	  is	  associated	  with	  refraining-­‐induced	  tSP.	  
	  
The	  specific	  AMPARs	  contacted	  by	  IL-­‐PFC	  input	  to	  NA	  shell	  that	  suppress	  drug	  seeking	  appear	  to	  
be	  calcium	  permeable	  (CP-­‐AMPARs)	  (Ma	  et	  al.,	  2014;	  Pascoli	  et	  al.,	  2014).	  In	  contrast,	  calcium	  
impermeable	  (CI)-­‐AMPARs	  inserted	  into	  PL-­‐PFC	  to	  NA	  core	  synapses	  promote	  drug	  seeking,	  and	  
reinstatement	  tSP	  inserts	  additional	  CI-­‐AMPARs	  into	  NA	  core	  neurons	  (Shen	  et	  al.,	  2014).	  I	  
hypothesize	  that	  refraining	  tSP	  involves	  a	  further	  insertion	  of	  CP-­‐AMPARs	  into	  NA	  shell	  MSNs.	  
	  
Below	  we	  test	  each	  hypothesis	  in	  turn,	  and	  find	  that	  refraining	  is	  associated	  with	  a	  transient	  
synaptic	  potentiation	  inasmuch	  as	  15	  min	  exposure	  to	  an	  extinguished	  environment	  increased	  
AMPA:NMDA	  in	  the	  NA	  shell,	  but	  not	  NA	  core.	  	  However	  in	  contrast	  to	  tSP	  induced	  in	  the	  NA	  
core	  by	  drug	  associated	  cues,	  the	  increase	  in	  AMPA:NMDA	  was	  not	  associated	  with	  an	  increase	  
in	  spine	  head	  diameter	  or	  MMP	  activity.	  	  Also,	  there	  was	  no	  electrophysiological	  evidence	  
found	  to	  suggest	  a	  change	  AMPAR	  subunit	  composition.	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Results	  
Assessment	  of	  transient	  synaptic	  potentiation	  (tSP)	  during	  refraining	  and	  reinstatement	  
The	  behavioral	  paradigm	  used	  to	  assess	  tSP	  is	  described	  in	  Figure	  4-­‐1.	  Rats	  self-­‐administered	  
cocaine	  for	  10	  days,	  during	  which	  each	  cocaine	  infusion	  was	  paired	  with	  a	  discrete	  cue	  (light	  +	  
tone),	  followed	  by	  2-­‐3	  weeks	  of	  extinction	  training	  (Figure	  4-­‐3)	  before	  engaging	  in	  one	  of	  two	  
15-­‐minute	  behavioral	  tests	  in	  the	  operant	  chamber.	  Re-­‐exposure	  to	  drug-­‐paired	  cues	  reinstated	  
drug	  seeking	  behavior,	  while	  re-­‐exposure	  to	  the	  extinguished	  context	  alone	  induced	  refraining	  
behavior,	  during	  which	  drug	  seeking	  (active	  lever	  pressing)	  was	  very	  low	  compared	  to	  cue-­‐
induced	  reinstatement	  (Welch’s	  corrected	  t-­‐test	  t(9.81)=9.795;	  p<0.0001;	  Figure	  4-­‐3).	  	  
	  
	  
Figure	  4-­‐1.	  Behavioral	  design	  to	  assess	  transient	  synaptic	  potentiation	  after	  extinction.	  Arrows	  
refer	  to	  time	  points	  of	  sacrifice	  for	  assessment	  of	  synaptic	  markers.	  Baseline	  measures	  were	  
taken	  24	  hours	  after	  the	  previous	  extinction	  session.	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Figure	  4-­‐2.	  Self-­‐administration	  and	  extinction	  behavior.	  Error bars are S.E.M. N= 36	  
	  
	  
Figure	  4-­‐3.	  Refraining	  and	  cue-­‐induced	  drug	  seeking	  following	  extinction. Re-exposure to the 
extinguished context alone induced refraining behavior. The addition of contingent cues robustly 
reinstated drug seeking (DS) as indicated by increased active lever pressing (Welch’s 
t(10.55)=9.366, p<0.0001). Error bars are S.E.M.	  
	  
tSP	  (AMPA/NMDA	  increase)	  occurs	  in	  NA	  shell	  during	  refraining	  but	  not	  during	  reinstatement	  
NA	  core	  and	  shell	  play	  opposite	  roles	  in	  cue-­‐induced	  reinstatement	  of	  cocaine	  seeking.	  
Prefrontal	  inputs	  to	  NA	  core	  drive	  cue-­‐induced	  reinstatement,	  while	  prefrontal	  inputs	  to	  NA	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shell	  suppress	  drug	  seeking,	  (McFarland	  and	  Kalivas,	  2001;	  Peters	  et	  al.,	  2008;	  Ma	  et	  al.,	  2014).	  
Transient	  synaptic	  potentiation	  (tSP)	  occurs	  in	  NA	  core	  during	  cue-­‐induced	  reinstatement	  of	  
cocaine	  seeking	  (Gipson	  et	  al.,	  2013a;	  Smith	  et	  al.,	  2014).	  Here,	  we	  show	  that	  tSP	  occurs	  in	  NA	  
shell	  during	  refraining,	  but	  not	  reinstatement	  (one-way ANOVA;	  F(3,	  60)	  =	  2.890,	  p=0.043;	  
Figure	  4-­‐4).	  15	  minutes	  of	  refraining	  behavior	  increased	  AMPA:NMDA	  ratios	  in	  NA	  shell,	  relative	  
to	  baseline	  (measured	  24	  hours	  after	  the	  previous	  extinction	  session).	  This	  AMPA:NMDA	  
potentiation	  was	  transient,	  and	  reverted	  to	  baseline	  levels	  by	  the	  end	  of	  two	  hours	  of	  
extinction	  behavior.	  Fifteen	  minutes	  of	  cue-­‐induced	  reinstatement	  did	  not	  significantly	  
potentiate	  AMPA:NMDA	  ratios	  in	  NA	  shell,	  but	  may	  have	  shown	  a	  trend	  toward	  potentiation.	  
This	  suggests	  that	  a	  sub-­‐population	  of	  NA	  shell	  MSNs	  responds	  to	  the	  extinguished	  
environment,	  regardless	  of	  the	  elicited	  behavior.	  Refraining	  tSP	  was	  not	  associated	  with	  
changes	  in	  sEPSC	  frequency	  (t(46)=0.5198;	  p=0.61)	  or	  amplitude	  (Welch’s	  corrected	  
t(42.50)=1.537;	  p=0.13)	  in	  NA	  shell	  (Figure	  4-­‐5).	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Figure	  4-­‐4.	  Transient	  synaptic	  potentiation	  (tSP)	  occurs	  in	  NA	  shell	  during	  refraining	  but	  not	  cue-­‐
induced	  drug	  seeking. AMPA:NMDA ratio is transiently elevated by 15 minutes of refraining and 
reverts to baseline by the end of a 2-hour extinction session. AMPA:NMDA ratio does not 
significantly increase during cue-induced drug seeking (one-way ANOVA;	  F(3,	  60)	  =	  2.890,	  
p=0.043). Statistical tests performed using cell values. Error bars represent S.E.M. Scale bars 
are 50 msec and 20 pA.	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Figure	  4-­‐5.	  Transient	  synaptic	  potentiation	  (tSP)	  in	  NA	  shell	  is	  not	  associated	  with	  increased	  
sEPSC	  amplitude	  or	  frequency.	  Statistical tests use cell values. Error bars represent S.E.M. Scale 
bars are 250 msec by 20 pA. 
	  
tSP	  occurs	  in	  NA	  core	  during	  reinstatement	  but	  not	  during	  refraining	  
We	  have	  previously	  characterized	  tSP	  in	  NA	  core	  as	  a	  highly	  sensitive	  correlate	  of	  drug	  seeking.	  
It	  occurs	  during	  reinstatement	  of	  cocaine	  seeking	  driven	  by	  cues	  (Gipson	  et	  al.,	  2013a),	  context	  
(Stankeviciute	  et	  al.,	  2013),	  and	  a	  priming	  injection	  of	  cocaine	  (Shen	  et	  al.,	  2014),	  as	  well	  as	  
reinstatement	  of	  nicotine	  seeking	  (Gipson	  et	  al.,	  2013b)	  and	  heroin	  seeking	  (Shen	  et	  al.,	  2011).	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However,	  all	  of	  these	  tests	  occurred	  in	  the	  extinguished	  context,	  and	  we	  have	  never	  
demonstrated	  that	  drug	  seeking	  per	  se	  is	  driving	  tSP.	  I	  show	  here	  that	  15	  minutes	  of	  
reinstatement	  behavior	  potentiates	  AMPA:NMDA	  ratios	  while	  merely	  returning	  to	  the	  
extinguished	  context	  during	  refraining	  does	  not	  (one	  way	  ANOVA:	  F(2, 33) = 6.567, p = 0.004; 
Figure	  4-­‐6).	  Finding	  that	  tSP	  cannot	  be	  induced	  simply	  by	  return	  to	  the	  extinguished	  context	  
during	  refraining	  suggests	  that	  NA	  core	  tSP	  is	  a	  specific	  and	  sensitive	  correlate	  of	  drug	  seeking.	  
Reinstatement	  tSP	  was	  not	  expressed	  as	  changes	  in	  sEPSC	  frequency	  (t(25)=0.2536;	  p=0.80)	  or	  
amplitude	  (t(25)=0.2175;	  p=0.83)	  (Figure	  4-­‐7).	  	  	  
	  
Figure	  4-­‐6.	  tSP	  occurs	  in	  NA	  core	  during	  cue-­‐induced	  reinstatement,	  but	  not	  refraining.	  
AMPA:NMDA	  ratio	  increases	  in	  NA	  core	  MSNs	  during	  15	  minutes	  of	  drug	  seeking	  (F(2, 33) = 
6.567, p = 0.004); DS-Cue was increased relative both to baseline (p = 0.004) and refraining (p 
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= 0.019) by post-hoc Tukey’s multiple comparisons. Statistical tests performed using cell values. 




Figure	  4-­‐7.	  Transient	  synaptic	  potentiation	  (tSP)	  in	  NA	  core	  is	  not	  associated	  with	  increased	  sEPSC	  
amplitude	  or	  frequency.	  Statistical tests performed using cell values. Error bars represent S.E.M. 
Scale bars are 250 msec and 20 pA.	  
	  
NA	  core	  but	  not	  shell	  tSP	  is	  expressed	  as	  spine	  head	  expansion	  
Cue-­‐induced	  drug	  seeking	  also	  transiently	  potentiates	  spine	  head	  diameter	  in	  NA	  core	  neurons	  
(t(3.09)=4.136, p=0.02; Figure	  4-­‐8) as previously described (Gipson et al., 2013a). Interestingly, 
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refraining	  does	  not	  potentiate	  spine	  head	  diameter	  in	  NA	  shell.	  Although	  potentiation	  of	  
AMPA:NMDA	  ratio	  and	  spine	  head	  diameter	  typically	  co-­‐occur	  (Matsuzaki	  et	  al.,	  2004;	  Bock	  et	  
al.,	  2013),	  we	  have	  previously	  observed	  that	  the	  time	  course	  of	  AMPA:NMDA	  and	  spine	  
potentiation	  diverges	  during	  cue-­‐induced	  reinstatement	  (Gipson	  et	  al.,	  2013a).	  In	  addition,	  NA	  
shell	  spine	  head	  diameter	  also	  did	  not	  potentiate	  during	  cue-­‐induced	  reinstatement,	  nor	  did	  NA	  
core	  spine	  head	  diameter	  during	  refraining	  (Figure	  4-­‐8).	  Spine	  density	  also	  did	  not	  change	  in	  NA	  




Figure	  4-­‐8:	  Increased	  spine	  head	  diameter	  parallels	  increased	  AMPA:NMDA	  ratio	  during	  drug	  
seeking	  but	  not	  refraining. Spine head diameter also does not increase during refraining in NA 
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core or during reinstatement in NA shell. Nested ANOVA results are described for NA core in 








Fs P variance 
component 
(percentage) 
among groups 0.1962 2 0.0981 4.7183 0.0443 32.81 
subgroups within groups 0.1823 9 0.0208 8.3217 4.75E-9 30.43 
within subgroups 0.2313 95 0.002435   36.76 
total 0.6098 106       100.00 
Table	  4-­‐1.	  Nested	  ANOVA	  for	  NA	  core	  spine	  diameter.	  Between	  group	  differences	  (baseline	  vs.	  
refraining	  vs.	  cue-­‐induced	  reinstatement)	  account	  for	  a	  third	  of	  the	  variance	  of	  spine	  head	  










Fs P variance 
component 
(percentage) 
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among groups 0.005712 2 0.002856 0.4810 0.6332 0 
subgroups within groups 0.0565 9 0.005938 2.1720 0.0259 12.49 
within subgroups 0.2499 96 0.002603 
  
87.51 
total 0.3122 108          100.00 
Table	  4-­‐2.	  Nested	  ANOVA	  for	  NA	  shell	  spine	  diameter.	  Between	  group	  differences	  (baseline	  vs.	  
refraining	  vs.	  cue-­‐induced	  reinstatement)	  do	  not	  account	  for	  any	  of	  the	  variance	  of	  spine	  head	  
diameter	  in	  NA	  shell.	  
	  
Figure	  4-­‐9.	  Spine	  density	  does	  not	  change	  during	  refraining	  or	  reinstatement	  in	  NA	  shell	  but	  	  
may	  change	  in	  NA	  core.	  NA	  core	  does	  show	  a	  trend	  towards	  between	  group	  differences	  (p	  =	  
0.075),	  but	  NA	  shell	  does	  not.	  Error bars represent S.E.M. Nested ANOVA results are described 
for NA core in Table	  4-­‐3 and for NA shell in Table	  4-­‐4.	  	  
	  




Fs P variance 
component 
(percentage) 
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among groups 6.8530 2 3.4265 3.6553 0.0745 21.30 
subgroups within groups 8.2365 9 0.9374 5.2373 8.88E-­6 25.49 
within subgroups 16.6004 95 0.1747 
  
53.21 
total 31.6899 106          100.00 
Table	  4-­‐3.	  Nested	  ANOVA	  for	  NA	  core	  spine	  density.	  Between	  group	  differences	  (baseline	  vs.	  
refraining	  vs.	  cue-­‐induced	  reinstatement)	  account	  for	  21%	  of	  the	  variance	  in	  spine	  density	  in	  NA	  
shell,	  which	  is	  a	  statistical	  trend	  (p	  =	  0.07).	  	  




Fs P variance 
component 
(percentage) 
among groups 0.5723 2 0.2862 0.1715 0.8451 0 
subgroups within groups 15.4372 10 1.6683 7.6165 7.68E-­9 44.63 
within subgroups 19.4574 96 0.2027 
  
55.37 
total 35.4669 108          100.00 
Table	  4-­‐4.	  Nested	  ANOVA	  for	  NA	  core	  spine	  density.	  Between	  group	  differences	  (baseline	  vs.	  
refraining	  vs.	  cue-­‐induced	  reinstatement)	  account	  for	  0%	  of	  the	  variance	  in	  spine	  density	  in	  NA	  
shell,	  similar	  to	  spine	  diameter.	  
	  
	  
Refraining	  does	  not	  increase	  gelatinase	  activity	  in	  NA	  shell	  
Gelatinases	  (matrix	  metalloproteinases	  (MMPs)	  2	  and	  9)	  activate	  in	  NA	  core	  during	  cue-­‐induced	  
drug	  seeking,	  and	  MMP	  activation	  in	  NA	  core	  is	  necessary	  for	  spine	  enlargement	  in	  NA	  core	  and	  
drug	  seeking	  behavior	  (Smith	  et	  al.,	  2014).	  The	  absence	  of	  spine	  head	  enlargement	  in	  NA	  shell	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during	  refraining	  behavior	  suggests	  that	  MMP	  activity	  may	  not	  increase	  in	  NA	  shell	  during	  
refraining	  either.	  Consistent	  with	  this	  hypothesis,	  un-­‐quenching	  of	  FITC	  fluorescence	  by	  MMP	  
activation	  did	  not	  increase	  in	  NA	  shell	  after	  15	  minutes	  of	  refraining	  behavior	  (Figure	  4-­‐10).	  	  
	  
Figure	  4-­‐10.	  Refraining	  tSP	  is	  not	  associated	  with	  matrix	  metalloproteinase	  (MMP)	  increases	  in	  
NA	  shell. FITC fluorescence is unquenched by cleavage of gelatin, and is thus a marker of MMP 
enzymatic activity. t(5) = 0.59, p = .58. Statistical tests done using animals, in which 4-6 slices 
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were averaged to create a single data point for each animal. Error bars represent S.E.M. 
Micrograph scale bar is 500 µm. 	  
 
 
AMPARs	  incorporated	  into	  NA	  shell	  during	  refraining	  are	  not	  calcium	  permeable	  
Calcium	  permeable	  (CP)	  AMPARs	  in	  NA	  shell	  suppress	  drug	  seeking	  in	  non-­‐incubation	  models	  of	  
cocaine	  exposure	  (Ma	  et	  al.,	  2014;	  Pascoli	  et	  al.,	  2014;	  Terrier	  et	  al.,	  2016).	  Incorporation	  of	  CP-­‐
AMPARs	  increases	  the	  AMPA:NMDA	  ratio	  as	  effectively	  as	  CI-­‐AMPARs,	  provided	  that	  spermine	  
is	  not	  included	  in	  the	  internal	  solution	  (Hearing	  et	  al.,	  2016).	  In	  addition,	  CP-­‐AMPARs	  have	  a	  
greater	  single	  channel	  conductance	  than	  calcium	  impermeable	  (CI)	  AMPARs	  (Liu	  and	  Cull-­‐
Candy,	  2000).	  Thus,	  I	  hypothesized	  that	  replacement	  of	  a	  portion	  of	  CI-­‐AMPARs	  with	  CP-­‐
AMPARs	  in	  NA	  shell	  neurons	  could	  potentiate	  AMPA:NMDA	  ratio	  without	  enlarging	  spines,	  and	  
simultaneously	  promote	  refraining.	  However,	  AMPAR	  rectification	  indices	  recorded	  in	  NA	  shell	  
did	  not	  increase	  during	  refraining	  (Figure	  4-­‐11),	  arguing	  against	  insertion	  of	  CP-­‐AMPARs.	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Figure	  4-­‐11.	  Refraining	  tSP	  is	  not	  driven	  by	  insertion	  of	  calcium	  permeable	  AMPARs.	  CP-­‐AMPARs	  
are	  not	  inserted	  into	  NA	  shell	  MSNs	  during	  refraining	  as	  indicated	  by	  a	  lack	  of	  increase	  in	  the	  
rectification	  index	  (t(20)=0.7222	  p=0.48).	  Rectification	  index	  is	  calculated	  by	  dividing	  inward	  
current	  I/V	  slopes	  by	  outward	  current	  I/V	  slopes.	  Error	  bars	  represent	  S.E.M.	  Scale	  bar	  is	  50	  pA	  
by	  50	  msec.	  
	  
Discussion	  
In	  these	  experiments	  I	  examined	  transient	  synaptic	  potentiation	  (tSP)	  during	  refraining	  and	  cue-­‐
induced	  reinstatement	  of	  drug	  seeking.	  NA	  shell	  MSNs	  expressed	  tSP	  during	  refraining	  (and	  
possibly	  during	  cue-­‐induced	  reinstatement),	  as	  indicated	  by	  transiently	  elevated	  AMPA:NMDA	  
ratios	  that	  reverted	  to	  baseline	  levels	  after	  two	  hours.	  Refraining	  was	  not	  associated	  with	  
increased	  calcium	  permeable	  (CP)-­‐AMPAR	  expression,	  matrix	  metalloproteinase	  (MMP)	  activity,	  
or	  dendritic	  spine	  head	  diameter	  in	  NA	  shell.	  In	  contrast,	  both	  dendritic	  spine	  head	  diameter	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and	  AMPA:NMDA	  ratio	  increased	  in	  NA	  core	  MSNs	  during	  cue-­‐induced	  reinstatement,	  but	  not	  
refraining.	  	  
	  
Overall,	  these	  data	  demonstrate	  important	  differences	  between	  transient	  synaptic	  potentiation	  
(tSP)	  induced	  by	  refraining	  and	  reinstatement.	  First,	  these	  two	  forms	  of	  tSP	  are	  doubly	  
dissociated	  anatomically.	  This	  is	  consistent	  with	  the	  prevailing	  understanding	  of	  the	  role	  of	  
these	  two	  accumbens	  subcompartments	  in	  appetitive	  behavior,	  including	  drug	  seeking	  (Kalivas	  
and	  McFarland,	  2003;	  Reynolds	  and	  Berridge,	  2003;	  Backstrom	  and	  Hyytia,	  2007;	  LaLumiere	  
and	  Kalivas,	  2008;	  LaLumiere	  et	  al.,	  2010;	  Millan	  et	  al.,	  2010;	  Rocha	  and	  Kalivas,	  2010;	  
Ghazizadeh	  et	  al.,	  2012;	  LaLumiere	  et	  al.,	  2012;	  Stefanik	  and	  Kalivas,	  2013;	  Stefanik	  et	  al.,	  2013;	  
Guillem	  et	  al.,	  2014;	  Ma	  et	  al.,	  2014;	  O'Connor	  et	  al.,	  2015;	  Prado	  et	  al.,	  2016;	  Stefanik	  et	  al.,	  
2016).	  However,	  a	  subpopulation	  of	  NA	  shell	  cells	  may	  have	  been	  potentiated	  during	  cue-­‐
induced	  reinstatement	  of	  drug	  seeking.	  It	  is	  possible	  that	  this	  sub-­‐population	  encodes	  the	  
extinguished	  context,	  which	  is	  present	  in	  both	  refraining	  and	  reinstatement.	  The	  role	  of	  NA	  
shell	  in	  encoding	  context	  is	  discussed	  in	  Chapter	  4,	  and	  of	  mediating	  refraining	  in	  Chapter	  5.	  
Although	  the	  information	  encoded	  by	  NA	  shell	  tSP	  remains	  somewhat	  ambiguous,	  my	  results	  
demonstrate	  that	  refraining	  tSP	  is	  expressed	  only	  in	  NA	  shell	  and	  not	  NA	  core.	  
	  
In	  addition	  to	  being	  anatomically	  distinct,	  refraining	  and	  reinstatement	  tSP	  depend	  on	  separate	  
signaling	  mechanisms.	  Reinstatement	  tSP	  requires	  activation	  of	  MMPs	  in	  NA	  core	  (Smith	  et	  al.,	  
2014),	  while	  our	  results	  show	  no	  MMP	  increase	  in	  NA	  shell	  during	  refraining.	  MMPs	  are	  
necessary	  for	  spine	  expansion	  during	  reinstatement	  tSP,	  and	  the	  lack	  of	  MMP	  increase	  shown	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here	  may	  explain	  the	  rather	  surprising	  finding	  that	  spine	  head	  diameter	  does	  not	  increase	  in	  
parallel	  with	  AMPA:NMDA	  ratio	  during	  refraining.	  Spines	  and	  AMPAR	  insertion	  typically	  co-­‐
occur	  (Matsuzaki	  et	  al.,	  2004).	  However,	  these	  two	  forms	  of	  plasticity	  partly	  depend	  on	  
separate	  intracellular	  signaling	  mechanisms	  (Wang	  et	  al.,	  2007;	  Cingolani	  and	  Goda,	  2008),	  and	  
possibly	  extracellular	  signaling	  mechanisms	  (e.g.	  MMP	  activity)	  as	  indicated	  by	  our	  results.	  	  
	  
The	  dissociation	  between	  AMPA:NMDA	  ratio	  and	  spine	  diameter	  could	  also	  result	  from	  
increased	  AMPAR	  conductance	  rather	  than	  AMPAR	  insertion.	  CP-­‐AMPARs	  have	  increased	  single	  
channel	  conductance	  relative	  to	  calcium	  impermeable	  (CI)	  AMPARs	  (Swanson	  et	  al.,	  1997),	  and	  
a	  substitution	  of	  CP-­‐AMPARs	  for	  CI-­‐AMPARs	  could	  increase	  AMPAR	  conductance	  without	  
increasing	  total	  AMPAR	  number	  (and	  hence	  not	  enlarge	  spines).	  CP-­‐AMPAR	  insertion	  can	  
increase	  AMPA:NMDA	  ratio	  when	  spermine	  is	  not	  included	  in	  the	  internal	  solution	  to	  replace	  
the	  endogenous	  polyamines	  that	  are	  lost	  during	  recording	  (Hearing	  et	  al.,	  2016).	  Moreover,	  CP-­‐
AMPARs	  in	  NA	  shell	  mediate	  the	  suppression	  of	  drug	  seeking	  by	  inputs	  from	  IL-­‐PFC	  (Ma	  et	  al.,	  
2014),	  and	  the	  IL-­‐PFC	  input	  to	  NA	  shell	  is	  necessary	  for	  refraining	  (Peters	  et	  al.,	  2008;	  
Ghazizadeh	  et	  al.,	  2012).	  However,	  the	  lack	  of	  increase	  in	  the	  AMPAR	  rectification	  index	  argues	  
against	  the	  role	  of	  CP-­‐AMPAR	  insertion	  in	  refraining	  tSP.	  To	  the	  extent	  that	  AMPAR	  insertion	  
mediates	  NA	  shell	  tSP	  during	  refraining,	  it	  appears	  that	  these	  AMPARs	  are	  calcium	  impermeable	  
and	  thus	  contain	  a	  GluA2	  subunit.	  As	  a	  result,	  refraining	  tSP	  can	  likely	  be	  prevented	  by	  peptides	  
that	  interfere	  with	  GluA2	  trafficking	  (Famous	  et	  al.,	  2008),	  and	  future	  studies	  will	  determine	  the	  
necessity	  of	  NA	  shell	  tSP	  for	  refraining.	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In	  summary,	  refraining	  is	  accompanied	  by	  a	  transient	  synaptic	  potentiation	  in	  NA	  shell	  but	  not	  
NA	  core,	  in	  which	  AMPA:NMDA	  ratios	  increase	  after	  15	  minutes	  and	  revert	  to	  baseline	  levels	  
after	  2	  hours.	  The	  increase	  in	  AMPA:NMDA	  ratio	  is	  likely	  driven	  at	  least	  in	  part	  by	  an	  insertion	  
of	  CI-­‐AMPARs.	  Refraining	  tSP	  is	  not	  associated	  with	  spine	  enlargement	  or	  MMP	  activation.	  In	  
contrast,	  reinstatement	  tSP	  occurs	  in	  NA	  core	  but	  not	  NA	  shell,	  and	  is	  expressed	  both	  as	  an	  
increase	  in	  AMPA:NMDA	  ratio	  and	  dendritic	  spine	  enlargement.	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Chapter	  5  Extinction	  induces	  metaplasticity	  in	  accumbens	  core	  and	  shell	  
Introduction	  
In	  the	  previous	  chapter,	  I	  discovered	  that	  refraining	  induces	  tSP	  in	  NA	  shell.	  My	  initial	  choice	  of	  
the	  NA	  shell	  as	  the	  potential	  anatomical	  locus	  of	  this	  synaptic	  plasticity	  was	  supported	  by	  a	  
study	  which	  found	  that	  extinction	  induces	  an	  upregulation	  of	  AMPARs	  in	  NA	  shell,	  which	  is	  
sufficient	  to	  hasten	  extinction	  learning	  and	  suppress	  drug	  seeking	  during	  foot	  shock-­‐induced	  
reinstatement	  (Sutton	  et	  al.,	  2003).	  With	  this	  in	  mind,	  I	  found	  a	  striking	  absence	  of	  any	  changes	  
in	  AMPA:NMDA	  ratio	  or	  other	  markers	  of	  synaptic	  incorporation	  of	  AMPARs	  in	  NA	  shell	  after	  
extinction.	  These	  data	  combined	  with	  a	  lack	  of	  a	  literature	  with	  findings	  supporting	  Sutton	  et	  al	  
(2003)	  in	  the	  intervening	  years	  since	  publication	  is	  likely	  explained	  by	  a	  comparison	  of	  the	  
synaptic	  changes	  induced	  by	  extinction	  and	  abstinence	  after	  cocaine	  self-­‐administration	  
(Knackstedt	  et	  al.,	  2010).	  Knackstedt	  et	  al.	  found	  no	  changes	  in	  AMPARs	  in	  the	  PSD	  sub-­‐fraction,	  
where	  they	  are	  expected	  to	  exist	  if	  they	  are	  actively	  contributing	  to	  measures	  such	  as	  the	  
AMPA:NMDA	  ratio.	  Together	  these	  studies	  left	  open	  the	  question	  that	  if	  NA	  shell	  AMPARs	  are	  
upregulated	  by	  extinction	  and	  if	  NA	  shell	  AMPAR	  upregulation	  promotes	  refraining,	  then	  how	  
can	  these	  AMPARs	  exert	  their	  effect	  if	  they	  are	  not	  constitutively	  inserted	  into	  synapses?	  My	  
finding	  in	  the	  previous	  chapter,	  that	  returning	  to	  an	  extinguished	  context	  simultaneously	  
induces	  refraining	  and	  tSP	  in	  NA	  shell	  addresses	  this	  discrepancy.	  
	  
However,	  it	  remains	  an	  open	  question	  whether	  NA	  shell	  tSP	  is	  specifically	  driven	  by	  refraining	  
or	  can	  be	  driven	  by	  any	  motivationally	  salient	  context.	  NA	  shell	  activity	  mediates	  both	  context-­‐
induced	  refraining	  (Peters	  et	  al.,	  2008)	  and	  reinstatement	  (Cruz	  et	  al.,	  2014).	  While	  the	  former	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depends	  on	  projections	  from	  IL-­‐PFC,	  the	  latter	  may	  depend	  on	  a	  combination	  of	  IL-­‐PFC	  and	  
vHPC	  input	  (Bossert	  et	  al.,	  2012;	  Bossert	  et	  al.,	  2016).	  In	  addition,	  simultaneous	  IL-­‐PFC	  input	  
and	  dopamine	  signaling	  in	  NA	  shell	  is	  necessary	  for	  context-­‐induced	  reinstatement	  (Bossert	  et	  
al.,	  2012),	  but	  dopamine	  in	  NA	  shell	  countermands	  the	  ability	  of	  IL-­‐PFC	  to	  suppressing	  cue-­‐
induced	  reinstatement	  of	  drug	  seeking	  (LaLumiere	  et	  al.,	  2012).	  	  
	  
It	  is	  possible	  that	  NA	  shell	  will	  express	  tSP	  during	  context-­‐induced	  drug	  seeking	  as	  well	  as	  
refraining.	  However,	  it	  is	  equally	  possible	  that	  context-­‐induced	  drug	  seeking	  will	  induce	  tSP	  in	  
either	  NA	  core	  or	  dorsolateral	  caudate	  putamen	  (dlCPu)	  rather	  than	  NA	  shell.	  These	  regions	  
have	  both	  been	  shown	  to	  mediate	  context-­‐induced	  drug	  seeking	  (Fuchs	  et	  al.,	  2006;	  Peters	  et	  
al.,	  2008)	  and	  NA	  core	  expresses	  tSP	  (in	  terms	  of	  dendritic	  spine	  expansion)	  during	  context-­‐
induced	  reinstatement	  after	  extinction	  (Stankeviciute	  et	  al.,	  2013).	  Also,	  drug	  seeking	  driven	  by	  
cues	  has	  repeatedly	  been	  shown	  to	  induce	  tSP.	  Therefore,	  even	  if	  I	  do	  not	  observe	  tSP	  during	  
drug	  seeking	  driven	  by	  context	  alone,	  I	  expect	  tSP	  in	  NA	  core	  during	  drug	  seeking	  driven	  by	  
context	  and	  cues,	  and	  possibly	  in	  NA	  shell,	  which	  seems	  independently	  capable	  of	  mediating	  
drug	  seeking	  induced	  by	  context	  and	  cues	  (Pascoli	  et	  al.,	  2014).	  	  	  
	  
In	  summary,	  I	  hypothesize	  that	  extinction	  will	  not	  induce	  basal	  potentiation	  of	  synapses	  in	  NA	  
core	  or	  NA	  shell.	  I	  hypothesize	  that	  context-­‐induced	  reinstatement	  will	  induce	  tSP	  either	  in	  NA	  
shell,	  NA	  core,	  and	  dlCPu.	  If	  this	  does	  not	  occur,	  I	  hypothesize	  that	  tSP	  will	  be	  rescued	  by	  the	  
addition	  of	  cues	  in	  at	  least	  one	  of	  these	  anatomical	  loci,	  and	  that	  tSP	  will	  be	  expressed	  both	  as	  
increased	  AMPA:NMDA	  ratio	  and	  dendritic	  spine	  head	  diameter.	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Results	  
Assessment	  of	  transient	  synaptic	  potentiation	  (tSP)	  
The	  timing	  of	  behavior	  and	  sacrifice	  is	  explained	  in	  Figure	  5-­‐1.	  Rats	  self-­‐administered	  cocaine	  
for	  10	  days	  (Figure	  5-­‐2),	  during	  which	  each	  cocaine	  infusion	  was	  paired	  with	  a	  discrete	  cue	  
(light	  +	  tone),	  followed	  by	  2-­‐3	  weeks	  of	  home-­‐cage	  abstinence	  before	  one	  of	  two	  15-­‐minute	  
behavioral	  tests	  in	  the	  operant	  chamber.	  The	  return	  to	  the	  drug-­‐paired	  context	  elicited	  drug	  
seeking,	  regardless	  of	  whether	  or	  not	  cues	  were	  presented	  after	  lever	  presses	  (Figure	  5-­‐3).	  	  
	  
Figure	  5-­‐1.	  Experimental	  design	  for	  chapter	  2.	  The	  effect	  of	  extinction	  vs.	  abstinence	  per	  se	  was	  
examined	  by	  comparing	  animals	  sacrificed	  at	  baseline	  (without	  return	  to	  the	  operant	  chamber).	  
tSP	  during	  drug	  seeking	  was	  examined	  after	  re-­‐exposure	  to	  the	  drug	  paired	  context,	  with	  or	  
without	  cues.	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Figure	  5-­‐2.	  Aggregated	  self-­‐administration	  data	  for	  all	  rats	  tested	  after	  abstinence.	  N	  =	  24,	  Error	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Figure	  5-­‐3.	  Drug	  seeking	  in	  rats	  after	  abstinence.	  Return	  to	  the	  drug-­‐paired	  context	  after	  
abstinence	  drives	  drug	  seeking	  (DS)	  regardless	  of	  whether	  or	  not	  active	  lever	  presses	  caused	  cue	  
delivery.	  Error	  bars	  represent	  S.E.M.	  
	  
Extinction	  does	  not	  potentiate	  synapses	  in	  NA	  shell	  or	  NA	  core	  
Extinction	  has	  previously	  been	  reported	  to	  increase	  AMPAR	  subunits	  in	  NA	  shell,	  relative	  to	  
abstinent	  withdrawal	  (Sutton	  et	  al.,	  2003).	  I	  did	  not	  observe	  a	  functional	  evidence	  of	  AMPAR	  
incorporation	  in	  NAshell	  MSNs	  (Figure	  5-­‐4).	  This	  is	  consistent	  with	  the	  finding	  that	  AMPAR	  
upregulation	  in	  NA	  shell	  by	  extinction	  training	  is	  seen	  in	  whole	  cell	  lysate	  but	  not	  the	  PSD	  
subfraction	  (Knackstedt	  et	  al.,	  2010).	  Interestingly,	  I	  saw	  a	  trend	  toward	  decreased	  
AMPA:NMDA	  ratio	  after	  extinction	  training	  in	  NA	  core	  (t(25)=1.86,	  p=0.08;	  Figure	  5-­‐4),	  
suggesting	  that	  extinction	  may	  depress	  these	  synapses.	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Figure	  5-­‐4.	  Extinction	  does	  not	  cause	  constitutive	  synaptic	  potentiation.	  Extinction	  does	  not	  
constitutively	  potentiate	  or	  depress	  synapses	  in	  NA	  core	  (t(25)=1.86,	  p=0.08)	  or	  NA	  shell	  
(t(46)=1.06,p=0.30).	  Extinction	  baseline	  shown	  above	  is	  from	  the	  previous	  chapter,	  and	  
abstinent	  baseline	  is	  the	  same	  as	  examine	  in	  the	  following	  figures.	  Statistical	  tests	  performed	  
using	  cell	  values.	  Error	  bars	  represent	  S.E.M.	  Scale	  bars	  are	  50	  msec	  and	  20	  pA.	  
	  
	  
Context-­‐induced	  drug	  seeking	  after	  abstinence	  does	  not	  induce	  AMPAR	  insertion	  in	  NA	  shell,	  NA	  
core,	  or	  dlCPu	  
I	  initially	  sought	  to	  determine	  whether	  tSP	  would	  occur	  in	  NA	  shell	  during	  context	  induced	  drug	  
seeking,	  due	  to	  the	  involvement	  of	  NA	  shell	  in	  context-­‐induced	  drug	  seeking	  (Bossert	  et	  al.,	  
2012;	  Cruz	  et	  al.,	  2014;	  Bossert	  et	  al.,	  2016).	  Context-­‐induced	  drug	  seeking	  did	  not	  induce	  tSP	  in	  
NA	  shell	  (Figure	  5-­‐5),	  increasing	  the	  likelihood	  that	  NA	  shell	  tSP	  is	  specific	  to	  refraining	  (and	  not	  
simply	  a	  response	  to	  a	  motivationally	  salient	  context).	  Next,	  I	  hypothesized	  that	  context-­‐
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induced	  drug	  seeking	  would	  induce	  AMPAR	  insertion	  into	  NA	  core,	  which	  expresses	  tSP	  under	  
all	  conditions	  previously	  studied.	  To	  our	  surprise,	  context-­‐induced	  drug	  seeking	  did	  not	  induce	  
tSP	  in	  NA	  core	  (Figure	  5-­‐6).	  Dorsolateral	  caudate	  putamen	  is	  necessary	  for	  context-­‐induced	  
drug	  seeking	  after	  abstinence	  (Fuchs	  et	  al.,	  2006),	  but	  context-­‐induced	  drug	  seeking	  did	  not	  
induce	  functional	  evidence	  of	  AMPAR	  insertion	  in	  dlCPu	  (Figure	  5-­‐7).	  	  
	  
Figure	  5-­‐5.	  NA	  shell	  does	  not	  express	  tSP	  during	  drug	  seeking	  after	  abstinence.	  AMPA:NMDA	  
ratio	  does	  not	  increase	  during	  15	  minutes	  of	  drug	  seeking	  after	  abstinence,	  regardless	  of	  
whether	  cues	  are	  present	  during	  drug	  seeking	  (F(2,	  37)	  =	  0.2827,	  p=0.76).	  Statistical	  tests	  
performed	  using	  cell	  values.	  Error	  bars	  represent	  S.E.M.	  Scale	  bars	  are	  50	  msec	  and	  20	  pA.	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Figure	  5-­‐6.	  NA	  core	  does	  not	  express	  tSP	  during	  drug	  seeking	  after	  abstinence.	  AMPA:NMDA	  
ratio	  does	  not	  increase	  during	  15	  minutes	  of	  drug	  seeking	  after	  abstinence,	  regardless	  of	  
whether	  cues	  are	  present	  during	  drug	  seeking	  (F(2,	  31)	  =	  0.9533,	  p=0.40).	  Statistical	  tests	  
performed	  using	  cell	  values.	  Error	  bars	  represent	  S.E.M.	  Scale	  bars	  are	  50	  msec	  and	  20	  pA. 
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Figure	  5-­‐7.	  Dorsolateral	  caudate	  putamen	  (dlCPu)	  does	  not	  express	  tSP	  during	  drug	  seeking	  
after	  abstinence.	  AMPA:NMDA	  ratio	  does	  not	  increase	  during	  15	  minutes	  of	  drug	  seeking	  after	  
abstinence	  (t(20)=1.667,	  p=0.11).	  Statistical	  tests	  performed	  using	  cell	  values.	  Error	  bars	  
represent	  S.E.M.	  Scale	  bars	  are	  50	  msec	  and	  20	  pA.	  
Cues	  do	  not	  rescue	  tSP	  during	  drug	  seeking	  after	  abstinence	  
Although	  some	  work	  has	  characterized	  tSP	  during	  context-­‐induced	  drug	  seeking	  in	  NA	  core	  
(Stankeviciute	  et	  al.,	  2013),	  the	  majority	  of	  our	  studies	  of	  tSP	  in	  NA	  core	  have	  involved	  cue-­‐
induced	  drug	  seeking	  (Gipson	  et	  al.,	  2013a;	  Smith	  et	  al.,	  2014;	  Smith	  et	  al.,	  2016).	  I	  therefore	  
hypothesized	  that	  drug	  seeking	  induced	  by	  a	  combination	  of	  context	  and	  cues	  would	  rescue	  the	  
loss	  of	  tSP	  in	  NA	  core.	  However,	  context	  +	  cue-­‐induced	  drug	  seeking	  neither	  induced	  AMPAR	  
incorporation	  (Figure	  5-­‐6)	  nor	  spine	  enlargement	  (Figure	  5-­‐8),	  although	  NA	  core	  spine	  density	  
may	  decrease	  during	  cue-­‐induced	  drug	  seeking	  (Figure	  5-­‐9).	  Context	  +	  cue-­‐induced	  drug	  
seeking	  also	  does	  not	  cause	  AMPAR	  incorporation	  into	  NA	  shell	  (Figure	  5-­‐5).	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Figure	  5-­‐8.	  NA	  core	  spines	  do	  not	  enlarge	  during	  drug	  seeking	  after	  abstinence.	  Spine	  head	  
diameter	  does	  not	  increase	  during	  15	  minutes	  of	  drug	  seeking	  after	  abstinence.	  Nested	  ANOVA	  
results	  are	  shown	  in	  Table	  5-­‐1.	  Error	  bars	  represent	  S.E.M.	  Scale	  bars	  are	  5	  µm. 
	  
Figure	  5-­‐9.	  NA	  core	  spine	  density	  may	  decrease	  during	  drug	  seeking	  after	  abstinence.	  Spine	  
head	  density	  shows	  a	  statistical	  trend	  toward	  decrease	  (p	  =	  .054)	  during	  15	  minutes	  of	  drug	  
seeking	  after	  abstinence.	  Nested	  ANOVA	  results	  are	  shown	  in	  Table	  5-­‐2.	  Error	  bars	  represent	  
S.E.M.	  Scale	  bars	  are	  5	  µm.	  








Fs P variance 
component 
(percentage) 
among groups 0.007169 1 0.007169 2.2191 0.2748 5.77 
subgroups within groups 0.0140 3 0.003230 0.5958 0.6705 0 
within subgroups 0.0998 17 0.005869 
  
94.23 
total 0.1209 22          100.00 
Table	  5-­‐1.	  Nested	  ANOVA	  results	  for	  spine	  head	  diameter	  during	  drug	  seeking	  after	  abstinence.	  
Drug	  seeking	  did	  not	  explain	  a	  significant	  portion	  of	  the	  variance	  in	  spine	  head	  diameter	  	  




Fs P variance 
component 
(percentage) 
among groups 0.7955 1 0.7955 9.4796 0.0542 38.87 
subgroups within groups 0.3430 3 0.0839 0.8394 0.5190 0 
within subgroups 1.7368 17 0.1022 
  
61.13 
total 2.8753 22          100.00 
Table	  5-­‐2.	  Nested	  ANOVA	  results	  for	  spine	  density	  during	  drug	  seeking	  after	  abstinence.	  Drug	  
seeking	  explained	  ~40%	  of	  the	  variance	  in	  spine	  density,	  a	  statistical	  trend	  (p	  =	  0.054).	  	  
Discussion	  
Despite	  the	  fact	  that	  re-­‐exposure	  to	  a	  drug-­‐paired	  context	  causes	  drug	  seeking,	  it	  fails	  to	  induce	  
tSP	  in	  NA	  shell,	  NA	  core,	  or	  dorsolateral	  caudate	  putamen	  (dlCPu).	  The	  addition	  of	  drug-­‐paired	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cues	  does	  not	  rescue	  tSP	  in	  NA	  core	  (either	  in	  terms	  of	  AMPA:NMDA	  ratio	  increase	  or	  dendritic	  
spine	  enlargement)	  or	  NA	  shell.	  In	  addition,	  extinction	  training	  does	  not	  produce	  an	  enduring	  
potentiation	  NA	  shell	  neurons	  relative	  to	  an	  equivalent	  period	  of	  abstinence,	  but	  may	  depress	  
NA	  core	  neurons.	  
	  
The	  lack	  of	  tSP	  in	  NA	  shell	  during	  context-­‐induced	  drug	  seeking	  suggests	  that	  tSP	  in	  NA	  shell	  is	  
not	  simply	  encoding	  all	  motivationally	  salient	  contexts,	  but	  rather	  is	  specific	  for	  the	  
extinguished	  context	  and/or	  the	  resulting	  refraining	  behavior.	  This	  is	  important	  in	  light	  of	  the	  
dual	  role	  NA	  shell	  plays	  in	  mediating	  both	  the	  refraining	  response	  to	  an	  extinguished	  context	  
(reviewed	  in	  the	  last	  chapter)	  and	  the	  drug-­‐seeking	  response	  to	  a	  drug-­‐paired	  context	  (Bossert	  
et	  al.,	  2012;	  Lee	  et	  al.,	  2013;	  Cruz	  et	  al.,	  2014;	  Pascoli	  et	  al.,	  2014;	  Bossert	  et	  al.,	  2016).	  	  
	  
I	  considered	  three	  possible	  explanations	  for	  the	  lack	  of	  tSP.	  First,	  NA	  shell	  may	  not	  have	  been	  
the	  anatomical	  substrate	  of	  drug	  seeking	  in	  our	  model.	  For	  example,	  the	  NA	  core	  (Peters	  et	  al.,	  
2008)	  or	  dorsolateral	  caudate	  putamen	  (dlCPu)	  (Fuchs	  et	  al.,	  2006)	  may	  be	  the	  anatomical	  locus	  
mediating	  context-­‐induced	  drug	  seeking.	  However,	  I	  determined	  that	  neither	  of	  these	  brain	  
regions	  expresses	  tSP	  during	  context-­‐induced	  drug	  seeking	  either.	  The	  second	  possibility	  is	  that	  
discrete	  cues	  might	  be	  necessary	  for	  tSP	  during	  drug	  seeking.	  Discrete	  cues	  activate	  circuitry	  
that	  contextual	  cues	  do	  not	  (Bossert	  et	  al.,	  2007;	  Stuber	  et	  al.,	  2011),	  and	  most	  previous	  studies	  
of	  tSP	  included	  discrete	  cues.	  However,	  discrete	  cues	  in	  combination	  with	  context	  did	  not	  
produce	  tSP	  either	  in	  NA	  core	  nor	  NA	  shell.	  The	  third	  possibility	  I	  considered	  is	  that	  dendritic	  
spines	  might	  express	  tSP	  during	  drug	  seeking	  after	  abstinence	  even	  though	  AMPA:NMDA	  ratio	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does	  not.	  As	  discussed	  in	  the	  previous	  chapter,	  these	  two	  markers	  of	  tSP	  can	  be	  differentially	  
expressed.	  Although	  I	  found	  no	  evidence	  of	  dendritic	  spine	  enlargement	  during	  drug	  seeking	  
induced	  by	  context	  and	  cues,	  NA	  core	  displayed	  a	  non-­‐significant	  trend	  of	  decreased	  spine	  
density	  during	  drug	  seeking	  after	  abstinence,	  as	  may	  also	  be	  the	  case	  during	  drug	  seeking	  after	  
extinction	  (Figure	  4-­‐9).	  	  
	  
These	  experiments	  are	  the	  first	  conducted	  that	  fail	  to	  show	  tSP	  during	  drug	  seeking	  (Shen	  et	  al.,	  
2011;	  Gipson	  et	  al.,	  2013a;	  Gipson	  et	  al.,	  2013b;	  Stankeviciute	  et	  al.,	  2013;	  Gipson	  et	  al.,	  2014;	  
Shen	  et	  al.,	  2014;	  Smith	  et	  al.,	  2014;	  Smith	  et	  al.,	  2016;	  Spencer	  et	  al.,	  2016;	  Stefanik	  et	  al.,	  
2016).	  All	  of	  our	  previous	  experiments	  examined	  drug	  seeking	  after	  extinction,	  while	  my	  
experiments	  in	  this	  chapter	  examined	  drug	  seeking	  after	  abstinence.	  This	  suggests	  that	  tSP	  
requires	  some	  form	  of	  metaplasticity	  that	  is	  conferred	  by	  extinction	  training.	  This	  metaplasticity	  
enables	  cues	  and	  context	  to	  induce	  tSP,	  but	  does	  not	  affect	  basal	  AMPA:NMDA	  ratios	  (although	  
extinction	  showed	  a	  trend	  (p	  <	  0.1)	  toward	  removing	  AMPARs	  from	  synapses	  in	  NA	  core).	  
	  
In	  conclusion,	  these	  experiments,	  considered	  in	  light	  of	  chapter	  1,	  suggest	  that	  tSP	  during	  
refraining	  and	  reinstatement	  of	  drug	  seeking	  require	  a	  form	  of	  metaplasticity	  that	  is	  induced	  by	  
extinction.	  However,	  the	  possibility	  is	  considered	  in	  the	  next	  chapter	  that	  extinction-­‐induced	  
metaplasticity	  is	  necessary	  for	  only	  one	  class	  of	  MSNs	  to	  undergo	  tSP.	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Chapter	  6  Extinction	  enables	  D2-­‐MSN	  tSP,	  drug	  seeking	  induces	  D1-­‐MSN	  
tSP	  
Introduction	  
The	  conclusion	  of	  the	  previous	  chapter	  is	  that	  extinction	  confers	  metaplasticity	  (without	  
constitutive	  synaptic	  potentiation)	  in	  NA	  core	  and	  shell.	  This	  is	  suggested	  by	  the	  inability	  of	  drug	  
seeking	  (driven	  by	  context	  +/-­‐	  cues)	  after	  abstinence	  to	  induce	  tSP;	  contrasting	  the	  extensive	  
literature	  characterizing	  tSP	  during	  drug	  seeking	  after	  extinction.	  In	  addition,	  neither	  refraining	  
behavior	  nor	  its	  associated	  tSP	  are	  seen	  in	  the	  absence	  of	  prior	  extinction	  training.	  To	  further	  
characterize	  the	  role	  of	  extinction	  in	  promoting	  tSP	  during	  drug	  seeking	  and	  the	  lack	  of	  effect	  
after	  abstinence,	  I	  examined	  D1-­‐MSNs	  and	  D2-­‐MSNs	  in	  transgenic	  reporter	  mice	  engaging	  in	  
refraining	  or	  drug	  seeking	  after	  abstinence	  or	  extinction.	  
	  
One	  possible	  explanation	  for	  the	  lack	  of	  tSP	  in	  rats	  is	  that	  neither	  D1-­‐MSNs	  nor	  D2-­‐MSNs	  
express	  tSP	  during	  drug	  seeking	  after	  abstinence.	  However,	  if	  either	  cell	  type	  in	  NA	  core	  
expresses	  tSP	  under	  these	  conditions,	  it	  is	  likely	  to	  be	  D1-­‐MSNs	  (Durieux	  et	  al.,	  2009;	  Hikida	  et	  
al.,	  2010;	  Lobo	  et	  al.,	  2010;	  Ferguson	  et	  al.,	  2011;	  Heinsbroek	  et	  al.,	  2016).	  However,	  if	  this	  is	  
the	  case,	  it	  would	  indicate	  that	  extinction-­‐induced	  metaplasticity	  is	  not	  expressed	  on	  D1-­‐MSNs,	  
and	  therefore	  must	  be	  expressed	  on	  D2-­‐MSNs.	  This	  possibility	  has	  logical	  appeal,	  considering	  
that	  both	  extinction	  (Buffalari	  et	  al.,	  2013;	  Kim	  et	  al.,	  2015)	  and	  potentiation	  of	  D2-­‐MSNs	  in	  NA	  
core	  (Bock	  et	  al.,	  2013)	  suppress	  drug	  seeking.	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In	  contrast,	  there	  is	  some	  evidence	  that	  D1-­‐MSNs	  in	  NA	  shell	  might	  suppress	  drug	  seeking	  (Ma	  
et	  al.,	  2014;	  Pascoli	  et	  al.,	  2014)	  and	  that	  D2-­‐MSNs	  might	  enhance	  drug	  seeking	  during	  
incubation	  of	  craving	  (Lee	  et	  al.,	  2013;	  Terrier	  et	  al.,	  2016).	  However,	  both	  of	  these	  seemingly	  
paradoxical	  effects	  are	  mediated	  by	  CP-­‐AMPARs,	  which	  were	  not	  involved	  in	  refraining	  tSP	  (see	  
Chapter	  1).	  In	  contrast,	  CI-­‐AMPARs	  on	  D1-­‐MSNs	  in	  NA	  shell	  appear	  to	  promote	  drug	  seeking	  
(Pascoli	  et	  al.,	  2014).	  It	  is	  not	  known	  how	  drug	  seeking	  is	  affected	  by	  D2-­‐MSN	  CI-­‐AMPAR	  
signaling	  in	  NA	  shell.	  However,	  D2-­‐MSN	  CI-­‐AMPAR	  signaling	  in	  NA	  core	  suppresses	  drug	  seeking	  
(Bock	  et	  al.,	  2013).	  Therefore,	  D2-­‐MSNs	  rather	  than	  D1-­‐MSNs	  are	  likely	  to	  express	  tSP	  in	  NA	  
shell	  during	  refraining.	  If	  D2-­‐MSNs	  tSP	  causes	  refraining	  then	  inhibiting	  D2	  MSNs	  should	  
prevent	  refraining.	  Two	  main	  mechanisms	  are	  important	  for	  MSN	  post-­‐synaptic	  potentiation:	  
NMDAR	  signaling	  and	  Gs-­‐GPCR	  signaling	  (Shen	  et	  al.,	  2008b).	  Gs	  signaling	  in	  D2-­‐MSNs	  requires	  
the	  adenosine	  A2a	  receptor.	  Thus,	  if	  D2-­‐MSN	  tSP	  causes	  refraining,	  then	  antagonizing	  A2aR	  
signaling	  in	  NA	  shell	  should	  suppress	  refraining	  (and	  cause	  reinstatement).	  	  
	  
Here,	  I	  hypothesize	  that	  D1-­‐MSNs	  in	  NA	  core	  express	  tSP	  during	  drug	  seeking,	  regardless	  of	  
whether	  or	  not	  animals	  had	  previously	  undergone	  extinction	  training,	  and	  that	  the	  magnitude	  
of	  drug	  seeking	  correlates	  with	  AMPA:NMDA	  ratio	  on	  D1-­‐MSNs	  in	  NA	  core.	  Conversely,	  I	  
hypothesize	  that	  extinction	  training	  is	  necessary	  to	  allow	  D2-­‐MSNs	  in	  NA	  core	  to	  undergo	  tSP	  
during	  drug	  seeking.	  Finally,	  I	  hypothesize	  that	  D2-­‐MSNs	  (but	  not	  D1-­‐MSNs)	  in	  NA	  shell	  express	  
tSP	  during	  refraining,	  and	  that	  selective	  blockade	  of	  D2-­‐MSN	  potentiation	  prevents	  refraining	  
and	  spontaneously	  reinstates	  drug	  seeking.	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Results	  
Extinction	  attenuates	  cue-­‐induced	  drug	  seeking.	  	  
Extinction	  training	  attenuated	  subsequent	  drug	  seeking	  in	  response	  to	  drug-­‐paired	  cues.	  Mice	  
that	  had	  previously	  undergone	  extinction	  completed	  significantly	  fewer	  operant	  responses	  
during	  a	  30	  minute	  cue-­‐induced	  drug	  seeking	  test	  (t(10)=2.746,	  p=0.02;	  Figure	  6-­‐2).	  However,	  
mice	  self-­‐administered	  drugs	  using	  different	  operands	  for	  the	  two	  conditions	  Figure	  6-­‐1.	  Mice	  
undergoing	  tests	  of	  drug	  seeking	  after	  abstinence	  had	  self-­‐administered	  cocaine	  using	  lever	  
presses.	  Mice	  failed	  to	  extinguish	  lever	  pressing,	  and	  so	  the	  operand	  was	  switched	  to	  
nosepokes	  for	  the	  tests	  of	  drug	  seeking	  after	  extinction.	  In	  order	  to	  control	  for	  the	  possibility	  
that	  different	  operands	  mediated	  the	  attenuation	  of	  drug	  seeking	  after	  extinction	  relative	  to	  
abstinence,	  we	  also	  examined	  cue-­‐induced	  drug	  seeking	  after	  abstinence	  and	  extinction	  in	  rats	  
(repeated	  from	  the	  previous	  two	  chapters)	  and	  found	  that	  extinction	  attenuates	  drug	  seeking	  
after	  abstinence	  when	  both	  tests	  are	  conducted	  using	  the	  same	  operand	  (Figure	  6-­‐3).	  This	  is	  
consistent	  with	  work	  from	  other	  groups	  that	  has	  shown	  that	  extinction	  attenuates	  drug	  seeking	  
(Buffalari	  et	  al.,	  2013;	  Kim	  et	  al.,	  2015).	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Figure	  6-­‐1.	  Self-­‐administration	  and	  extinction	  data	  for	  mice.	  Mice	  pressed	  levers	  during	  self-­‐
administration	  in	  the	  experiments	  designed	  to	  investigate	  drug	  seeking	  after	  abstinence	  (lower	  
panel).	  The	  failure	  of	  mice	  to	  extinguish	  lever	  pressing	  prompted	  a	  switch	  to	  a	  nosepoke	  
operand	  in	  the	  groups	  designed	  to	  test	  drug	  seeking	  or	  refraining	  after	  extinction	  (upper	  panel).	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Figure	  6-­‐2.	  Extinction	  attenuates	  cue-­‐induced	  drug	  seeking	  in	  mice.	  Mice	  decreased	  active	  and	  
possibly	  inactive	  operant	  responses	  after	  extinction	  training,	  although	  mice	  continued	  to	  
discriminate	  active	  from	  inactive	  responses.	  Operant	  responses	  were	  nose	  pokes	  after	  
extinction,	  and	  lever	  presses	  after	  abstinence.	  Two-­‐way	  ANOVA:	  main	  effect	  of	  extinction	  (F	  (1,	  
20)	  =	  16.90;	  p	  =	  0.0005;	  post-­‐hoc	  comparisons	  with	  Sidak	  correction	  for	  multiple	  comparisons	  
indicate	  significantly	  decreased	  active	  lever	  pressing	  (p	  =	  0.004)	  and	  a	  trend	  toward	  decreased	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Figure	  6-­‐3.	  Extinction	  attenuates	  cue-­‐induced	  drug	  seeking	  in	  rats.	  Rats	  decreased	  active	  lever	  
presses	  after	  extinction	  training,	  although	  they	  continued	  to	  demonstrate	  lever	  discrimination	  
during	  cue-­‐induced	  drug	  seeking.	  Operant	  responses	  were	  lever	  presses	  for	  both	  groups.	  Two-­‐
way	  ANOVA:	  main	  effect	  of	  extinction	  (F	  (1,	  36)	  =	  13.99;	  p	  =	  0.0006);	  post-­‐hoc	  comparisons	  with	  
Sidak	  correction	  for	  multiple	  comparisons	  indicate	  significantly	  decreased	  active	  lever	  pressing	  
(p	  =	  0.0001)	  but	  no	  effect	  on	  inactive	  lever	  pressing	  (p	  =	  0.687).	  Error	  bars	  are	  S.E.M.	  
	  
Drug	  seeking	  causes	  transient	  synaptic	  potentiation	  in	  D1-­‐MSNs	  in	  NA	  coreregardless	  of	  
extinction	  	  
AMPA:NMDA	  ratios	  in	  D1-­‐MSNs	  increased	  after	  30	  minutes	  of	  cue-­‐induced	  drug	  seeking.	  
However,	  neither	  D1-­‐MSN	  tSP	  nor	  baseline	  D1-­‐MSN	  AMPA:NMDA	  ratios	  were	  influenced	  by	  a	  
history	  of	  extinction	  training	  (two-­‐way	  ANOVA:	  Main	  effect	  of	  cue	  exposure:	  F(1,	  41)	  =	  5.376,	  P	  
=	  0.0255;	  no	  main	  effect	  of	  extinction	  training,	  or	  interaction	  Figure	  6-­‐4).	  While	  it	  is	  known	  that	  
D1-­‐MSNs	  incorporate	  AMPARs	  into	  synapses	  after	  cocaine	  self-­‐administration	  in	  both	  NA	  core	  
and	  shell	  (Bock	  et	  al.,	  2013;	  Pascoli	  et	  al.,	  2014),	  this	  is	  the	  first	  demonstration	  that	  D1-­‐MSNs	  
incorporate	  additional	  synaptic	  AMPARs	  during	  drug	  seeking	  (i.e.	  show	  tSP).	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Figure	  6-­‐4.	  D1-­‐MSN	  tSP	  occurs	  during	  drug	  seeking	  and	  does	  not	  depend	  on	  prior	  extinction	  
training.	  30	  minutes	  of	  cue-­‐induced	  drug	  seeking	  is	  associated	  with	  increased	  AMPA:NMDA	  
ratio	  recorded	  from	  D1-­‐MSNs.	  Two-­‐way	  ANOVA:	  Main	  effect	  of	  cue	  exposure:	  F(1,	  41)	  =	  5.376,	  P	  
=	  0.0255;	  No	  main	  effect	  of	  extinction	  F(1,	  41)	  =	  0.0006,	  P	  =	  0.98;	  no	  interaction	  F(1,	  41)	  =	  
0.0003,	  P	  =	  0.99).	  Statistical	  tests	  performed	  using	  cell	  values.	  Error	  bars	  represent	  S.E.M.	  Scale	  
bars	  are	  50	  msec	  and	  20	  pA.	  
	  
	  
D2-­‐MSN	  tSP	  occurs	  after	  extinction	  training	  
In	  contrast	  to	  D1-­‐MSNs,	  the	  D2-­‐MSN	  tSP	  required	  extinction	  training	  in	  addition	  to	  
reinstatement	  of	  drug	  seeking.	  Extinction	  training	  per	  se	  did	  not	  alter	  baseline	  AMPA:NMDA	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ratios	  in	  D2-­‐MSNs,	  but	  cued	  drug	  seeking	  markedly	  augmented	  AMPA:NMDA	  in	  D2-­‐MSNs	  of	  
extinguished	  but	  not	  abstinent	  mice	  (interaction:	  F(1,	  37)	  =	  4.363,	  P	  =	  0.044;	  Figure	  6-­‐5;	  no	  
main	  effects	  of	  extinction	  or	  drug	  seeking).	  	  
	  
Figure	  6-­‐5.	  Extinction	  is	  necessary	  for	  D2-­‐MSN	  tSP	  during	  cue-­‐induced	  drug	  seeking.	  
AMPA:NMDA	  ratios	  recorded	  from	  D2-­‐MSNs	  after	  30	  minutes	  of	  drug	  seeking	  are	  potentiated	  in	  
animals	  with	  prior	  extinction	  training	  relative	  to	  animals	  having	  undergone	  homecage	  abstinent	  
withdrawal.	  Two-­‐way	  ANOVA:	  No	  main	  effect	  of	  cue	  exposure:	  F(1,	  37)	  =	  0.4810,	  P	  =	  0.4923;	  No	  
main	  effect	  of	  extinction	  F(1,	  37)	  =	  2.227,	  P	  =	  0.14;	  significant	  interaction	  effect	  F(1,	  37)	  =	  4.363,	  
P	  =	  0.0437.	  Post-­‐hoc	  analyses	  show	  no	  differences	  at	  baseline	  (p=0.66)	  but	  significant	  
differences	  after	  cue	  re-­‐exposure	  (p=0.038).	  Statistical	  tests	  performed	  using	  cell	  values.	  Error	  
bars	  represent	  S.E.M.	  Scale	  bars	  are	  50	  msec	  and	  20	  pA.	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Drug	  seeking	  behavior	  is	  correlated	  with	  D1-­‐MSN	  AMPA:NMDA	  ratio	  only	  after	  extinction	  
In	  studies	  where	  tSP	  was	  measured	  in	  rats	  without	  phenotyping	  MSNs,	  drug	  seeking	  during	  cue-­‐
induced	  reinstatement	  was	  positively	  correlated	  with	  both	  AMPA:NMDA	  and	  spine	  head	  
diameter	  (Gipson	  et	  al.,	  2013a).	  Here,	  I	  show	  that	  D1-­‐MSN	  AMPA:NMDA	  ratio	  correlated	  
strongly	  with	  drug	  seeking	  behavior	  after	  extinction	  (r	  =	  0.95,	  n	  =	  6,	  p	  =	  0.004;	  Figure	  6-­‐6),	  but	  
not	  abstinence	  (Figure	  6-­‐7).	  Interestingly,	  D2-­‐MSNs	  also	  showed	  a	  trend	  toward	  correlating	  
with	  drug	  seeking	  behavior	  after	  extinction	  (r	  =	  0.76,	  n	  =	  6,	  p	  =	  0.075,	  Figure	  6-­‐6),	  but	  not	  after	  
abstinence	  (Figure	  6-­‐7).	  
	  
	  
Figure	  6-­‐6.	  tSP	  correlates	  with	  cue-­‐induced	  drug	  seeking	  after	  extinction.	  The	  correlation	  
between	  drug	  seeking	  and	  the	  AMPA:NMDA	  ratio	  during	  drug	  seeking	  is	  highly	  significant	  for	  
D1-­‐MSNs	  and	  a	  statistical	  trend	  for	  D2-­‐MSNs.	  Each	  scatterplot	  dot	  represents	  one	  animal.	  




Figure	  6-­‐7.	  tSP	  does	  not	  correlate	  with	  cue-­‐induced	  drug	  seeking	  after	  abstinence.	  The	  
correlation	  between	  drug	  seeking	  and	  the	  AMPA:NMDA	  ratio	  during	  drug	  seeking	  is	  not	  
significant	  for	  either	  D1-­‐MSNs	  or	  D2-­‐MSNs.	  Each	  scatterplot	  dot	  represents	  one	  animal.	  
	  
Drug	  seeking	  induced	  by	  context	  alone	  selectively	  potentiates	  D1-­‐MSNs	  
Activity	  in	  NA	  shell,	  rather	  than	  NA	  core,	  likely	  mediates	  context-­‐induced	  drug	  seeking	  after	  
extinction	  (Cruz	  et	  al.,	  2014).	  However,	  context-­‐induced	  drug	  seeking	  after	  extinction	  causes	  
tSP	  in	  NA	  core	  (Stankeviciute	  et	  al.,	  2013).	  Here	  we	  sought	  to	  determine	  whether	  D1-­‐MSNs	  in	  
NA	  core	  would	  also	  display	  tSP	  during	  drug	  seeking	  induced	  by	  context	  in	  the	  absence	  of	  cues.	  
We	  discovered	  that	  context	  alone	  was	  sufficient	  to	  induce	  drug	  seeking	  (Figure	  6-­‐8)	  and	  tSP	  on	  
D1-­‐MSNs	  (t(23)=2.682,	  p=0.013;	  Figure	  6-­‐9),	  but	  not	  D2-­‐MSNs	  (Figure	  6-­‐9).	  However,	  D1-­‐MSN	  
AMPA:NMDA	  ratio	  was	  not	  correlated	  with	  drug	  seeking	  behavior	  (Figure	  6-­‐10),	  further	  
suggesting	  that	  extinction	  somehow	  strengthens	  this	  relationship.	  	  




Figure	  6-­‐8.	  Context	  alone	  induces	  drug	  seeking	  behavior	  in	  mice.	  Error	  bars	  are	  S.E.M.	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Figure	  6-­‐9.	  Context	  induced	  drug	  seeking	  is	  also	  associated	  with	  tSP	  in	  D1-­‐MSNs	  but	  not	  D2-­‐
MSNs.	  Similar	  to	  drug	  seeking	  induced	  by	  cues	  after	  abstinence,	  D1-­‐MSN	  AMPA:NMDA	  ratio	  
increases	  during	  30	  minutes	  of	  drug	  seeking	  induced	  by	  context	  (t(23)=2.682,	  p=0.013),	  while	  
D2-­‐MSN	  AMPA:NMDA	  ratio	  does	  not	  (t(24)=0.377,	  p=0.70).	  Statistical	  tests	  performed	  using	  cell	  
values.	  Error	  bars	  represent	  S.E.M.	  Scale	  bars	  are	  50	  msec	  and	  20	  pA.	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Figure	  6-­‐10.	  tSP	  does	  not	  correlate	  with	  context-­‐induced	  drug	  seeking	  after	  abstinence.	  The	  
correlation	  between	  drug	  seeking	  and	  the	  AMPA:NMDA	  ratio	  during	  drug	  seeking	  is	  not	  
significant	  for	  either	  D1-­‐MSNs	  or	  D2-­‐MSNs.	  Each	  scatterplot	  dot	  represents	  one	  animal.	  
	  
Refraining	  tSP	  in	  NA	  shell	  is	  expressed	  selectively	  on	  D2-­‐MSNs	  
So	  far,	  I	  have	  shown	  that	  drug	  seeking	  potentiates	  D1-­‐MSNs,	  and	  extinction	  confers	  
metaplasticity	  to	  D2-­‐MSNs.	  	  Next	  I	  hypothesized	  that	  NA	  shell	  tSP	  is	  selectively	  expressed	  on	  
D2-­‐MSNs.	  Refraining	  was	  not	  associated	  with	  statistically	  significant	  synaptic	  changes	  in	  either	  
cell	  type	  considered	  alone,	  but	  was	  associated	  with	  a	  synaptic	  re-­‐balancing	  that	  favored	  D2-­‐
MSN	  synaptic	  input	  over	  D1-­‐MSN	  synaptic	  input	  (Figure	  6-­‐11.)	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Figure	  6-­‐11.	  NA	  shell	  MSNs	  undergo	  a	  transient	  synaptic	  re-­‐balancing	  during	  refraining	  that	  
favors	  D2-­‐MSN	  over	  D1-­‐MSN	  activation.	  Neither	  D1-­‐MSNs	  nor	  D2-­‐MSNs	  in	  NA	  shell	  show	  a	  
statistically	  significan	  pattern	  of	  synaptic	  alteration	  during	  refraining.	  However,	  there	  is	  a	  
significant	  increase	  in	  the	  D2/D1	  ratio,	  calculated	  by	  dividing	  the	  average	  AMPA:NMDA	  ratio	  of	  
D2-­‐MSNs	  by	  that	  of	  D1-­‐MSNs	  for	  each	  animal	  (t(10)=2.887,	  p=0.016).	  This	  suggests	  a	  refraining-­‐
associated	  synaptic	  rebalancing,	  enabling	  glutamatergic	  inputs	  to	  favor	  D2-­‐MSN	  activation	  over	  
D1-­‐MSN	  activation.	  Statistical	  tests	  use	  cell	  values	  in	  panel	  A	  and	  animal	  values	  in	  panel	  B.	  Error	  
bars	  represent	  S.E.M.	  Scale	  bars	  are	  50	  msec	  and	  20	  pA.	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Refraining	  and	  its	  associated	  tSP	  require	  adenosine	  A2a	  receptors	  
Transient	  synaptic	  potentiation	  is	  expressed	  post-­‐synaptically,	  and	  both	  D1-­‐	  and	  D2-­‐MSNs	  
require	  concurrent	  NMDAR	  and	  Gs	  GPCR	  signaling	  to	  undergo	  post-­‐synaptic	  LTP	  (Shen	  et	  al.,	  
2008b).	  The	  source	  of	  obligatory	  Gs	  signaling	  in	  D2-­‐MSNs	  is	  the	  A2a	  adenosine	  receptor	  since	  
blockade	  of	  this	  receptor	  prevents	  post-­‐synaptic	  LTP	  in	  D2-­‐MSNs	  (Shen	  et	  al.,	  2008b).	  I	  
hypothesized	  that	  antagonizing	  adenosine	  A2aRs	  in	  NA	  shell,	  that	  are	  expressed	  only	  on	  D2	  
MSNs,	  prevents	  refraining	  and	  thereby	  dose-­‐dependently	  promotes	  drug	  seeking	  behavior.	  
MSX-­‐3	  is	  an	  A2aR	  antagonist	  with	  1000	  fold	  selectivity	  over	  A1	  adenosine	  receptors	  (Yuzlenko	  
and	  Kiec-­‐Kononowicz,	  2006).	  I	  microinjected	  500	  nL	  of	  vehicle	  (saline)	  with	  either	  0,	  10,	  or	  20	  
µg	  of	  MSX-­‐3	  (O'Neill	  et	  al.,	  2012)	  into	  NA	  shell.	  Blockade	  of	  NA	  shell	  A2aR	  reinstated	  drug	  
seeking	  in	  the	  absence	  of	  cues	  (F	  (2,	  16)	  =	  8.288;	  p	  =	  0.003),	  suggesting	  the	  necessity	  of	  A2aR	  
signaling	  (and	  likely	  D2-­‐MSN	  tSP)	  in	  NA	  shell	  to	  sustain	  refraining	  in	  an	  extinguished	  context	  
(Figure	  6-­‐12).	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Figure	  6-­‐12.	  NA	  shell	  adenosine	  A2a	  receptors	  are	  necessary	  for	  refraining.	  MSX-­‐3	  (A2aR	  
antagonist),	  microinjected	  into	  NA	  shell,	  increases	  drug	  seeking	  in	  the	  absence	  of	  cues.	  Two-­‐way	  
repeated	  measures	  ANOVA:	  main	  effect	  of	  dose	  (F	  (2,	  12)	  =	  11.26,	  p	  =	  0.002).	  Post-­‐hoc	  test	  
comparison	  with	  Sidak	  correction	  shows	  20	  µg	  dose	  increases	  active	  lever	  pressing	  relative	  to	  




In	  these	  experiments,	  I	  have	  demonstrated	  that	  extinction	  training	  attenuated	  subsequent	  cue-­‐
induced	  drug	  seeking.	  In	  parallel,	  extinction	  enabled	  transient	  synaptic	  potentiation	  (tSP)	  of	  D2-­‐
MSNs	  in	  NA	  core	  during	  cue-­‐induced	  drug	  seeking.	  In	  contrast,	  D1-­‐MSNs	  in	  NA	  core	  express	  tSP	  
during	  cue-­‐induced	  drug-­‐seeking	  regardless	  of	  prior	  extinction	  training.	  D1-­‐MSN	  tSP	  correlated	  
with	  cue-­‐induced	  drug	  seeking	  after	  extinction,	  but	  not	  abstinence.	  Context-­‐induced	  drug	  
seeking	  was	  also	  associated	  with	  tSP	  of	  D1-­‐MSNs	  but	  not	  D2-­‐MSNs.	  In	  contrast,	  refraining	  was	  
associated	  with	  tSP	  of	  D2-­‐MSNs	  in	  NA	  shell	  but	  not	  D1-­‐MSNs.	  Blockade	  of	  adenosine	  A2a	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receptors	  in	  NA	  shell,	  which	  are	  necessary	  for	  D2-­‐MSN	  tSP	  (Shen	  et	  al.,	  2008b),	  prevented	  
refraining	  (i.e.	  spontaneously	  reinstated	  drug	  seeking	  in	  the	  absence	  of	  cues),	  suggesting	  that	  
D2-­‐MSN	  tSP	  in	  NA	  shell	  may	  be	  a	  cause	  rather	  than	  a	  mere	  correlate	  of	  refraining.	  
	  
Figure	  6-­‐13.	  Summary	  of	  transient	  synaptic	  potentiation	  (tSP)	  in	  D1-­‐MSNs	  and	  D2-­‐MSNs.	  D1-­‐
MSNs	  in	  NA	  core	  express	  tSP	  during	  drug	  seeking.	  D2-­‐MSNs	  express	  tSP	  in	  NA	  core	  during	  
reinstatement,	  and	  in	  NA	  shell	  during	  refraining.	  The	  cell	  type	  expression	  of	  tSP	  in	  NA	  core	  
during	  refraining	  and	  in	  NA	  shell	  during	  drug	  seeking	  remain	  unknown.	  	  
	  
The	  evidence	  from	  the	  previous	  two	  chapters	  suggests	  that	  tSP	  in	  NA	  core	  during	  reinstatement	  
and	  in	  NA	  shell	  during	  refraining	  requires	  some	  form	  of	  metaplasticity	  that	  in	  turn	  depends	  on	  
extinction	  training.	  This	  chapter	  suggests	  that	  extinction-­‐induced	  metaplasticity	  affects	  D2-­‐
MSNs	  selectively.	  Extinction-­‐induced	  metaplasticity	  enables	  D2-­‐MSN	  tSP,	  which	  suppresses	  
drug	  seeking	  during	  reinstatement	  and	  refraining.	  In	  contrast,	  D1-­‐MSN	  tSP	  occurs	  in	  NA	  core	  
during	  drug	  seeking	  regardless	  of	  prior	  extinction	  training	  or	  the	  particular	  environmental	  
stimuli	  eliciting	  drug	  seeking	  (e.g.	  cues,	  context,	  or	  the	  combination).	  
	  
Metaplasticity	  resulting	  from	  drugs	  of	  abuse	  differentially	  affects	  ex	  vivo	  and	  in	  vivo	  synaptic	  
potentiation.	  Brain	  slices	  made	  from	  drug-­‐exposed	  animals	  are	  resistant	  to	  the	  induction	  of	  LTP	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and	  LTD	  in	  nucleus	  accumbens	  (Thomas	  et	  al.,	  2001;	  Martin	  et	  al.,	  2006;	  Moussawi	  et	  al.,	  2009;	  
Grueter	  et	  al.,	  2010;	  Kasanetz	  et	  al.,	  2010;	  Pascoli	  et	  al.,	  2014;	  Creed	  et	  al.,	  2015).	  In	  contrast,	  
transient	  synaptic	  potentiation	  during	  drug	  seeking	  requires	  previous	  chronic	  drug	  exposure	  
(e.g.	  does	  not	  occur	  during	  sucrose	  seeking	  (Gipson	  et	  al.,	  2013a)	  or	  after	  a	  drug	  injection	  in	  a	  
naïve	  animal	  (Shen	  et	  al.,	  2011).	  The	  metaplasticity	  signaling	  cascade	  supporting	  tSP	  includes	  
mGluR5,	  matrix	  metalloproteinases	  (Smith	  et	  al.,	  2014),	  and	  neuronal	  nitric	  oxide	  synthase	  
(Smith	  et	  al.,	  2016).	  This	  cascade	  is	  most	  likely	  necessary	  for	  D1-­‐MSN	  tSP	  in	  NA	  core	  during	  drug	  
seeking,	  and	  also	  possibly	  responsible	  for	  NA	  core	  D2-­‐MSN	  tSP	  during	  drug	  seeking	  after	  
extinction.	  
	  
In	  contrast	  to	  the	  extensive	  literature	  describing	  drug-­‐induced	  metaplasticity,	  relatively	  little	  is	  
known	  about	  metaplasticity	  induced	  by	  extinction	  per	  se.	  It	  is	  known	  that	  extinction	  causes	  
mGlur5	  endocytosis,	  likely	  via	  Homer1b/c	  upregulation,	  which	  prevents	  the	  subsequent	  
electrical	  induction	  of	  LTD	  in	  an	  anesthetized	  animal	  (Knackstedt	  et	  al.,	  2010).	  The	  current	  study	  
indicates	  that	  this	  or	  another	  form	  of	  metaplasticity	  selectively	  affects	  D2-­‐MSNs,	  and	  enables	  
them	  to	  undergo	  tSP.	  Unlike	  D1-­‐MSN	  tSP,	  D2-­‐MSN	  tSP	  occurs	  in	  the	  absence	  of	  drug	  seeking.	  
Instead,	  D2-­‐MSN	  tSP	  may	  actually	  suppress	  drug	  seeking.	  Cue-­‐induced	  drug	  seeking	  was	  
decreased	  by	  extinction	  training	  in	  both	  mice	  and	  rats.	  D1-­‐MSN	  tSP	  was	  equivalent	  regardless	  
of	  prior	  extinction	  training,	  but	  D2-­‐MSN	  tSP	  occurred	  only	  after	  extinction	  training.	  Thus	  D2-­‐
MSN	  tSP	  is	  a	  likely	  explanation	  for	  extinction	  attenuating	  drug	  seeking	  driven	  by	  cues.	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D2-­‐MSN	  tSP	  also	  likely	  suppresses	  drug	  seeking	  during	  refraining.	  Adenosine	  A2a	  receptor	  
signaling	  is	  necessary	  for	  D2-­‐MSN	  potentiation	  (Shen	  et	  al.,	  2008b),	  and	  my	  results	  demonstrate	  
that	  it	  is	  also	  necessary	  for	  refraining.	  This	  suggests	  a	  causal	  rather	  than	  a	  mere	  correlative	  
relationship	  between	  D2-­‐MSN	  tSP	  and	  refraining.	  It	  also	  indicates	  that	  D2-­‐MSN	  tSP	  may	  be	  
evoked	  by	  different	  mechanisms	  in	  NA	  core	  during	  reinstatement	  and	  in	  NA	  shell	  during	  
refraining.	  Reinstatement	  tSP	  requires	  glutamate	  spillover	  to	  activate	  extrasynaptic	  glutamate	  
receptors.	  A2aR-­‐mediated	  LTP,	  in	  contrast,	  occurs	  during	  Hebbian	  plasticity	  induction	  (Shen	  et	  
al.,	  2008b),	  and	  requires	  relatively	  little	  glutamate	  release.	  Furthermore,	  reinstatement	  tSP	  
requires	  MMP	  activation	  in	  NA	  core	  (Smith	  et	  al.,	  2014),	  but	  refraining	  is	  not	  associated	  with	  
MMP	  activity	  in	  NA	  shell.	  Taken	  together,	  these	  data	  suggest	  that	  the	  two	  forms	  of	  D2-­‐MSN	  tSP	  
described	  here	  may	  rely	  on	  different	  mechanisms	  despite	  their	  common	  ability	  to	  suppress	  
drug	  seeking.	  
	  
In	  summary,	  extinction	  training	  induces	  metaplasticity	  in	  D2-­‐MSNs	  that	  allows	  them	  to	  undergo	  
transient	  synaptic	  potentiation.	  This	  D2-­‐MSN	  tSP	  occurs	  in	  NA	  core	  during	  reinstatement	  and	  in	  
NA	  shell	  during	  refraining.	  The	  net	  effect	  of	  this	  D2-­‐MSN	  tSP	  appears	  to	  suppress	  drug	  seeking	  
behavior.	  In	  contrast,	  D1-­‐MSN	  tSP	  occurs	  during	  drug	  seeking	  regardless	  of	  prior	  extinction	  
training.	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Chapter	  7  General	  discussion	  and	  future	  directions	  
In	  summary	  of	  the	  preceding	  chapters,	  cocaine	  self-­‐administration	  and	  subsequent	  extinction	  
training	  induce	  two	  distinct	  forms	  of	  metaplasticity.	  Self-­‐administration-­‐induced	  metaplasticity	  
enables	  transient	  synaptic	  potentiation	  (tSP)	  of	  D1-­‐MSNs	  during	  drug	  seeking,	  while	  extinction-­‐
induced	  metaplasticity	  enables	  tSP	  of	  D2-­‐MSNs.	  Reinstatement	  of	  drug	  seeking	  after	  extinction	  
thus	  potentiates	  both	  MSN	  classes,	  while	  drug	  seeking	  after	  abstinence	  potentiates	  only	  D1-­‐
MSNs.	  In	  addition	  to	  enabling	  D2-­‐MSN	  tSP,	  extinction	  attenuates	  cue-­‐induced	  drug	  seeking	  in	  
both	  mice	  and	  rats.	  Refraining	  from	  drug	  seeking	  is	  associated	  with	  tSP	  of	  D2-­‐MSNs	  (but	  not	  
D1-­‐MSNs)	  in	  NA	  shell,	  likely	  due	  to	  insertion	  of	  calcium	  impermeable	  AMPARs.	  Refraining	  and	  
reinstatement	  tSP	  involve	  different	  mechanisms.	  Reinstatement	  of	  drug	  seeking	  involves	  a	  well-­‐
characterized	  signaling	  cascade	  in	  NA	  core,	  in	  which	  glutamate	  spills	  into	  the	  extrasynaptic	  
space	  and	  indirectly	  activates	  matrix	  metalloproteinases	  (MMPs)	  that	  cause	  spine	  head	  
enlargement	  (Smith	  et	  al.,	  2014).	  While	  refraining	  requires	  glutamate	  transmission	  from	  IL-­‐PFC	  
to	  NA	  shell,	  this	  glutamate	  is	  likely	  confined	  to	  the	  synaptic	  cleft	  and	  therefore	  does	  not	  
activate	  MMPs	  or	  cause	  spine	  enlargement.	  In	  addition,	  refraining	  requires	  adenosine	  signaling	  
through	  A2a	  receptors,	  suggesting	  that	  D2-­‐MSN	  tSP	  is	  a	  cause	  rather	  than	  a	  mere	  correlate	  of	  
refraining,	  due	  to	  the	  dependence	  of	  D2-­‐MSN	  post-­‐synaptic	  potentiation	  on	  these	  receptors.	  In	  
conclusion,	  D2-­‐MSN	  tSP,	  though	  likely	  driven	  by	  different	  mechanisms	  in	  reinstatement	  and	  
refraining,	  mediates	  the	  ability	  of	  extinction	  to	  suppress	  drug	  seeking	  in	  both	  models.	  
	  
D2-­‐MSN	  tSP	  in	  NA	  core	  requires	  extinction.	  I	  propose	  that	  extinction	  eliminates	  a	  
countermanding	  synaptic	  depression	  that	  affects	  D2-­‐MSNs	  but	  not	  D1-­‐MSNs	  and	  is	  responsible	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for	  masking	  D2-­‐MSN	  tSP	  during	  drug	  seeking	  after	  abstinence.	  I	  illustrate	  my	  hypothesized	  
model	  below	  (Figure	  7-­‐1).	  In	  this	  model,	  mGluR5	  signals	  through	  nNOS	  interneurons	  to	  induce	  
tSP	  of	  both	  D1-­‐	  and	  D2-­‐MSNs	  (Smith	  et	  al.,	  2014;	  Smith	  et	  al.,	  2016).	  A	  separate	  population	  of	  
mGluR5s	  signal	  through	  TRPV1	  channels	  on	  D2-­‐MSNs	  to	  induce	  AMPAR	  endocytosis.	  mGluR5s	  
on	  D2-­‐MSNs	  but	  not	  nNOS	  neurons	  are	  removed	  by	  extinction	  training	  Figure	  7-­‐2.	  	  
	  
Figure	  7-­‐1.	  Hypothesized	  mechanism	  inhibiting	  D2-­‐MSN	  tSP	  during	  drug	  seeking	  after	  
abstinence.	  	  Presentation	  of	  a	  cue	  causes	  glutamate	  overflow	  which	  activates	  two	  populations	  
of	  mGluR5s	  (metabotropic	  glutamate	  receptors	  -­‐	  type	  5).	  mGluR5s	  on	  interneurons	  expressing	  
nNOS	  (neuronal	  nitric	  oxide	  synthase)	  cause	  nitrosylation	  and	  activation	  of	  matrix	  
metalloproteinases,	  which	  cause	  tSP	  of	  both	  D1-­‐	  and	  D2-­‐MSNs.	  mGluR5s	  on	  D2-­‐MSNs	  activate	  
TRPV1	  channels	  (transient	  receptor	  potential	  vanilloid	  type	  1)	  that	  cause	  endocytosis	  of	  AMPARs	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on	  D2-­‐MSNs	  (Figure	  7-­‐3)	  and	  thereby	  inhibit	  D2-­‐MSN	  tSP.	  As	  a	  result,	  D1-­‐MSN	  tSP	  is	  unopposed	  




Figure	  7-­‐2.	  Hypothesized	  mechanism	  facilitating	  D2-­‐MSN	  tSP	  during	  drug	  seeking	  after	  
extinction.	  	  Extinction	  causes	  endocytosis	  of	  mGluR5s	  in	  NA	  core,	  and	  I	  propose	  that	  this	  
primarily	  affects	  D2-­‐MSNs.	  As	  a	  result,	  glutamate	  overflow	  in	  response	  to	  a	  cue	  is	  only	  able	  to	  
activate	  the	  nNOS	  pathway,	  which	  induces	  tSP	  of	  both	  D1-­‐	  and	  D2-­‐MSNs.	  This	  enables	  D2-­‐MSNs	  
to	  attenuate	  drug	  seeking.	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Figure	  7-­‐3.	  Mechanism	  of	  mGluR5	  induced	  depotentiation	  of	  D2-­‐MSNs.	  mGluR5	  stimulation	  
causes	  anandamide	  production,	  which	  suppresses	  glutamate	  release	  via	  presynaptic	  CB1	  
receptors	  (cannabinoid	  receptor	  type	  1).	  This	  cascade	  results	  from	  mGluR5	  activation	  in	  all	  
MSNs.	  However,	  specifically	  in	  D2-­‐MSNs	  within	  nucleus	  accumbens,	  anandamide	  also	  activates	  
post-­‐synaptic	  TRPV1	  channels	  (transient	  receptor	  potential	  vanilloid	  type	  1).	  Calcium	  influx	  via	  
TRPV1	  causes	  AMPAR	  endocytosis	  (e.g.	  synaptic	  depression)	  of	  D2-­‐MSNs.	  This	  figure	  taken	  from	  
(Grueter	  et	  al.,	  2010).	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This	  model	  reconciles	  a	  known	  mechanism	  of	  extinction-­‐induced	  metaplasticity	  (endocytosis	  of	  
mGluR5s	  (Knackstedt	  et	  al.,	  2010))	  with	  my	  observation	  that	  extinction	  is	  necessary	  for	  D2-­‐MSN	  
tSP	  during	  cue-­‐induced	  drug	  seeking.	  In	  contrast,	  mGluR5s	  on	  nNOS	  interneurons	  are	  likely	  
spared	  from	  extinction-­‐induced	  endocytosis	  (Smith	  et	  al.,	  2016).	  Although	  D1-­‐MSN	  mGluR5s	  
may	  also	  undergo	  endocytosis	  after	  extinction,	  this	  population	  of	  mGluR5s	  would	  be	  unlikely	  to	  
mask	  tSP	  during	  drug	  seeking,	  due	  to	  the	  lack	  of	  AMPAR	  endocytosis	  mechanisms	  downstream	  
of	  mGluR5s	  on	  D1-­‐MSNs	  (Grueter	  et	  al.,	  2010).	  	  
	  
This	  model	  can	  be	  tested	  in	  several	  ways.	  mGluR5s	  on	  D2-­‐MSNs	  and	  nNOS	  interneurons	  
modulate	  D2-­‐MSN	  tSP	  via	  different	  signaling	  cascades.	  Microinjecting	  capsazepine	  (a	  TRPV1	  
antagonist)	  into	  NA	  core	  during	  drug	  seeking	  after	  abstinence	  should	  unmask	  D2-­‐MSN	  tSP	  and	  
simultaneously	  decrease	  drug	  seeking.	  Conversely,	  microinjecting	  capsaicin	  (a	  TRPV1	  agonist)	  
into	  NA	  core	  during	  drug	  seeking	  after	  extinction	  should	  prevent	  D2-­‐MSN	  tSP	  and	  enhance	  drug	  
seeking.	  However,	  D2-­‐MSN	  mGluR5	  signaling	  depotentiates	  inputs	  to	  D2-­‐MSNs	  via	  pre-­‐synaptic	  
mechanisms	  in	  addition	  to	  AMPAR	  endocytosis	  (Figure	  7-­‐3).	  Therefore,	  D2-­‐MSN	  tSP	  may	  be	  
modulated	  by	  TRPV1	  manipulation	  while	  the	  continued	  pre-­‐synaptic	  inhibition	  of	  D2-­‐MSNs	  
protects	  drug	  seeking.	  Simultaneously	  mimicking	  both	  downstream	  consequences	  of	  mGluR5	  
removal	  from	  D2-­‐MSNs	  requires	  non-­‐pharmacological	  approaches,	  as	  cell-­‐type	  specific	  mGluR5	  
antagonists	  do	  not	  exist.	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Selectively	  antagonizing	  D2-­‐MSN	  mGluR5s	  might	  be	  possible	  with	  the	  recently	  developed	  
approach	  termed	  “drugs	  acutely	  restricted	  by	  tethering”	  (DART)	  (Shields	  et	  al.,	  2017).	  In	  this	  
approach,	  a	  drug	  (e.g.	  the	  mGluR5	  antagonist	  MTEP)	  is	  conjugated	  via	  a	  long	  flexible	  polymer	  to	  
a	  chemical	  moiety	  termed	  the	  “Halotag	  ligand.”	  This	  ligand	  is	  bound	  by	  Halotag,	  a	  modified	  
bacterial	  haloalkane	  dehalogenase	  (Los	  et	  al.,	  2008),	  which	  can	  be	  expressed	  in	  a	  cell	  type	  
specific	  manner	  and	  is	  trafficked	  to	  the	  cell	  surface.	  When	  Halotag	  binds	  the	  Halotag	  ligand,	  it	  
prevents	  free	  diffusion	  of	  the	  conjugated	  MTEP,	  causing	  MTEP	  to	  concentrate	  selectively	  
around	  D2-­‐MSNs.	  As	  a	  result,	  the	  conjugated	  MTEP	  can	  be	  microinjected	  into	  NA	  core	  at	  
concentrations	  normally	  incapable	  of	  antagonizing	  mGluR5s,	  and	  the	  concentrating	  effect	  of	  
Halotag	  will	  enable	  the	  conjugated	  MTEP	  to	  antagonize	  only	  mGluR5s	  expressed	  on	  D2-­‐MSNs.	  
The	  advantage	  of	  this	  technique	  is	  that	  Halotag	  does	  not	  engage	  in	  cell	  signaling	  cascades	  and	  
thus	  the	  manipulation	  doesn’t	  require	  overexpression	  of	  any	  cell	  signaling	  components.	  Any	  
antagonist	  can	  be	  conjugated	  to	  the	  Halotag	  ligand	  and	  the	  manipulation	  is	  acute	  and	  
reversible	  (although	  the	  half-­‐life	  is	  markedly	  increased).	  	  The	  disadvantage	  of	  the	  technique	  is	  
that	  it	  is	  only	  weakly	  selective;	  the	  potency	  is	  shifted	  ~75	  fold	  in	  favor	  of	  receptors	  on	  the	  cell	  
type	  of	  interest	  as	  opposed	  to	  other	  cell	  types.	  	  
	  
Another	  strategy	  to	  examine	  mGluR5	  signaling	  in	  a	  cell	  type	  specific	  manner	  requires	  the	  use	  of	  
transgenic	  mice	  expressing	  Cre-­‐dependent	  Cas9	  (Platt	  et	  al.,	  2014).	  Crossing	  these	  mice	  with	  
mice	  express	  Cre	  in	  D2-­‐MSNs	  thus	  results	  in	  mice	  that	  express	  Cas9	  only	  in	  D2-­‐MSNs.	  
Subsequently,	  single	  guide	  RNAs	  (sgRNAs)	  can	  be	  introduced	  into	  NA	  core	  (e.g.	  using	  AAV)	  and	  
the	  cells	  expressing	  Cas9	  will	  use	  these	  sgRNAs	  to	  edit	  the	  genome.	  Genes	  can	  then	  be	  knocked	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out	  or	  knocked	  in	  selectively	  in	  the	  cell	  type	  of	  interest.	  Knockout	  occurs	  via	  non-­‐homologous	  
end	  joining	  that	  randomly	  causes	  insertions	  and	  deletions,	  while	  knock	  in	  occurs	  via	  homology	  
directed	  repair.	  Knocking	  out	  mGluR5	  would	  cause	  complete	  and	  permanent	  removal	  of	  all	  
mGluR5	  from	  any	  D2-­‐MSNs	  transfected	  by	  the	  AAV.	  In	  addition,	  nearly	  any	  gene	  can	  be	  
knocked	  out	  in	  a	  cell-­‐type	  specific	  manner	  using	  this	  approach,	  which	  would	  enable	  targeting	  of	  
intracellular	  molecules	  inaccessible	  to	  traditional	  pharmacology.	  The	  pitfall	  to	  this	  method	  is	  
that	  gene	  knockout	  occurs	  over	  a	  variable	  length	  of	  time,	  as	  non-­‐homologous	  end	  joining	  is	  
typically	  a	  fidelitous	  process	  and	  must	  be	  repeated	  several	  times	  before	  insertions	  or	  deletions	  
occur.	  The	  permanence	  of	  the	  manipulation	  is	  also	  arguably	  a	  drawback.	  	  	  	  
	  
The	  second	  set	  of	  experiments	  I	  propose	  concerns	  a	  possible	  explanation	  for	  the	  dissociation	  
between	  spine	  diameter	  and	  AMPA:NMDA	  ratio	  during	  refraining	  tSP.	  Increased	  AMPA:NMDA	  
ratio	  is	  normally	  assumed	  to	  reflect	  AMPAR	  insertion,	  but	  it	  can	  equally	  reflect	  NMDAR	  
endocytosis.	  Spine	  size	  can	  change	  bidirectionally	  in	  parallel	  with	  either	  AMPARs	  (Matsuzaki	  et	  
al.,	  2004),	  or	  NMDARs	  (Wang	  et	  al.,	  2007).	  If	  AMPAR	  insertion	  co-­‐occurs	  with	  NMDAR	  
endocytosis,	  these	  adaptations	  would	  both	  increase	  AMPA:NMDA	  ratio	  but	  oppose	  each	  
other’s	  influence	  on	  spine	  size.	  	  
	  
The	  first	  set	  of	  experiments	  would	  confirm	  that	  AMPAR	  insertion	  occurs	  during	  refraining	  and	  is	  
necessary	  for	  the	  AMPA:NMDA	  ratio	  increase.	  Increased	  quantal	  amplitude	  observed	  using	  
assays	  such	  as	  mEPSCs	  or	  asEPSCs	  can	  confirm	  the	  occurrence	  of	  AMPAR	  insertion	  in	  
combination	  with	  increased	  AMPA:NMDA	  ratio.	  mEPSCs	  reflect	  changes	  across	  synapses	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contacted	  by	  multiple	  inputs,	  and	  the	  sEPSCs	  recorded	  in	  my	  studies	  are	  similar	  to	  mEPSCs	  but	  
may	  reflect	  evoked	  as	  well	  as	  quantal	  release	  (due	  to	  spontaneous	  action	  potentials).	  In	  
contrast,	  asEPSCs	  represent	  AMPAR	  insertion	  in	  synapses	  contacted	  by	  a	  defined	  input.	  Thus	  
synapses	  contacted	  by	  one	  input	  (IL-­‐PFC)	  may	  incorporate	  AMPARs	  selectively,	  leading	  to	  
increased	  AMPA:NMDA	  ratio	  and	  asEPSC	  amplitude	  but	  not	  mEPSC	  amplitude	  (Thomas	  et	  al.,	  
2001).	  Thus,	  the	  apparent	  discrepancy	  between	  AMPA:NMDA	  ratio	  increases	  and	  the	  lack	  of	  
sEPSC	  amplitude	  increase	  in	  NA	  shell	  during	  refraining	  and	  NA	  core	  during	  reinstatement	  
suggests	  that	  tSP	  is	  expressed	  only	  on	  a	  subset	  of	  synapses	  receiving	  a	  specific	  input,	  and	  
asEPSCs	  should	  be	  used	  to	  confirm	  AMPAR	  insertion.	  	  
	  
To	  the	  extent	  that	  AMPAR	  insertion	  mediates	  increased	  AMPA:NMDA	  ratio	  during	  tSP,	  this	  
insertion	  appears	  confined	  to	  CI-­‐AMPARs	  (due	  to	  the	  lack	  of	  increased	  AMPAR	  rectification	  
index).	  Calcium	  impermeability	  depends	  on	  the	  presence	  of	  a	  GluA2	  subunit,	  which	  is	  trafficked	  
to	  the	  synapse	  via	  interaction	  with	  PICK1	  (protein	  interacting	  with	  C	  kinase	  1)	  (Haglerod	  et	  al.,	  
2017).	  PICK1-­‐dependent	  GluA2	  trafficking	  can	  be	  prevented	  using	  a	  peptide	  targeting	  this	  
interaction.	  NA	  core	  GluA2	  trafficking	  is	  necessary	  for	  reinstatement	  of	  cocaine	  seeking	  
(Famous	  et	  al.,	  2008),	  and	  I	  propose	  that	  GluA2	  trafficking	  in	  NA	  shell	  is	  similarly	  necessary	  for	  
refraining	  behavior.	  
	  
Next,	  I	  would	  use	  a	  similar	  approach	  to	  determine	  the	  role	  of	  NMDAR	  endocytosis	  in	  NA	  shell	  
for	  refraining	  tSP.	  Quantal	  analyses	  of	  NMDAR-­‐mediated	  EPSCs	  are	  possible	  (Kourrich	  et	  al.,	  
2007),	  and	  in	  theory	  could	  be	  applied	  to	  asEPSCs	  if	  a	  global	  synaptic	  change	  does	  not	  occur.	  If	  
	   117	  
the	  extended	  decay	  kinetics	  of	  NMDAR-­‐mediated	  asEPSCs	  prohibit	  distinguishing	  separate	  
events,	  then	  an	  alternative	  strategy	  is	  required.	  One	  possible	  solution	  involves	  evoking	  NMDAR	  
EPSCs	  at	  single	  spines	  via	  optogenetic	  input	  stimulation	  (MacAskill	  et	  al.,	  2014)	  and	  
pharmacologically	  isolating	  the	  NMDAR	  component	  of	  these	  EPSCs	  (Bock	  et	  al.,	  2013).	  Although	  
measuring	  NMDAR	  endocytosis	  in	  defined	  synapses	  is	  relatively	  challenging,	  assessing	  the	  
contribution	  of	  NMDAR	  endocytosis	  to	  AMPA:NMDA	  ratio	  increase	  can	  be	  accomplished	  
pharmacologically	  using	  a	  calcineurin	  inhibitor	  (e.g.	  cyclosporine).	  Calcineurin	  is	  necessary	  for	  
both	  NMDAR	  endocytosis	  and	  the	  corresponding	  spine	  shrinkage	  (Wang	  et	  al.,	  2007),	  and	  
inhibiting	  calcineurin	  should	  simultaneously	  attenuate	  AMPA:NMDA	  ratio	  increase	  and	  unmask	  
spine	  enlargement	  during	  refraining	  tSP.	  
	  
Simultaneous	  AMPAR	  insertion	  and	  NMDAR	  endocytosis	  during	  refraining	  tSP	  has	  implications	  
for	  refraining.	  AMPARs	  suppress	  appetitive	  behavior	  and	  NMDARs	  promote	  appetitive	  behavior	  
(Reynolds	  and	  Berridge,	  2003),	  and	  the	  simultaneous	  adaptations	  hypothesized	  here	  might	  thus	  
both	  drive	  refraining.	  The	  use	  of	  MSX-­‐3	  in	  our	  experiments	  likely	  prevents	  AMPAR	  insertion	  but	  
not	  NMDAR	  endocytosis,	  which	  should	  partly	  attenuate	  AMPA:NMDA	  ratio	  increases	  and	  lead	  
to	  spine	  shrinkage	  (and	  a	  similar	  result	  should	  occur	  when	  preventing	  GluA2	  trafficking).	  
Conversely,	  calcineurin	  should	  also	  decrease	  refraining.	  The	  capability	  of	  simultaneously	  
inducing	  AMPAR	  insertion	  and	  NMDAR	  endocytosis	  in	  accumbens	  MSNs	  with	  a	  single	  
stimulation	  protocol	  should	  further	  contribute	  to	  the	  discovery	  of	  additional	  signaling	  
mechanisms	  (Kombian	  and	  Malenka,	  1994),	  which	  can	  then	  be	  targeted	  during	  refraining.	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In	  summary,	  I	  have	  characterized	  in	  these	  experiments	  a	  novel	  form	  of	  metaplasticity,	  induced	  
by	  extinction,	  that	  enables	  environmental	  cues	  to	  synaptically	  potentiate	  D2-­‐MSNs	  in	  vivo	  and	  
thereby	  suppress	  drug	  seeking.	  Future	  studies	  will	  determine	  the	  mechanism	  by	  which	  this	  D2-­‐
MSN	  metaplasticity	  occurs,	  which	  may	  thereby	  lead	  to	  new	  therapies	  for	  treating	  addiction.	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